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Abstract 
Introduction: Hyperlipidemia is a medical condition characterized by an elevation of any or all 
lipid profile and/or lipoprotein in the blood, Exposure to Hyperlipidemia in all ages makes our 
health in risk for cardiovascular disease, cancer, diabetes mellitus, hypertension, and other diseases, 
which are considered the main causes of morbidity and mortality in the world.     
Objective: The aim of this study is to determine the prevalence and determinants of hyperlipidemia 
among blood donors in the MoH hospitals among Gaza governorates. 
Method: A cross sectional study was carried out among 379 males blood donors selected 
proportionally according to the total population in the five governorates of the Gaza Strip with age 
range between 20 - 50 years. Blood donors underwent an interviewed questionnaire regarding 
socio-demographic information, their medical history, family history, physical activity, smoking 
status, diet intake, and diet habits. Weight, height, waist circumferences, and blood pressure 
measurements were reported. Furthermore, blood samples from the participants were collected 
after fasting 12 - 14 hours for assessing the lipid profile. 
Results: The prevalence of hypercholesterolemia, and hypertriglyceridemia was 22.7%, and 41.2% 
respectively. Low High Density Lipoprotein showed a prevalence of 11.9% and high Low Density 
Lipoprotein of 17%. The prevalence of Total Cholesterol, Triglyceride, low High Density 
Lipoprotein, and high Low Density Lipoprotein increased with age, marital status, Body Mass 
Index (BMI), and Waist Circumferences (WC), the relationships reached High statistical significant 
level (P<0.001). Lipid profile was increased in the individuals with positive family history of 
diabetes and obesity. Total Cholesterol and low High Density Lipoprotein were increased among 
individuals who consumed sweets, salty snacks, and fried food (P<0.05), while Triglyceride levels 
increased among participants who consumed salty snacks and meat, Low Density Lipoprotein 
levels decreased with consuming juice. Total Cholesterol, Triglyceride, and low High Density 
Lipoprotein levels were high in the serum of past smoking individuals. Total Cholesterol and Low 
Density Lipoprotein levels were low among the participants with high physical activity. Also there 
was statistically significant relationship between Total Cholesterol, Triglyceride, low High Density 
Lipoprotein levels and diastolic blood pressure (P<0.05). 
Conclusion: This study reveals that high prevalence of hyperlipidemia, hypertriglyceridemia, and 
hypercholesterolemia were found. Hyperlipidemia is associated with non-modifiable determinants 
as age, marital status, and family history and group of modifiable variables as obesity, lack of 
physical activity, and smoking. Interventions to control modifiable determinants can reduce risk for 
hyperlipidemia and subsequently minimize associated morbidity and mortality.  
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Chapter 1: 
Introduction 
1.1 Backgrounds   
Hyperlipidemia is a medical condition characterized by an elevation of any or all lipid 
profile and/or lipoprotein in the blood. It is divided into two subtypes familial 
Hyperlipidemia, also called primary and caused by specific genetic abnormalities, and 
acquired, also called secondary which is resulting from another underlying disorder that 
leads to alterations in plasma lipid and lipoprotein metabolism (Farooq, 2013). American 
heart association defined hyperlipidemia as high level of fats in the blood (Hassan, 2013). 
These fats, called lipids include Cholesterol and Triglycerides. There are different types of 
hyperlipidemia depending on which lipid levels are high in the blood. First is 
Hypercholesterolemia, in which there is a high-level of Cholesterol and the second is 
Hypertriglyceridemia, in which there is a high-level of Triglycerides, the most common fat 
form. In addition, hyperlipidemia may be idiopathic, that is without known cause. The fat-
protein complexes in the blood are called lipoproteins. The best-known lipoproteins are 
Low-Density Lipoprotein (LDL) and High-Density Lipoprotein (HDL). Excess of Low 
Density Lipoprotein Cholesterol contributes to the blockage of arteries, which eventually 
leads to heart attack (Nirosha et al., 2014).  
 
Globally, a third cause of ischemic heart disease is attributable to High Cholesterol level, 
raised Cholesterol is estimated to cause 2.6 million deaths (4.5% of total deaths) and 29.7 
million disabilities, the global prevalence of raised Total Cholesterol among adults in 2008  
was 39%, 37% for males, and 40% for female (WHO, 2008). Prevalence of 
Hypercholesteremia in Egypt, Jordan, and Iraq was estimated: 39%, 48.8%, and 44% 
among adults (Musaiger & Al-Hazzaa, 2012). On the other side, many factors that cause 
hyperlipidemia, like hereditary factors, a diet high in saturated fat and cholesterol increases 
blood cholesterol and triglyceride levels, diabetes mellitus, kidney disease, and 
hypothyroidism (Navar-Boggan et al., 2015). Certain drugs, such as estrogen, 
corticosteroids, retinoid, protease inhibitors, thiazide diuretics, and beta-blockers, may 
cause hypertriglyceridemia (Herink & Ito, 2015). Obesity, chronic, excessive alcohol use 
increases the risk of hypertriglyceridemia. Smoking and lack exercising may lead to 
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hyperlipidemia (Perk et al., 2012). Some of these determinants are not modifiable like 
hereditary factors but others can be modifiable and preventable. 
Blood donors are considered an important group in our country and they represent the 
healthy population. In our study, we try to identify the main determinants of 
hyperlipidemia among blood donors in Gaza Strip, which is considered the main cause of 
cardiovascular, coronary heart, and cerebrovascular disease.  
1.2 Research problem 
In the recent decades, Non Communicable diseases (NCDs), which called also chronic 
diseases, had been become the primary causes of mortality and morbidity for women and 
men in the world. According to Palestinian Ministry of Health, (2014) the 10 leading cause 
of deaths in West Bank was Cardiovascular diseases 29.5%, Cancer deaths 14.2%, 
Cerebrovascular diseases 11.3%, Diabetes mellitus 8.9%, Respiratory system diseases 
5.4%, Prenatal Period Conditions 5.2%, Accidents 5%, Renal failure 3.9%, Infectious 
disease 3.3% and Senility 3.1%. Most of the NCDs like Cardiovascular, Cancer, 
Cerebrovascular, Diabetes Mellitus, and Hypertension are associated with Hyperlipidemia, 
There is no data available about Hyperlipidemia among healthy population in Gaza Strip, 
and we are not familiar with the variation of hyperlipidemia among the population in Gaza 
Strip. Blood donors reflect healthy population in Gaza, we will try to identify the 
prevalence and main determinants of Hyperlipidemia among these blood donors, this will 
help in putting plans in the future by decision makers to control Hyperlipidemia which is 
strong associated with NCDs. 
1.3 Justification  
Exposure to hyperlipidemia in all ages makes our health in risk for cardiovascular disease, 
cancer, diabetes mellitus, hypertension, and other diseases, which are considered the main 
causes of morbidity and mortality in the world. Hyperlipidemia is caused by several 
factors; most of them are preventable factors, so we need to conduct this study on the 
healthy population in Gaza Strip Governorates to identify the prevalence and determinants 
of hyperlipidemia. This will help to focus on the preventable factors to avoid 
Hyperlipidemia and this will help in future other researchers and decision makers to 
improve their programs and plans to prevent Hyperlipidemia and avoiding several diseases, 
which play the major causes of death in Gaza Strip. 
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1.4 General objective 
Measuring of the prevalence and determinants of hyperlipidemia among blood donors in 
Gaza Strip 
1.5 Specific objectives 
1. To identify the prevalence of hyperlipidemia among blood donors in Gaza 
governorates 
2. To identify the relationship between hyperlipidemia and sociodemographic factors  
3. To verify the relationship between hyperlipidemia and lifestyle 
4. To examine the relationship between hyperlipidemia and morbidity 
5. To examine the relationship between hyperlipidemia and obesity 
6. To examine the relationship between hyperlipidemia and family history 
1.6 Study context 
1.6.1 Demography and socioeconomic context: 
Gaza Strip is located in the Middle East at (31°25ʹN, 34°20ʹE), on the eastern coast of the 
Mediterranean Sea, to the north of Egypt and the west southern edge of Palestine. It is 
approximately 41 km long, and between 6 and 12 km wide, with a total area of 362
 
km
2
 
(Arnon, 2007) . The Gaza Strip has an arid climate, with mild winters, and dry, hot 
summers subject to drought. Environmental problems include decertification; salinity of 
fresh water; sewage treatment; water-borne disease; soil degradation; and depletion and 
contamination of underground water resources.  
The total population of Palestine at mid of 2015 was about 4.68 million, 2.38 million males 
and 2.3 million females. The estimated population of the Gaza Strip totaled 1.82 million of 
which 925 thousand males and 895 thousand females (PCBS, 2015). 
The economic situation in the SoP is a complex problem as the economy has been 
deteriorating especially in the GS. The ongoing deterioration economic situation in the GS 
lead to rise in the unemployment rate to 44% in 2013 and to increase in the poverty rate to 
unprecedented level. In 2013, 80% of households live under the poverty line (UNRWA, 
2015). 
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1.6.2 Health status context 
The population in Palestine is in epidemiologic transition, with the burden of the no 
communicable disease rising. In 2014, heart disease was the leading cause of death in the 
West Bank, causing 31.2% of all reported deaths (PHIC, 2014). Cancers when combined 
together were the second leading cause of death, accounting for 14.2% of reported deaths, 
followed by cerebrovascular disease (11.3%), diabetes mellitus (8.9%) and infant diseases 
and prenatal conditions (5.2%). This disease burden has contributed to the increasing in 
costs in the health sector and necessitates a greater focus on health prevention and 
integrated disease management. In spite of the protracted crisis and as noted by the 
Palestinian Ministry of health with the support of the international community, 
achievements have been made in relation to some health indicators in recent years although 
they compare negatively to health indicators in Israel. In 2014 and according to Palestinian 
Health Information Centre PHIC (2014), life expectancy was 71.3 years for men and 74.1 
years for women, under-5 mortality rate dropped to 14.9, and infant mortality rate 
decreased to 12.6 per 1000 live births. Vaccination coverage is close to 100%, women 
receive antenatal care, and 99.7% of registered newborns are delivered in hospitals. 
Communicable diseases are under control. The Gaza Strip experienced an outbreak mumps 
since April 2013, which has continued to spread at an increasing rate. In addition, viral 
meningitis outbreak, started in March 2014 and has continued to spread but at a decreasing 
rate. The incidence of tuberculosis is lower than in the surrounding countries and the 
Palestinian territory is poliomyelitis free (Palestinian National Institute of Public Health. 
Vaccine preventable diseases in Palestine & Health, 2014). In the Gaza Strip, more than 
6000 people with disabilities and injuries that require rehabilitation are particularly 
vulnerable. According to the WHO estimates of up to 20% as the prevalence rate for 
mental disorders among emergency affected population, up to 360 000 people could be 
suffering psychological trauma and would need interventions. These numbers may 
underestimate the real burden of disease in Gaza Strip.   
1.6.3 Health services 
The ministry of health provides health services to Palestinians under its jurisdiction in 
accordance with the Palestinian Basic Low, which serves the interim constitutions, and the 
Public Health Low. Ministry of Health (MoH), UNRWA, Nongovernmental Organizations 
(NGOs) and the private sector, delivers health services in Gaza strip. The Ministry of 
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Health  is responsible for the largest network of facilities, with 472 (PHCCs, 418 in the 
West Bank and 54 in Gaza Strip) and 26 hospitals (13 in the West Bank and 13 in Gaza 
Strip) with 2857 beds in the WB and GS (PHIC, 2014). Nongovernmental organizations play 
an important role in service delivery, especially in providing tertiary, ambulatory, and rehabilitative 
care services. In 2014, Nongovernmental Organizations operated 137 PHC centers (129 in the West 
Bank and 8 in Gaza Strip) and 34 hospitals (20 in the West Bank and 14 in Gaza Strip), supplying 
about one-third of bed availability, in the occupied Palestinian territory. They are important 
providers especially for mental health counseling, physical therapy, and rehabilitation. 
UNRWA provides services mainly through fixed and mobile primary health care clinics, as 
well as contracted hospitals to registered refugees: to 727 471 people in the West Bank 
through 42 primary health centers and one hospital, and to 1 167 572 people in Gaza Strip 
through  22 primary health centers and about 74% of eligible refugees utilized UNRWA‘s health 
services in 2014 (UNRWA, 2014). 
The private health sector is growing; in 2014 there were 16 private hospitals, supplying 8.6% of 
bed capacity, as well as pharmacies, laboratories and rehabilitation centers. A pharmaceutical 
industry has also developed, which is able to supply about one half of total Palestinian demand 
for prescription medicine (PHIC, 2014). 
The Ministry of Interior runs 23 primary health care clinics and three hospitals for military 
employees, but not their families. 
The surveillance system for communicable diseases in the occupied Palestinian territory is robust 
and well established. The Central Public Health Laboratory in Ramallah and its affiliate in Gaza 
Strip conduct public health related investigations concerning water and food safety, vector and 
waste control. In spite of the diverse access barriers within the occupied Palestinian territory, 
delays of transporting samples were reported as rare occurrences. A lack of reagents, some 
laboratory capacity and training opportunities was noted, however. 
Emergency medical services are transitioning gradually to a system whereby all ambulances 
(including from private providers) will be registered with the Ministry of Health and coordinated 
by the Palestinian Red Crescent Society (PRCS), which is the main ambulance provider with 144 
ambulances, 27 centers and sub-centers, two training institutes and about 350 employees. One 
ambulance center with three types of ambulances (for emergency transport, patient transportation 
and for dead bodies) per 30 000 inhabitants is planned. A fixed fee per kilometer will be charged to 
the patients. 
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1.6.4 Blood Donation 
1.6.4.1 Importance and uses of Blood transfusion 
Blood transfusion is an essential component of health care, which saves millions of lives 
each year. Every second, someone in the world needs blood for surgery, trauma, severe 
anaemia or complications of pregnancy/delivery (WHO, 2008).  
World Health Organization (WHO) gives high priority to availability of adequate safe 
blood throughout the world. Realizing its universal importance, the theme of the WHO 
Day for the year 2000 and then for the year 2007 was dedicated to safe blood with thought 
provoking slogan of "Safe blood starts with me. Blood saves life. Safe blood starts with the 
donor security" (Sujatha, 2007) with great emphasis on safe blood for sick, injured and 
also safe motherhood.  
The highest ratios of blood transfusions apply to hospitals with more specialized needs as 
complex surgical procedures, such as cardiac surgery (4 units at least per each patient). 
Blood is universally required for the management of patients suffering from cancer, 
kidney diseases and blood diseases such as Aplastic anaemia, Thalassaemia (around 300 
patients in Gaza), sickle cell disease, haemophilia (around 100 patients in Gaza) severe 
iron deficiency anaemia and leukaemia (Hamad, 2010). However, the pattern of blood 
usage differs markedly across the globe. In developed countries, transfusion is most 
commonly used to support advanced medical and surgical procedures, including trauma, 
cardiovascular surgery, neurosurgery, and transplantation. In countries where diagnostic 
and treatment options are limited, a much greater proportion of blood is used to treat 
women with obstetric emergencies and children suffering from severe anaemia, often 
resulting from malaria and malnutrition. Globally, more than half a million women die 
each year during pregnancy, childbirth or in the postpartum period – 99% of them in the 
developing world (WHO, 2008). About 25% of those deaths are caused by severe bleeding 
during childbirth, making this the most common cause of maternal mortality (WHO, 
2008). 
1.6.4.2 Needs for blood donation 
While the need for blood is universal, millions of patients requiring transfusion do not have 
timely access to safe blood and there is a major imbalance between developing and 
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industrialized countries in access to safe blood. Of the estimated 80 million units of blood 
donated annually worldwide, less than 45% is collected in developing countries, home to 
80% of the world‘s population (WHO, 2008). The average number of blood donations per 
1,000 population is 10 times higher in high-income countries than in low-income countries. 
Developed countries use approximately one unit of RBCs for every 20 members of their 
population every year (around 5% of the population donate). Thus, the US with a 
population of 280 million, collects approximately 14 million units of RBCs each year and 
in Britain with 60 million, approximately 3 million. Almost all of this blood is used locally 
to provide routine medical care and treat victims of injury. Disasters and war both create 
additional injury victims in need of blood and remove individuals from the donor 
population (Hess and Thomas, 2003). Whole blood donors may donate every 56 days 
while plasma donors may donate twice a week. Platelets donors may donate a maximum of 
24 times per year. Other specialized donations are subject to other rules (WHO, 2008). 
Hess and Thomas, (2003) reported disasters and war also increase the inefficiencies in a 
blood supply system. Supplying the US force in Bosnia with RBCs for five years from 
1995 to 2000 required approximately 5600 units to ensure that the 79 units actually used 
were available when needed. 
Blood Banks/centers are responsible about organizing the blood service, recruitment of 
donors, collection, processing, storage and distribution of blood and blood components, in 
addition operate laboratory investigations, participation in clinical use of blood and blood 
components, teaching and training, finally research and development (National  AIDS  
Control  Organization-India -NACO,  2007). However, blood collection can be done either 
at a static donor session at the blood center or at outdoor mobile donor sessions. In 
addition, to guidelines for indoor collection of blood, standard operating procedures should 
also be provided for outdoor donor sessions, which should be monitored (WHO, 2008). 
Outdoor collections organized at crowded places, in open grounds, gardens and other 
places with unclean environment, may lead to contamination of blood, and should therefore 
be discouraged. 
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1.6.4.3 Types of blood donors 
 Voluntary Blood Donor (Non-Remunerated) 
A person who gives blood, plasma or other blood components of his, her own free will 
and does not receive payment for it, either cash or kind which could be considered a 
substitute for money, this includes time off work (WHO, 2008). 
 Regular voluntary donor 
A voluntary non-remunerated blood donor who donates blood on a regular basis 
without any break for a longer duration between two donations or a voluntary non-
remunerated blood donor who has donated at least three times, the last year and continues 
to donate regularly at least once per year (NACO, 2007). 
 Family Replacement Blood Donor 
A family replacement donor is one who gives blood when a member of his, her family 
or community requires it (NACO, 2007). A member of the family or a friend of the 
patient who donates blood in replacement of blood needed for the particular patient 
without involvement of any monetary or other benefits from any source (Sujatha, 2007). 
 Paid professional Blood Donor 
A donor whose donates blood in exchange of money or other form of payment (NACO, 
2007). 
 Forced Blood Donor 
A person who is not willing to donate blood on his, her own but is being forced by their 
superiors or employer for donation, there is always a fear of losing one's own job or 
promotion (Sujatha, 2007). 
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 Autologous Blood Donor 
A patient who donates his/her blood to be stored and rein fused, if needed during 
surgery to avoid or reduce the need for an allergenic blood transfusion. The patient 
themselves acts as a blood donor (NACO, 2007). 
 Aphaeresis' Donor 
A donor who donates only one of their blood components through the process of cell 
separation this donor may be either voluntary or replacement donor (Sujatha, 20007). Life-
saving resource of blood from donors to recipients, blood is a unique resource in that it 
is supplied through volunteer donors (Cant, 2006). Donate blood save a life (NACO, 
2007).  
Cant (2006) wrote blood is not something that can be manufactured or produced by 
machines. It must be given by healthy, charitable adults who are willing to donate 
their own blood for the use of complete. 
1.6.4.4 Blood Bank Services in Gaza 
In Gaza, the need for blood donation is increasing not only for ordinary cases such as 
delivery, operations, anaemia, chronic diseases, and so on but also to save patients injured 
from the political conflicts, internal division and un-intentional injuries. Both MoH and 
other sectors offer Blood bank services inside major hospitals. Each governorate in Gaza 
is almost self-sufficient of blood with few exchanges among them. In the Gaza Strip, 
there are 7 Blood banks within hospitals; six belong to MOH and one to an NGO's facility. 
In addition, MOH laboratories and Blood Bank Directorate is responsible for the overall 
blood transfusion services. The NGO's Blood banks are working under the MOH technical 
supervision (MOH, 2009). 
MOH owns and operates 10 hospitals in Gaza Strip, which mostly receive victims and 
injured and also treat complicated cases which require sophisticated care including blood 
transfusions. MOH hospitals provide blood units to other NGOs such as Al-Awda, El 
Salam and Ahli Arab Hospitals. Also, people with bleeding tendencies such as 
Haemophilia (around 100 patients in Gaza) and Thalassaemia (around 300 patients in 
Gaza) are treated within the MOH hospitals.   MOH reports indicate that the annual use of 
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blood in the Gaza Strip is around 35,000 units; more than 60% of these units are provided 
through family replacement (MOH, 2009). 
A study conducted in 2009 to evaluate the blood bank services during the OCL revealed 
that health providers reported that stocks and consumables ran out during the war, 
screening kits ran out as reported by 46% of lab staff, 16% reported that blood bags ran 
out (Abu Zanada, 2010). Additionally, 9% reported lack of blood group typing reagents, 
and 24% reported lack of alcohol. More importantly, 26% reported experiencing shortages 
of blood units needed for rescuing victims. 39% reported shortages in O- Negative (O-ve) 
blood units, 34% reported shortages of fresh frozen plasma, and 28% faced shortages of 
cryoprecipitate during the war. In addition, 72% reported shortages of items needed for 
separating blood components (Abu Zanada, 2010). 
According to the same study, 68.8% of the blood bank director's reported absence of 
national guidelines on donation and transportation of blood and blood products, no 
national guidelines on storage of blood and blood components were available. Regarding 
hazardous wastes disposable, 34% discarded wastes into the sewage system, 33%-
discarded wastes with other domestic wastes (general wastes) and 21% discarded liquids in 
the sink.  
90% of blood bank managers and staff reported inadequacy of the donation areas. 
Regarding blood donation chairs, 10% of blood bank staff reported not having any 
donation chairs, and 87% disagreed that the number of donation chairs were sufficient for 
working during crises (Abu Zanada, 2010). 
The increased number of injuries has resulted in increasing the demand for the blood units, 
and managers compensated that by volunteers donation (93.8%), 37.5% by camping 
during the war, 75% were supplied by other local blood banks, 31.3% had encouraged 
volunteers inside hospitals to donate during the war. In addition, 87.5% received blood 
units from regional countries particularly from Egypt, Jordan, Saudi Arabia, Turkey and 
Lebanon.  Donations from charity organizations including MAP and Arab countries beside 
the blood included; disposable (64.3%), blood bags (35.7%) reagents (28.6%) as reported 
by Abu Zanada (2010). 
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The Central Blood Bank Society in Gaza has been established in 1971 with the aim of 
ensuring the availability of blood units and its derivatives to the needy population. The 
CBBS succeeded in its fight to compact blood trade (Remunerated professional blood 
donors) which was common phenomenon in Gaza in sixties and seventies. CBBS also 
increases awareness of the local population about the importance of blood donations. So 
far, CBBS is regarded as a key player for the supply of hospitals with blood units and 
works with all providers regardless of their affiliation, sector, and status. The organization 
operates through its three offices located in Gaza Strip as follows; Gaza centre (the main 
office), Khanyounis centre and Rafah centre. Each year, around 7000-8000 blood units are 
dealt with at the CBBS (CBBS records). CBBS contributed to saving the life of tens of 
thousands of sick and injured. Around 20 persons work as full timers in CBBS plus many 
volunteers among them, 16 are laboratory technicians. Historically, the organization is 
recognized as a well-respected delivering high quality blood donation services to all the 
people of the Gaza Strip. Recently, the organization developed an electronic database 
record of blood donations and for rare blood groups (Hamad, 2010). 
According to Palestinian ministry of health there are 26 blood banks in Palestine (WB: 
19/GS: 7). Seven B.B. belong to MoH, twelve to NGOs and private hospitals in west bank 
(WB). While, in Gaza Governorates (GG) there are one belongs to NGOs facility (the 
central B.B. Society with two branches is only NGOs blood bank) and other blood banks 
to MoH. Services of B.B. are mostly hospital based. Each governorate is almost self 
sufficient of blood and blood products with minimal exchange among them. In Palestine 
MoH laboratories and B.B. directorates is responsible for overall blood transfusion 
services. Private and NGOs B.B. are supervised by MoH and follow the same regulations 
and rules as MoH blood banks do (Abu-Zinada, 2010). The total number of blood donors 
was 42 406, of whom 30.7% were voluntary donors, while 69.3% donated blood to a 
relative or friend. Laboratory tests for blood-borne diseases are carried out on all units of 
donated blood prior to transfusion (MoH, 2013).  
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1.7 Operational definitions 
Hypercholesterolemia 
Cholesterol is a fat-like substance produced by our bodies and found only in food of 
animal origin. Our tissues make 75% of the cholesterol in our bodies. The rest comes from 
the foods we eat. A total cholesterol level of less than 200 mg/dl is normal, a total 
cholesterol level of 200 to 239 mg/dl is borderline high, and if a total cholesterol level 
greater than or equal to 240 mg/dl is high (Williams, 2002). 
 
Hypertriglyceridemia 
Triglycerides are also fatty substances found in your bloodstream, coming from food and 
liver, Triglyceride levels are divided as follows: Normal is less than 150 mg/dl, borderline 
high 150 to 199 mg/dl, high level 200 to 499 mg/dl, and very high greater than 500 mg/dl 
(Williams, 2002). 
 
High Density Lipoprotein (HDL) 
Lipoproteins are combination of fats and proteins, and they are the form in which lipids are 
transported in the blood, HDL transports cholesterol from tissue of the body to the liver, a 
level greater than or equal to 60 mg/dl is excellent, while levels of HDL cholesterol less 
than 40 mg/dl are lower than desired (Williams, 2002). 
 
Low Density Lipoprotein (LDL) 
 
Lipoproteins, which are combination of fats and proteins, are the form in which lipids are 
transported in the blood. LDL transports the cholesterol from the liver to the tissue of the 
body, and good levels are <130 mg / dl (Grundy et al., 2004). 
 
Hypertension (HTN)  
Hypertension is defined as any individuals who have a blood pressure reading equal or 
greater than 140/90 or who has reported by a physician that have hypertension (Perk, et al., 
2012).  
 
Smoker 
According to CDC, smoker defined as anyone who smoked 100 cigarettes in their lifetime 
and currently smokes cigarettes every day or some days (CDC, 2010).  
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Never smoker 
According to CDC, never smoker defined as anyone who never smoked a cigarette or who 
smoked fewer than 100 cigarettes in their entire lifetime (CDC, 2010). 
 
Body mass index (BMI) 
Body mass index (BMI) is a measure of body fat based on height and weight that applies to 
adult men and women; it can be derived from the formula: 
BMI= weight (kg)/height
2
(m
2
), Normal BMI range: 18.5 kg/m
2
 - 25 kg/m
2
 (Barba, et al., 
2004). 
 
Obesity 
Obesity is defined as any individuals who have a BMI equal or greater than 30 kg/m
2
  
 (CDC, 2011).  
 
Overweight 
Over weight defined in this study as any individuals who have a BMI between 25 and 29.9 
kg/m
2
 (CDC, 2011). 
 
Normal weight 
Normal weight defined in this study as any individuals who have a BMI between 18.5 and 
24.9 kg/m
2
 (CDC, 2011).  
 
Waist circumferences (WC) 
According to the National Institution of health (NIH) protocol, WC measurement is taken 
at the level of the superior border of the iliac crest and parallel to the floor (NIH, 2006). 
Cut off was ≥ 94 cm. 
 
Physical activity 
It's defined as any body movement produced by skeletal muscles and require energy 
expenditure (WHO, 2009). It's classified as vigorous, moderate, light activity or in active 
(Al Asadi, 2010)  
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2 Chapter 2:  
Literature Review 
 
Hyperlipidemia poses one of the greatest public health problems for the 21st century, with 
particularly alarming trends in several parts of the world.  
This chapter starts with the explanation of the conceptual framework of the study. 
Definitions classification and consequences of hyperlipidemia are presented. Then 
prevalence of hyperlipidemia internationally and in some Arabic regions is also discussed. 
Moreover, the determinants associated with hyperlipidemia are explained based on the 
review of the related literature.  
 
  
Figure (‎2.1): The Study Conceptual Framework 
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2.1 Conceptual framework 
The researcher constructed the conceptual framework that addresses the major aspects of 
the study after reviewing the available literature about the concept under investigation. 
The researcher described the most common factors that could be associated with 
hyperlipidemia and select some of these determinants, which may affect hyperlipidemia in 
the community such as socio demographic factors, life style factors include smoking, 
nutrition, and physical activity; also, we have obesity, family history, and morbidity.  
 Socio demographic variables 
Several studies highlight the associations between socio demographic factors and 
hypercholesterolemia as a risk factor of cardiovascular disease these sociodemographic 
factors refer to age, sex, place of residence, religion, educational level, marital status, and 
total income (Ghazali et al., 2015).  
 Life style variables 
The available information comes from too many studies illustrated that hyperlipidemia 
patients can lower their lipid profile by changing their life style, which includes physical 
activity, smoking, and nutrition (Mannu et al., 2013). 
 Obesity variables 
Obesity is commonly associated with hyperlipidemia based on clinical and epidemiological 
studies (Sullivan et al., 2008). Obesity here is expressed with body mass index and waist 
circumferences. 
 Family history variables 
Family members share genes, behaviors, lifestyles, and environments that can influence 
their health and their risk for disease. High cholesterol can run in a family, and risk for 
high cholesterol can increase (CDC, 2014).  
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 Morbidity variables 
Morbidity is defined as the incidence of disease, many studies explained that 
hyperlipidemia could be resulted from several diseases like thyroid disorders, liver disease, 
diabetes, and genetic disorders (Jin & Teng, 2014).  
2.2 Hyperlipidemia: 
Hyperlipidemia is a medical condition characterized by an elevation of any or all lipid 
profiles and/or lipoproteins in the blood (Farooq et al., 2013). Lipid profiles are the levels 
of serum triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol 
(HDL-C), low density lipoprotein cholesterol (LDL-C) and very low density lipoprotein 
cholesterol (Agrawal et al., 2015). 
2.2.1 Definition of Hyperlipidemia 
Hyperlipidemia is defined as elevations of fasting total cholesterol concentration, which 
may or may not be associated with elevated TG concentration. However, lipids are not 
soluble in plasma, but are instead transported in particles known lipoproteins (Sheeler, 
2013). Hyperlipidemia is characterized with elevated lipids in the blood; this condition is 
also called hypercholesterolemia and hyperlipoproteinemia (Gupta et al., 2011). According 
to Zenni, (2013) Hyperlipidemia is characterized by an excess of lipids in the blood, these 
lipids include cholesterol, cholesterol esters, phospholipids, and triglycerides. Lipids are 
transported in the blood as large lipoproteins, including five major classes, based on 
density: Chylomicrons, Very Low-Density Lipoproteins (VLDL), Intermediate-Density 
Lipoproteins (IDL), Low-Density Lipoproteins (LDL), and High-Density Lipoproteins 
(HDL). Most triglyceride is transported in Chylomicrons or VLDL, and most cholesterol is 
carried in LDL and HDL. 
Atherogenic dyslipidemia characterized by abnormal changes in lipid profile, a study was 
conducted in Turkey to evaluate the levels of lipid profile and (EMC) which is erythrocyte 
membrane cholesterol content (Uydu et al., 2014), the researcher compared these markers 
in normal and dyslipidemic subjects; in order to investigate whether (EMC) is a useful 
marker to predict atherogenic dyslipidemia. Finally, he concluded that (EMC) and TG are 
useful markers to predict small-dense LDL in hypercholestrolemic patients. 
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2.2.2 Classification of hyperlipidemia   
Hyperlipidemia is divided into primary hyperlipidemia caused by genetic factors, and 
secondary hyperlipidemia may result from diseases such as diabetes, thyroid disease, renal 
disorders, liver disorders, and Cushing's syndrome, as well as obesity, alcohol 
consumption, estrogen administration, and other drug-associated changes in lipid 
metabolism. Hyperlipidemia is a major, modifiable risk factor for atherosclerosis and 
cardiovascular disease, including coronary heart disease; this is true both of disorders 
involving hypercholesterolemia and hypertriglyceridemia. Although hyperlipidemia does 
not cause symptoms, it can significantly increase your risk of developing cardiovascular 
disease, including disease of blood vessels supplying the heart (coronary artery disease), 
brain (cerebrovascular disease), and limbs (peripheral vascular disease). These conditions 
lead to chest pain, heart attacks, strokes, and other problems (Rosenson, 2015).  
2.2.3 Causes of hyperlipidemia 
Causes of hyperlipidemia may include excessive drinking of alcohol, side effects of 
medications such as hormones or steroids, diabetes, kidney disease, underactive thyroid 
gland, and pregnancy (Davis, 2015). Beside this, several factors can make patients more 
likely to develop hyperlipidemia, including a diet high in saturated fats and cholesterol; 
family history; being overweight or obese; and getting older. Increasing of cholesterol 
level may lead to a buildup of plaque inside the arteries known as atherosclerosis; this 
condition narrows the space available for blood flow and can trigger heart disease. The 
well established association between lipid concentrations and the risk of cardiovascular 
disease (CVD), the leading cause of death in the United States make the health provider 
more concerned with hyperlipidemia (Hoyert & Xu, 2012).  
Landmark study is an intervention study; the basic of this study depends on lowering 
cholesterol level in order to reduce the risk of cardiovascular morbidity and mortality. The 
medical communities and scientific took several decades to agree that this relation is exists 
(Graversen et al., 2014) and exposure to hyperlipidemia in young adulthood increases the 
risk in future with coronary heart disease. A study was carried out in Iran, Togha et al., 
(2011) to compare lipid profile among three groups of stroke: hemorrhagic group, ischemic 
group, and control one. The study found that age, cholesterol, and low-density lipoprotein 
influenced the risk of developing an ischemic stroke; high triglyceride level has a 
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protective role against hemorrhagic events. Also high lipid profiles influence plasma 
viscosity which is strongly related to common carotid elasticity indexes (Levin, 2006).  
According to study, of Pirih et al. (2012) hyperlipidemia affects bone regeneration and 
mechanical strength, because the increase of lipids from high fat diets influences the risk 
for generation of lipid oxidative products which accumulate in the sub endothelial spaces 
of vasculature and bone, also induces secondary hyperparathyroidism and impairs bone 
regeneration and mechanical strength. Cardiovascular disease CVDs, are the most 
common cause of death worldwide, including (40%) in high-income countries, and (28%) 
in low and middle-income countries (Donelly, 2012).  
According to Palestinian Ministry of Health, cardiovascular diseases are accounting for 
29.5% of total deaths in the west bank (MoH, 2014). The most common manifestation of 
cardiac disease is coronary heart disease (CHD), where the number of deaths resulting 
from ischemic heart disease and hypertensive heart disease in the Middle East and North 
Africa region was 294/100,000 and 115/100,000 respectively. Also, the number of 
Disability-Adjusted Life Years (DALYs) resulting from ischemic and hypertensive heart 
disease is 3702/100,000 and 1389/100,000, respectively, in the same region (Lawes et al., 
2008). 
2.2.4 Hyperlipidemia in the world 
Global variations in the prevalence of elevated cholesterol among patients with history of 
hyperlipidemia are associated with country-level economic development and health system 
indices. These results support the need for strengthening efforts toward effective 
cardiovascular disease prevention and control and may provide insight for health policy 
setting at the national level, no significant associations were found for patients without 
history of hyperlipidemia (Venkitachalam et al., 2012).  
According to global health observatory data a 10% reduction in serum cholesterol in men 
aged 40 has been reported to result in a 50% reduction in heart disease within 5 years; the 
same serum cholesterol reduction for men aged 70 years can result in an average 20% 
reduction in heart disease occurrence in the next 5 years. In Ireland, a 30% reduction in the 
heart disease death rate has been attributed to 4.6% reduction of the population mean for 
total cholesterol. In Finland, 50% of the decline in heart disease mortality has been 
explained by the reduction of cholesterol level among the population, also the prevalence 
of raised total cholesterol increased noticeably according to the income level of the 
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country. In low income, countries around a quarter of adults had raised total cholesterol, in 
lower middle-income countries this rose to around a third of the population for both sexes. 
In high-income countries, over 50% of adults had raised total cholesterol; more than 
double the level of the low-income countries (WHO, 2016). 
According to the (WHO, 2014) Europe has the highest prevalence of high cholesterol in 
the world and with 54% for both men and women. High cholesterol or ‗bad‘ cholesterol 
contributes to 2.6 million deaths per year, worldwide and statistics found that the main 
causes for high cholesterol are both an unhealthy lifestyle and/or genes.  
According to study of Deng, et al., (2012) which was carried out in China with sample size 
1415 individuals aged 22 – 84 years to assess prevalence of hyperlipidemia which was 
(49.3%). A study was conducted in Kuwait republic among the university students with 
sample size 484, and age of 17 – 24 years to determine the prevalence of elevated levels of 
lipid profile and obesity (AlMajed et al., 2011). The researcher findings were, prevalence 
of dyslipidemia, overweight, and obesity were 10.5%, 30.6%, and 19.8% respectively, high 
cholesterol was found in 2.3% of the subjects, and high triglyceride was found in 8.7% of 
them. Also AlMajed et al., (2011) found that waist circumference was found in 41.8% of 
the subjects. The researcher here took his sample from young population so the results 
were lower comparing with other studies using older age.  
A study was conducted in north Jordan, the subjects ages were 25 and more, (Khader et al., 
2010). The study aimed to estimate the prevalence of different types of dyslipidemia and 
their related factors, findings were 48.8% had high TC level, 40.7% had high LDL-C, 
40.1% had low HDL-C, 43.6% had high triglyceride levels, and 75.7% had at least one 
abnormal lipid level. The researcher also found that Age was associated with high 
triglycerides, high LDL-C, and high TC. 
2.2.5 Lipids metabolism 
The two main lipids in the plasma are cholesterol and triglyceride. The primary function of 
TGs is to store energy in adipocytes and muscle cells; cholesterol is a ubiquitous 
constituent of cell membranes, steroids, bile acids, and signaling molecules. Lipids are 
hydrophobic, insoluble in water; require transporting within hydrophilic, spherical 
structures called lipoproteins, which possess surface proteins (apoproteins, or 
apolipoproteins) that are cofactors and ligands for lipid-processing enzymes. The main 
  
20 
 
apolipoproteins, apo B-100/48, apo A-I, apo A-II, apo E, and the apo Cs, are integral 
components. Apo B is a component of all atherogenic lipoproteins (chylomicron remnants, 
VLDL and their remnants, lDL, lipoprotein (a) [Lp(a)] and LDL), whereas apo A-I and apo 
A-II are components of HDL. The apo B-containing lipoproteins and the apo A-I/A-II 
lipoprotein classes are closely interrelated via several metabolic pathways (Chapman et al., 
2011).  
 Exogenous lipid metabolism 
Over 95% of dietary lipids are TGs; the rest are phospholipids, free fatty acids, cholesterol 
(present in foods as esterified cholesterol), and fat-soluble vitamins. Dietary TGs are 
digested in the stomach and duodenum into monoglycerides and free fatty acids by gastric 
lipase, emulsification from vigorous stomach peristalsis, and pancreatic lipase. Dietary 
cholesterol esters are de-esterified into free cholesterol by these same mechanisms. 
Monoglycerides, free fatty acids and free cholesterol are then solubilized in the intestine by 
bile acid micelles, which shuttle them to intestinal villi for absorption. Once absorbed into 
enterocytes, they are reassembled into TGs and packaged with cholesterol into 
chylomicrons, the largest lipoproteins (Goldberg, 2015). 
 Endogenous lipid metabolism 
Lipoproteins synthesized by the liver transport endogenous TGs and cholesterol. 
Lipoproteins circulate through the blood continuously until the TGs they contain are taken 
up by peripheral tissues or the lipoproteins themselves are cleared by the liver. Factors that 
stimulate hepatic lipoprotein synthesis generally lead to elevated plasma cholesterol and 
TG levels (Goldberg, 2015). 
2.2.6 Cholesterol  
Cholesterol is an essential component of cell membranes, brain and nerve cells, and bile, 
which helps the body absorb fats and fat-soluble vitamins. The body uses cholesterol to 
make vitamin D and various hormones, such as estrogen, testosterone, and cortisol. The 
body can produce all the cholesterol that it needs, but it also obtains cholesterol from food. 
A high total cholesterol level can increase your risk of cardiovascular disease. However, 
decisions about when to treat high cholesterol are usually based upon the level of LDL or 
HDL cholesterol, rather than the level of total cholesterol. The total cholesterol level can 
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be measured any time of day. It is not necessary to fast (avoid eating for 12 hours) before 
testing (Miller et al., 2011). A study was conducted to test the hypothesis that elevated 
nonfasting remnant cholesterol is a causal risk factor for ischemic heart disease 
independent of reduced high-density lipoprotein (HDL) cholesterol, suggests that a 1 
mmol/l (39 mg/dl) increase in nonfasting remnant cholesterol is associated with a 2.8-fold 
causal risk for ischemic heart disease, independent of reduced HDL cholesterol (Varbo et 
al., 2013). 
2.2.7 Triglyceride  
Triglycerides, which are contained in fat cells, can be broken down, and then used to 
provide energy for the body‘s metabolic processes, including growth. Triglycerides are 
produced in the intestine and liver from smaller fats called fatty acids. Some types of fatty 
acids are made by the body, but others must be obtained from food (Hallberg et al., 2015). 
Triglyceride is the most common type of fat in the body. Normal triglyceride levels vary 
by age and sex. A high triglyceride level combined with low HDL cholesterol or high LDL 
cholesterol is associated with atherosclerosis, the buildup of fatty deposits in artery walls 
that increases the risk for heart attack and stroke. Triglycerides should be measured after 
fasting for 12 to 14 hours.  
2.2.8 Lipoproteins  
Cholesterol, triglycerides, and high-density lipoproteins are important constituents of the 
lipid fraction of the human body. Cholesterol is an unsaturated alcohol of the steroid 
family of compounds; it is essential for the normal function of all animal cells and is a 
fundamental element of their cell membranes. It is also a precursor of various critical 
substances such as adrenal and gonadal steroid hormones and bile acids. Triglycerides are 
fatty acid esters of glycerol and represent the main lipid component of dietary fat and fat 
depots of animals. Cholesterol and triglycerides, are non-polar lipid substances (insoluble 
in water), need to be transported in the plasma associated with various lipoprotein 
particles. Plasma lipoproteins are separated by hydrated density; electrophretic mobility; 
size; and their relative content of cholesterol, triglycerides, and protein into five major 
classes: chylomicrons, very low-density lipoproteins (VLDL), intermediate-density 
lipoproteins (IDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). 
Since the levels of plasma lipids have a bell-shaped distribution in the general population, 
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the definition of either a high or a low value of these substances has remained an arbitrary 
statistical decision. High values have been traditionally considered as those in the 90th and 
95th percentiles; low values were considered to be those below the 5th percentile.  
The NIH Consensus Conference has recently revised the values concerning cholesterol, 
however, in view of clear evidence of an increased risk of coronary atherosclerosis in 
persons falling in the 75th to 90th percentiles. According to this last statement, cholesterol 
levels below 200 mg/dl are classified as "desirable blood cholesterol," those 200 to 239 
mg/dl as "borderline-high blood cholesterol," and those 240 mg/dl and above as "high 
blood cholesterol" Cholesterol is fat like substance, located in our bodies, the body makes 
75%, and the remain 25% is obtained by food (Clark & Kruse, 1990). Cholesterol is vital 
in our life, because it enters in the cell membrane, helps in the functions of cells, and it is 
essential for making vitamins and hormones, but if it is found in high amounts it will make 
risk for human health and leads to serious diseases and heart attacks (Donelly, 2012). 
Hyperlipidemia is a hidden or silent risk factor because it has no symptoms, one of the 
biggest health burdens on our society today. High concentration of LDL and low 
concentration of HDL are strongly associated with cardiovascular disease because they 
promote atheroma (plaque) formation in arteries, which is atherosclerosis, and this leads to 
myocardial infarction, stroke, and peripheral vascular disease. High levels of LDL and low 
levels of HDL contribute more to this process than total cholesterol levels. LDL are termed 
bad cholesterol because they have been linked to atheroma formation while high 
concentrations of HDL can remove cholesterol from cells and reverse atheroma formation, 
hence it offers protection from atherosclerosis and is referred to as good cholesterol. 
2.2.8.1 Low Density Lipoprotein   
A low LDL cholesterol level is considered good for your heart health. However, your LDL 
number should no longer be the main factor in guiding treatment to prevent heart attack 
and stroke, according to new guidelines from the American Heart Association. For patients 
taking statins, the guidelines say they no longer need to get LDL cholesterol levels down to 
a specific target number. A diet high in saturated and Tran's fats raises LDL cholesterol. 
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2.2.8.2 High Density Lipoprotein   
High-density lipoproteins (HDL) are one of the five major groups of lipoproteins. 
Lipoproteins are complex particles composed of multiple proteins, which transport all fat 
molecules (lipids) around the body within the water outside cells. They are typically 
composed of 80-100 proteins per particle (organized by one, two, or three Apo A; more as 
the particles enlarge picking up and carrying more fat molecules) and transporting up to 
hundreds of fat molecules per particle. Unlike the larger lipoprotein particles, which 
deliver fat molecules to cells, HDL particles remove fat molecules from cells, which need 
to export fat molecules. The fats carried include cholesterol, phospholipids, and 
triglycerides; amounts of each are quite variable. Increasing concentrations of HDL 
particles are strongly associated with decreasing accumulation of atherosclerosis within the 
walls of arteries. This is important because atherosclerosis eventually results in sudden 
plaque ruptures, cardiovascular disease, stroke and other vascular diseases. HDL particles 
are sometimes referred to as "good cholesterol" because they can transport fat molecules 
out of artery walls, reduce macrophage accumulation, and thus help prevent or even 
regress atherosclerosis. However, studies have shown that HDL-lacking mice still have the 
ability to transport cholesterol to bile, suggesting that there are alternative mechanisms for 
cholesterol removal (Sheeler, 2013).  
HDL is the smallest of the lipoprotein particles. It is the densest because it contains the 
highest proportion of protein to lipids. Its most abundant apolipoproteins are apo A-I and 
apo A-II (Zenni, 2013). The liver synthesizes these lipoproteins as complexes of 
apolipoproteins and phospholipid, which resemble cholesterol-free flattened spherical 
lipoprotein particles; the complexes are capable of picking up cholesterol, carried 
internally, from cells by interaction with the ATP-binding cassette transporter A1(Aljefree 
& Ahmed, 2015). A plasma enzyme called lecithin-cholesterol acyltransferase converts the 
free cholesterol into cholesteryl ester (a more hydrophobic form of cholesterol), which is 
then sequestered into the core of the lipoprotein particle, eventually causing the newly 
synthesized HDL to assume a spherical shape. HDL particles increase in size as they 
circulate through the bloodstream and incorporate more cholesterol and phospholipid 
molecules from cells and other lipoproteins. With HDL cholesterol, higher levels are 
better. Low HDL cholesterol puts you at higher risk for heart disease. People with high 
blood triglycerides usually also have lower HDL cholesterol. Genetic factors, type 2 
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diabetes, smoking, being overweight, and being sedentary can all result in lower HDL 
cholesterol. Similar to total cholesterol, the HDL-cholesterol can be measured on any 
blood specimen. It is not necessary to be fasting. 
2.2.8.3 VLDL 
Very-low-density lipoprotein (VLDL) is a type of lipoprotein made by the liver.
 
VLDL is 
one of the five major groups of lipoproteins that enable fats and cholesterol to move within 
the water-based solution of the bloodstream (Fauci A, 2008). VLDL is assembled in the 
liver from triglycerides, cholesterol, and apolipoproteins. VLDL is converted in the 
bloodstream to low-density lipoprotein (LDL). VLDL particles have a diameter of 30-80 
nm. VLDL transports endogenous products, whereas chylomicrons transport exogenous 
products. Very low-density lipoproteins transport endogenous triglycerides, phospholipids, 
cholesterol, and cholesteryl esters. It functions as the body's internal transport mechanism 
for lipids. In addition, it serves for long-range transport of hydrophobic intercellular 
messengers, like the morphogen Indian hedgehog protein (Queiroz et al., 2010). 
2.2.8.4 Treatment of Hyperlipidemia 
Some people, diet, and lifestyle changes may be enough for them but medication may also   
be needed. Various medications can lower blood cholesterol levels. Statins are 
recommended for most patients because they are the only cholesterol-lowering drug class 
that has been directly associated with reduced risk for heart attack and stroke. The drug 
works in the liver to prevent the formation of cholesterol, thus lowering the amount of 
cholesterol circulating in the blood. Statins are most effective at lowering LDL cholesterol, 
but also have modest effects on lowering triglycerides and raising HDL. 
Most side effects are mild and generally go away as the body adjusts. Muscle problems and 
liver abnormalities are rare, but doctor may order regular liver function tests. Patients who 
are pregnant or who have active or chronic liver disease should not take statin (Gupta et al., 
2011).  
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2.3 Socio demographic factors and hyperlipidemia: 
Demographic characteristics can refer to age, sex, and place of residence, religion, 
educational level, marital status, household total income, and family members. 
2.3.1 Hyperlipidemia and age 
AL-Ajlan, (2011) study concluded that the correlation between age and all lipid parameters 
were statistically non-significant. According to Sun et al.,(2014), the prevalence of total 
cholesterol increases significantly with advancing of age. The researcher concluded that 
higher HDL cholesterol levels were significantly associated with survival to 85 years of 
age. 
Rahilly-Tierney, et al., (2011) tried to determine whether high-density lipoprotein (HDL) 
cholesterol levels are associated with survival to 85 years of age in a prospective cohort of 
aging men. The researcher selected 652 men with mean age 65 years, and categorized 
initial HDL cholesterol into <40 mg/dl (reference group), 40 to 49 mg/dl, or ≥50 mg/dl. 
Information on co-morbidities, lifestyle factors, measured lipid parameters, and 
medications were collected during triennial visits. Rahilly-Tierney, et al., (2011) used 
proportional hazards to determine hazard ratios (HRs) for mortality before age 85 years for 
each category of initial HDL cholesterol compared to the reference adjusting for co-
morbidities, calculated low-density lipoprotein cholesterol, medications, smoking, body 
mass index, and alcohol consumption. Treating HDL cholesterol as a continuous predictor, 
also determined the HR for each 10-mg/dl increment in HDL cholesterol. Fully adjusted 
HR (95% confidence interval) for survival to 85 years of age for participants with an initial 
10-mg/dl increment in HDL cholesterol was associated with a 14% (HR 0.86, 0.78 to 0.96) 
decrease in risk of mortality before 85 years of age. 
2.3.2 Hyperlipidemia and marital status   
A study was carried out in Iran (Charan & Biswas, 2013) in order to assess the effect of 
marital status on metabolic syndrome disease which include diabetes, dyslipidemia, 
abdominal obesity, and hypertension. The researcher selected his population with age 15 – 
90 years and categorized them into consistent married status, and transition married status, 
then calculate metabolic z score of WC, SBP, DBP, FBS, TC, TG, and HDL 
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concentrations and compare the results and found that marital status may affect metabolic 
syndrome risk z score in differently among the two genders. 
2.3.3 Hyperlipidemia and years of education 
According to Schneider et al., (2006) a study was conducted in Argentina, which is 
considered the fourth highest rate of cardiovascular mortality in the Americas. The study 
aimed to study the associations between lipid profiles and socio-demographic risk factors. 
It found that the women with less than 7 years of education 39% had normal cholesterol 
and 61% had borderline and high levels but the percentage of normal cholesterol among 
the women with more than 7 years of education was 50%. According to Egeland et al., 
(2003), the levels of cholesterol and triglyceride decreased with the increasing of years of 
education.  
2.3.4 Hyperlipidemia and total family income 
 Al-Daghri et al., (2014) in his study in Saudi Arabia revealed that there was a positive 
relationship between high income and metabolic disease. Another study was carried out to 
evaluate the association between socioeconomic status and the presence of cardiovascular 
risk factors in children from Madrid (Arias et al., 1992), found that there was a positive 
correlation between socioeconomic status and total cholesterol, Apo A, Apo B and Apo 
A/Apo B, whereas socioeconomic status and triglycerides were inversely related. Arias et 
al., (1992) concluded that children belonging to high socioeconomic status have a more 
atherogenic lipid profile than those of middle low or low socioeconomic levels. 
A study was carried out to evaluate the lipid profile of schoolchildren attending private 
(paid) and public/philanthropic (free) schools (Scherr et al., 2007) demonstrated the 
positive correlation of total cholesterol and its LDL fraction with eating habits and more 
intense and regular physical activity, benefiting the most needy children, compared to 
those enrolled in private schools. A study was carried out in order to estimate the 
socioeconomic status and coronary heart disease (Egeland et al., 2003) found that 
cholesterol, and triglyceride levels decreased with the increase of total income.   
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2.4 Life style: 
Lifestyle is a way of living or the manner in which people conduct their day-to-day 
activities. It includes smoking, physical activity, and nutrition, lifestyle and individuals 
behaviors is considered the best  choice to influence the health (Hassan, 2013). 
2.4.1 Life style and hyperlipidemia 
A cross-sectional study was done in India, search for the associations between diets, 
exercise, and lipid profiles. The results confirm that diet and exercise routines significantly 
affect the serum lipid profile (Chitra et al., 2012). Another study concluded that 
adolescents of Birjand in Iran republic have high prevalence of dyslipidemia. Preventive 
measures are recommended to improve lifestyle, including healthy nutrition, encouraging 
adolescents to exercise, and more mobility (Taheri et al., 2015). 
2.4.1.1 Smoking and hyperlipidemia 
Previous studies showed that smoking is related with heart disease, and it influence the fat 
in the body, also it affects the lining layers of the blood vessels, in addition smoking 
cessation increase HDL and decrease the risk of heart disease (Gepner et al., 2011). 
Howard (1998) found that active smoking and environmental tobacco smoke exposures are 
associated with the progression of an index of atherosclerosis, also smoking is of particular 
concern for patients with diabetes and hypertension. Howard concluded that pack-years of 
smoking but not current vs. past smoking is related with developing of atherosclerosis 
suggest that some adverse effects of smoking may be cumulative and irreversible. Another 
study was carried out on three groups of males subjects (Rao, 2013), the first was non 
smokers and non chewers, the second was smokers and non-chewers, the third group was 
chewers and non smokers. The study results revealed that serum TC and low-density 
lipoprotein is significantly increased in tobacco users comparing with non-users. 
There was a study carried out in China among all residents aged 90 years or more in a 
district, and there were 2,311,709 inhabitants in 2005 (Mannu et al., 2013). Mannu et al.,  
found that among Chinese nonagenarians/centenarians, cigarette-smoking habits were not 
associated with increased risk for dyslipidemia, which was different from the association 
of smoking habits with dyslipidemia in general population. Current smokers had lower 
levels of TC (4.05 ± 0.81 vs. 4.21 ± 0.87, t = 2.403, P = 0.017) and lower prevalence of 
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hypercholesterolemia (9.62% vs. 15.13%, χ2 = 3.018, P = 0.049) than nonsmokers. 
Unadjusted and adjusted multiple logistic regressions showed that cigarette smoking was 
not associated with risk for abnormal serum lipid/lipoprotein. 
A study was conducted in India to test the association between smoking and the lipids 
levels among 100 selected smokers and nonsmokers (Lyons & Langille, 2000). The study 
shows that as the intensity and duration of smoking increases a significant increase in the 
levels of very low-density lipoprotein -cholesterol, low-density lipoprotein -cholesterol, 
triglyceride, and total cholesterol are noted in almost all groups of cigarette smokers as 
compared to nonsmokers. Simultaneously a significant reduction in the level of High-
density lipoprotein-cholesterol is observed in cigarette smokers as the intensity and 
duration is increased. These findings add another health enhancing benefit by the cessation 
of smoking (Grundy, et al., 2004).  
According to Tayem et al.,(2012) in the West Bank the prevalence of smoking among 553 
students from Al-Quds university aged 17 – 26 years was 29.1%. On the other side there 
was a study conducted in the Gaza Strip, (Abed & Abu-Haddaf, 2013), to determine risk 
factors of hypertensive among UNRWA health care centers, the study found that the 
former smokers percentage was 15.5% among the cases. 
2.4.1.2 Physical activity and hyperlipidemia 
Several research was studied the relation between training and physical activity and lipid 
profile levels which is the marker of hyperlipidemia. A follow up study was conducted to 
assess the effect of exercise training on lipid profile (Shriram et al., 2015), the researchers 
suggested that regular physical activity and increasing in duration of exercise training 
period improve the lipid profile; in addition regular physical activity decreases the risk of 
diseases like diabetes type 2 and coronary heart disease.  
A study included 51 obese adults with sedentary lifestyle (Perk, et al., 2012), one group 
follow moderate intensity and the other follow high intensity the researcher found there 
was significant reduction in LDL among the high intensity exercise, and there was a 
significant difference in BMI, lipid profile and blood pressure in both the moderate and 
high intensity exercise group.  
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2.4.1.3 Nutrition and hyperlipidemia 
Lipid profile and obesity are one of risk factors for cardiovascular disease, and 
atherosclerosis begins from the childhood, a cross sectional study was conducted among 
147 overweight and obese children in Botucatu city in Brazil, the study aimed to 
investigate the relationship between dietary intake and blood lipids levels in overweight 
and obese schoolchildren (Rinaldi et al., 2012). Rinaldi et al., (2012) found that total 
Cholesterol levels positively related to full-fat dairy products, while triglycerides levels 
were positively associated to saturated fat percentage. These results support that the 
necessity of healthy dietary habits among childhood in order to reduce the risks of 
cardiovascular diseases in adulthood. Randomized clinical trial was conducted on 
hyperlipidemic patients in Iran, sample size was fifty eight subjects (51 female and 7 
males) by Noroozi, et al., (2012), who aimed in this study to see the effect of using olives 
oil on the lipid profile. The researcher concluded that olive oil with low-calorie diet, as a 
part of healthy diet, lowered the LDL levels. This was after using olive oil as treatment for 
4 weeks and measure lipid profile and anthropometric measurements before and after the 
intervention, but there was no significant association between the use of olive oil and other 
measurements. 
According to Damasceno et al., (2011), the study was carried out in Spain, the three 
intervention diets were associated with significant reductions from baseline of total 
cholesterol, LDL-cholesterol and the LDL/HDL ratio. The mean reduction in LDL-
cholesterol was 0.36 mmol/L (7.3%) with the VOO diet, 0.51 mmol/L (10.8%) with the 
walnut diet, and 0.61 mmol/L (13.4%) with the almond diet. No changes were observed in 
HDL-cholesterol, triglycerides. Bradlee et al., (2014) confirmed in their study that higher 
intake of fruit and non starchy vegetable are associated with favorable lipid profile than 
lower intakes. Also, they found that diet included higher intakes of lean red meat in 
combination with higher intakes of fruits and non-starchy vegetables were also associated 
with a more favorable lipid profile as well as a lower risk of having abnormal lipid levels. 
Fruit and non-starchy vegetable consumption, has beneficial effect on LDL-C while diets 
were the participants whose diets were higher in both red meat and fruits and non-starchy 
vegetables had higher HDL levels and a slightly lower risk of an abnormal LDL: HDL 
ratio. Consumption of lean red meat was associated with lower triglyceride levels. Eating 
fatty fish can be heart healthy because of its high levels of omega-3 fatty acids, which can 
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reduce your blood pressure and risk of developing blood clots. In people who have already 
had heart attacks, fish oil or omega-3 fatty acids may reduce the risk of sudden death. 
Although omega-3 fatty acids don't affect LDL levels, because of their other heart benefits, 
the American Heart Association recommends eating at least two servings of fish a week 
(Mayo-Clinic, 2015). 
 A study was conducted to examine the relation between MDS and hyperlipidemia, the 
study revealed that few gender-specific associations were found between the MDS 
components and blood lipids; MDS was negatively related with LDL cholesterol and the 
ratio TC/HDL cholesterol while positively with HDL cholesterol. In women cereals, and in 
men three (fruits & nuts, meat and alcohol) of the nine MDS components were related with 
blood lipids (Mertens et al., 2014).  
Hirose et al, (2015) study was conducted in Tokyo medical and dental university, among 
95 women with age 40 – 60 years. The study aimed to estimate the effect of tomato juice 
on resting energy and improving triglyceride levels, the study concluded that taking tomato 
juice alleviating menopausal symptoms, including anxiety, increased heart rate, and 
lowered high baseline serum TG levels in middle-aged women. 
A study was carried out in Sao Paulo in Brazil (Júnior et al., 2012) to investigate the 
relationship between skipping meals and biochemical variables among obese children and 
adolescents revealed that action of skipping meals especially breakfast enhances the risk to 
increase glucose, and lipid profile among these participants. 
A according to Huangs' study (2011), the consumption of nuts, a diet high in carbohydrates 
and protein, green tea, and red wine, as well as the supplementation with red yeast rice 
extract, improve the lipid profile, while the supplements of garlic, chromium, vitamin C, 
magnesium-pyridoxal-phosphate-glutamate, cannot be recommended (Huang et al., 2011). 
2.5 Obesity: 
Overweight or obesity refers to the excess of weight, and is measured by body mass index. 
BMI is the ratio of weight in kilograms divided by the height in meters squared. 
Overweight is defined as BMI between 25.0 and 29.9 kg/m
2
 and obesity is defined as BMI 
higher than 30.0 kg/m
2
 (Ellulu et al., 2014), Waist circumference is the simplest and most 
common way to measure ―abdominal obesity‖-the extra fat found around the middle that is 
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an important factor in health, even independent of BMI. It‘s the circumference of the 
abdomen, measured at the natural waist (in between the lowest rib and the top of the hip 
bone), the umbilicus (belly button), or at the narrowest point of the midsection (Barba et 
al., 2004). A study was carried out in Palestine by using the data of survey from 1999 to 
2000, among 3617 adults aged 18 – 64 years and the results were prevalence of 
overweight, and obesity was 35.5%, 31.5% among women, and 40.3%, 17.5% among men 
respectively (Abdeen et al., 2012).   
2.5.1 Obesity and hyperlipidemia 
Hyperlipidemia is commonly associated with obesity, which is known as a risk factor for 
CVD, (Ito et al., 2004). Estimates from the World Health Organization (WHO) suggested 
that CVDs contributed to approximately 17.5 million individuals deaths in 2012 (WHO, 
2015). Obesity is a worldwide health problem. It is associated with excessive fat 
accumulation in the body to the extent that health and well-being are adversely affected. 
With changing food habits and sedentary lifestyles, the prevalence of obesity has increased 
markedly in Western countries faster than the developing one (Antipatis & Gill, 2001). 
According to WHO, (2011) study which conducted in EMR by WHO Stepwise survey 
(2003-2007) found that, Kawait showed the highest prevalence of overweight (75.4%) 
followed by KSA (68.6%), while Oman has the lowest score (29.6%) followed by Iran 
(42.8%). The prevalence rate of overweight and obesity in Sudan was 53.9%, Egypt 66%, 
in comparison to Syrian Arab Republic 56.3%, Jordan 57% and Iraq 66.9% (WHO, 2011).  
According to Hu, (2004) obesity epidemic first started in the United States and 
industrialized nations then spreading to the developing countries especially their urban 
areas. Obesity may increase the risk of many diseases such as diabetes, atherosclerosis, 
hypertension, hyperlipidemia, gall bladder diseases, and cardiovascular diseases (Saeed, 
2013)  
Also in Zawawi study, (2014) the body mass index was classified into the same categories. 
Study results suggested that lipid, obesity-inflammation, and insulin sensitivity domains 
predominantly exist among obese children. These factors might be applied to predict the 
outcomes of cardiovascular diseases in the future (Chang et al., 2014). According to the 
WHO, unhealthy diet, physical inactivity, tobacco use, and harmful use of alcohol affect 
heart disease and stroke. These effects on the risk individuals appear as raised blood 
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pressure, raised blood glucose, raised blood lipids, and overweight and obesity. These 
intermediate risks factors can be measured in primary care facilities and indicate an 
increased risk of developing a heart attack, stroke, heart failure and other complications 
(WHO, 2015). 
 A cross sectional study was conducted in China (Rao et al., 2016) aimed to explore the 
association between anthropometric measures and hyperlipidemia, the sample size was 
21,435 subjects (aged 18 - 79 years) the prevalence of overweight and obesity was 31.89% 
and 6.23% respectively, this study results were that body mass index variance associated 
significantly with hyperlipidemia.  
A study was carried out among Swiss conscripts from 2006 to 2012 (N=174,872, mean age 
=19.75 years), revealed that the mean of total cholesterol increased by increasing of the 
body mass index among study participants. Whereas mean TCL was lower than 4.0 mmol/l 
among underweight young men (3.919 mmol/l, 95 % CI 3.902–3.936), mean TCL was ≥ 
4.6 mmol/l in all WHO subcategories of (CDC, 2014). 
 Another study was conducted in Egypt on 384 university students to estimate the 
prevalence of lipid profile and associated factors may lead to dyslipidemia (Wahed et al., 
2016). Wahed et al., (2016) found that there was highly statistically association between 
waist circumferences and high cholesterol (P<0.001), statistically significant relationship 
between WC and high triglyceride (P=0.01), statistically significant relationship between 
WC and high LDL (P=0.002), and statistically significant relationship between WC and 
low HDL (P=0.011). Body mass index was statistically significant related with lipid profile 
except low HDL (P=0.67).  
In Jordan, there was a study among 1121 participants aged 25 years and older to estimate 
the various types of dyslipidemia, and determine their associated factors among adults in 
north of Jordan (Khader et al., 2010). Khader, et al., (2010) found that triglyceride levels 
increased with the increase of body mass index and waist circumferences. The World 
Health Organization (WHO) estimated that 43 million children are overweight and obese 
even in their preschool years and 35 million of these children are in developing countries 
(Gepner, et al., 2011). 
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Many studies were carried out in Saudi Arabia to estimate the prevalence of obesity, one of 
them was (Issa, 2014) and his results was that the prevalence of obesity and overweight 
were 16.1% and 28.5%, respectively among 1473 male students.  
According to a cohort study was conducted in Finland among children to test the 
associations between preschool weight and body mass index (BMI) and adult BMI, central 
obesity and metabolic alterations the findings were that there was a relation between low 
level of high density lipoprotein and body mass index (Graversen et al., 2014).  
2.6 Family history: 
A family history is a record of medical information about an individual and their biological 
family. Human genetic data is becoming more prevalent and easy to obtain. Increasingly, 
this data is being used to identify individuals who are at increased risk for developing 
genetic disorders that run in families (NHGRI, 2015).  
2.6.1 Family history and hyperlipidemia 
A study was conducted to examine the lipid profile in children born to parents with history 
of premature ischemic heart disease and studied the effect of diet, lifestyle factors, and 
obesity among them. The study concluded that these children have significant incidence of 
dyslipidemia. The risk factors like BMI, diet and physical activity increase the incidence of 
dyslipidemia. Therefore, all children of premature IHD patients should be screened for 
dyslipidemia (Savitha & Sandeep, 2011). Another study was carried out in Gambia (Van 
der Sande et al., 2001) consists of 5389 adults aged ≥ 15 years, the study aimed to examine 
if family history has significant risk factor for non-communicable disease, that individuals 
with family history of diabetes had higher levels of cholesterol and there were highly 
statistically significant (P=<0.001). Also mean of cholesterol among participants of family 
history of obesity was (184.6 ± 40.4), and it is more than the mean of cholesterol among 
the participants of no family history of obesity (169 ± 37.1). The difference in means here 
was highly statistically significant (P=<0.001), but it did not reach statistically significant 
in Van der Sande study. There was a significant relation between cholesterol levels and the 
subjects with positive family history of hypertension, compared with those without family 
history of hypertension but it doesn‘t reach statistically significant level (P=0.48). 
According to Berentzen et al. (2016) which was carried out in the Netherlands among 
  
34 
 
1374, 12 years children to examine how a family history of CVD and/or diabetes relates to 
cardio metabolic markers in offspring, and to what extent these diseases independently 
contribute to cardio metabolic markers. Berentzen, (2016) in his study found that One-third 
of the children had a strong family history of CVD and/or diabetes. These children had 
higher TC levels and TC/HDL ratios than children with no family history did. A strong 
family history of MI or diabetes was independently associated with unfavorable cardio 
metabolic markers specific to those diseases. 
Parents are responsible for not only genetic structure but also the behavior of their children 
in their lives. There was a study (Charan & Biswas, 2013) to examine the relationship 
between school-age children obesity and their parents obesity and also the children obesity 
and their parents educational level. An inverse relationship was observed between the 
parents' educational level and child obesity, the lowest educational level corresponding to 
the highest prevalence of obese children: 9.3% for mothers with a low educational level 
compared to 5.8% for mothers with a high educational level (p = 0.15); similarly, the 
corresponding prevalence for fathers was 9.5% compared to 4.5% (p = 0.03). 
2.7 Morbidity: 
Morbidity is referred to any departure, subjective or objective, from a state of 
physiological or psychological well - being. Morbidity rates measure the frequency of 
illness within specific populations. Time and place must always be specified. The most 
commonly used morbidity rates include: prevalence, point prevalence, period prevalence, 
incidence, and attack rate (Abed, 2013).  
2.7.1 Morbidity and hyperlipidemia 
According to the World Health Organization (WHO), morbidity could be measured in 
terms like: number of persons who were ill, illnesses these persons experienced, and the 
duration of these illnesses. Deng et, al, (2012) determines the prevalence of hyperlipidemia 
among the populations living at moderate altitude on the Yunnan-Kweichow Plateau in 
Southwestern China, this study reveals a higher prevalence of hyperlipidemia, 
hypercholesterolemia, hypertriglyceridemia, increased BMI and WHR values in men, as 
well as a slightly higher prevalence of low HDL-C and high LDL-C in women from 
Yunnan-Kweichow Plateau. The incidence of hyperlipidemia also increased with age, as 
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did the prevalence of an abnormal TC, TG, LDL-C, and WHR. A high BMI, and less 
healthy living habits and dietary preferences thus play significant roles in the onset of 
hyperlipidemia. Shahnam et al., (2010), conducted his study on adults population living in 
rural and urban areas in central Iran in order to assess the correlation between stress level 
and lipid profile disorders concluded that interventions activities must be applied to 
lowering the level of stress and this may be useful as a part of strategies of cardiovascular 
disease prevention. 
Akkaloori et al., (2014) found that there is a relation between chronic periodontitis and 
cardiovascular risk factors like hyperlipidemia. LDL-cholesterol was significantly 
increased in participants with chronic periodontitis than in healthy individuals, which is 
risk factor for cardiovascular diseases. HDL-cholesterol levels were significantly increased 
in healthy individuals than in individuals with chronic periodontitis. Total cholesterol 
levels were increased in chronic periodontitis patients than in healthy individuals, but there 
was no significant difference between chronic periodontitis group and healthy group 
related to total cholesterol levels. Triglycerides and VLDL Cholesterol levels were 
increased in individuals with chronic periodontitis than in individuals without 
periodontitis, but there was no significant difference between them. Hence, chronic 
periodontitis patients may have high risk of getting cardiovascular diseases like 
atherosclerosis and angina pectoris, which can lead to high morbidity and mortality among 
periodontitis patients. 
 A study in Turkey, (Kepez et al., 2015) found that participants with hyperlipidemia were 
observed to have significantly depressed heart rate variability compared to participants 
with normal lipid profile, and the study suggests that patients with hyperlipidemia, in 
particular with hypertriglyceridemia display higher subtle cardiac sympathetic activity 
which may be associated with increased cardiovascular morbidity and mortality. 
 A study was conducted to explore the effects of insulin resistance on lipid levels in 
relation to atherosclerotic coronary artery disease, found that patient populations show 
statistically significant relationships between changes in glucose or hemoglobin A1c and 
changes in the various components of the lipid panel over the same time period. The only 
component that did not show statistical significance in both groups was that of HDL 
(Gierach et al., 2014).   
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Mixed Hyperlipidemia also called multiple lipoprotein-type hyperlipidemia is a genetic 
disorder in which a combination of high cholesterol and high triglycerides is inherited and 
passed down from family members. This is one of the most common contributors to early 
heart attacks. The condition may be worsened by other disorders, like hypothyroidism, 
diabetes, and alcoholism. 
Many patients with mixed hyperlipidemia are asymptomatic, others do experience 
symptoms, including chest pain or angina; xanthoma which is a condition in which fat 
builds up under the skin's surface; xanthelasma of the eyelid which is the same as a 
xanthoma, but is located on the eyelid; pain in the abdomen; spleen enlargement; and 
enlarged liver (Grundy, 1999). Patients with mixed hyperlipidemia are at a higher risk of 
developing early coronary artery disease and heart attacks, and have an increased rate of 
glucose intolerance and obesity. In patients with mixed hyperlipidemia, the elevated 
triglycerides are generated by an increase in fatty acid flux to the liver. This increase is 
caused either by enhanced free fatty acid release from excess visceral adipose tissue or by 
increased remnant lipoprotein delivery of triglycerides to the liver by excess caloric 
consumption, leading to increased hepatic lipogenesis, which stimulates increased 
assembly and secretion of VLDL. A study was carried out in Bangladesh to assess the 
relationship between serum lipid profiles in hypertensive patients with normotensive 
control participants, (Wahiduzzaman, 2014). The logistic regression analysis showed that 
hypertensive patients had 1.1 times higher TC and TG, 1.2 times higher LDL, and 1.1 
times lower HDL than normotensives, which was statistically significant (P=0.05). 
A study was carried out in the United Kingdom, (Marcovecchio et al., 2009) on the 
diabetes type one subjects, the researcher wanted to explore prevalence of lipid 
abnormalities and their relationship with albumin excretion and microalbuminuria in 
adolescents with type 1 diabetes. The results were that lipid profile tests higher in females 
than males, this longitudinal study of adolescents with type-1 diabetes, concluded that 
sustained lipid abnormalities were related to age, duration, BMI, and A1C. Furthermore, 
albumin creatine ratio was related to both total cholesterol and non-HDL cholesterol, 
indicating a potential role in the pathogenesis of diabetic nephropathy. 
A case control study was carried out in Bangladesh to study lipid profile among 100 
hypertensive participants and equal number of normotensive as a control group (Sarwar et 
al., 2014). Sarwar explored that hypertensive patients have higher level of TC, TG, LDL 
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and VLDL cholesterol but lower level of HDL cholesterol than the normotensive 
participants. Many studies found that there were strong relations between abnormal lipid 
profile and type 2 diabetes, which include reduced HDL cholesterol, a predominance of 
small dense LDL particles, and elevated triglyceride levels (Krauss, 2004). These 
abnormal lipids are associated to cardiovascular disease the leading cause of death in 
patients with type 2 diabetes. Hypothyroidism is associated with coronary heart disease 
and this is due to elevated of lipid profile among the hypothyroidism patients, lipid profile 
are decreased when hypothyroidism is treated with thyroid hormone (Obrien et al., 1993). 
A study was carried out to determine lipid profile in patients with cirrhosis and to asses if it 
relates to the severity of the cirrhosis (Mohammad, et al., 2010) concluded that Serum 
total, LDL and HDL cholesterol level in patients with cirrhosis is inversely correlate with 
severity of cirrhosis. 
Also according to Chawda et al., (2011) study that was conducted in order to investigate 
the alterations and clinical significance of plasma lipid profiles in untreated head and neck 
cancer patients, an inverse relationship was found between the lipid levels and the 
occurrence of oral cancer. Hence, the lower plasma lipid status may be a useful indicator to 
detect the initial changes seen in neoplastic process. 
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3 Chapter 3:  
Methodology 
This chapter describes methodology, which is defined as the way at which relevant 
information is gathered in ordered to answer the research questions or analyze the research 
problem including research approach, research design, instrument modification, 
recruitment sample, study population, eligibility criteria, pilot study, data collection 
procedure and plan for data analysis and ethical and administrated approval. Finally, it 
describes limitation of the study. 
3.1 Study design 
Descriptive and analytical cross-sectional study was conducted on blood donors who 
attend blood banks centers in Gaza for donating blood and they reflect healthy population 
in ordered to determine risk factors of hyperlipidemia among healthy group. A cross 
sectional study had been selected because it is rapid, quick, cheap, and easily undertaken. It 
is generally carried out at a point of time or over a short period. Cross sectional study gives 
more insight into the association between variables in the study. This design is limited, 
because it is carried out at one point of time, so there is no sequences of events and we 
cannot judge that whether exposure come before or after the disease. This being so, it is 
impossible to infer causality (Levin, 2006). 
3.2 Setting of the study 
The Gaza strip is consisted from five main Governorates, which are North Gaza, Gaza, 
Middle Zoon, Khanyounis and Rafah Governorates. The main hospitals in Gaza strip are 
Al Shifa hospital serving both Gaza governorate and North Gaza, Nasir hospital and 
European Gaza hospital in Khanyounis governorate, Shohadaa Al Aqsa hospital in the 
Middle Zoon governorates and al Najjar hospital in Rafah. Every hospital contains a blood 
bank center so we will conduct this study in these central blood banks. 
3.3 Study  population 
The population is the set of entities under study, but sample is subsets of this population 
use this sample to draw inferences about the population under study. According to BCPS 
(2015), total population in Gaza Strip was 1,82 million, total males population was 925 
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thousands. Study population of this study was the males from the age of 20 to 50 years 
who were in total 336,509 thousands of Gaza Strip population in 2015. Our study was 
carried out on blood donor's males who donate their blood in blood banks centers of the 
main hospitals of the Ministry of Health in Gaza Strip with the age between 20 and 50 
years. 
3.4 Sample size formula: 
n   =   Z
2
1-α/2 P(1-P)/d
2
, where: 
n         = sample size 
Z
2
1-α/2 = confidence interval 
P = estimated proportion 
d = desired precision 
  
In our study sample size = ( 1.96)
2
(0.44)*(0.56)/(0.05)
2
 
Sample size = 379 participants 
This formula was from: (Charan & Biswas, 2013) 
3.5 Sampling 
The sample was proportional sample for the difference localities in the Gaza Strip  as 
shown in table (3.1), and the participants were selected based to their positive response for 
the researcher phone call. 
Table (‎3.1): Distribution of the Study Sample According to Gaza Governorate 
Governorate Population % Sample 
North Gaza 20 76 
Gaza 34 129 
Mid Zone 15 57 
Khan Younis 19 72 
Rafah 12 45 
Total 100 379 
 
In addition, it must be accurate. Gaza strip consists of five governorates, here we took the 
population in each one of these governorates, and we calculated the percentage of our 
study population, which included the males with ages from 20 to 50 years. In every 
governorate, we calculated the exactly number of subjects from the whole sample size. 
There are five major hospitals in the Gaza strip. We selected our sample for study as 
proportional sample from blood bank centers in every hospital according to every region 
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population, which follow this hospital. This table will be express the exactly numbers of 
the participants in our study as proportional sample depends on the number of population 
of every governorate in Gaza strip and the number of males with age from 20 to 50 years 
who were our study population. 
3.6 Eligibility criteria 
These criteria specify the characteristics that people in the population must possess in order 
to be included in the study; inclusion criteria are a set of predefined subjects who were 
included in a research study. Inclusion criteria, along with exclusion criteria, make up the 
selection or eligibility criteria used to rule in or out the target population for a research 
study (Salkind, 2010). 
3.6.1 Inclusion criteria 
The participants of this study were males with age between 20 years and 50 years who 
attended blood banks centers of the main MoH hospitals for blood donation.  
 
3.6.2 Exclusion criteria 
 Male donors with age less than 20 years and over 50 years were excluded; also, females 
were excluded from this study.  
3.7 Ethical and administrative consideration 
1. Approval letter was obtained from School of Public Health at Al Quds University 
2. Approval letter from hospitals General Directorate of MoH in Gaza Strip 
3. An official letter of approval to conduct the study was obtained from Helsinki 
Committee in the Gaza strip 
4. Informed consent form was taken from blood donors who agreed to participate in 
this study. This consent included details about the purpose of the study, and every 
one received personally his results. According to Polit and Beck, consent should 
entail the following: anonymity, confidentiality, the right to privacy, protection 
from harm and discomfort, and the right to withdraw from the study at any time 
(Polit & Beck, 2004). 
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3.8 Research instrument 
Two types of research instrument were used in this study: 
3.8.1 Direct instrument 
Hyperlipidemia risk factors were measured by assessment of anthropometric measures, 
like body mass index (BMI) and waist circumferences (WC). In addition, blood samples of 
the participants were taken after fasting between 12 to 16 hours. Serum was tested for 
measuring total cholesterol TC, triglycerides TG, High-density lipoprotein HDL, and low-
density lipoprotein LDL. The tests was carried out by using Diasys reagents which were 
programmed on the Mendary 300 Chemistry Analyzer. Quality control was performed with 
every run of participant's samples to ensure that we obtained accurate results. 
 
3.8.1.1 Kits/ DiaSys company 
 
3.8.1.1.1 Cholesterol  
a- Method 
CHOD-PAP: Enzymatic photometric test 
 
b- Principle 
Determination of Cholesterol after enzymatic hydrolysis and oxidation,  the 
colorimetric indicator is quninemine which is generated from 4-aminoantipyrine and 
phenol by hydrogen peroxide under the catalytic action of peroxidase. 
Cholesterol ester + H2O ---CHE----> Cholesterol + fatty acid 
Cholesterol + O2 --CHO--> Cholesterol -3-one + H2O2 
2 H2O2 + 4-aminoantipyrine + Phenol --POD--> Quninemine + 4H2O2 
 
c- Specimen 
Serum, heparin plasma or EDTA plasma 
StaVbility 7 days at 20-25 °C or 7 days at 4-8 °C or 3 months at -20 °C. 
 
d- Sample procedures  
Add 10 µL of serum to 1000 µL from reagents mix; incubate for 20 minutes at 37 °C. 
Read absorbance within 60 minutes against blank.  
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e- Calculations: 
The analyzer will divide absorbance of sample and absorbance of standard and 
multiply with the concentration of the standard to get the concentration of the 
cholesterol in the sample (DiaSys, 2014a).  
 
f- Normal range:  
Desirable                            < 200 mg/dl 
Borderline high risk          200 – 240 mg/dl 
High risk:                            > 240 mg/ dl 
3.8.1.1.2 Triglyceride 
a- Method 
Colorimetric enzymatic test using glycerol-3-phosphate-oxidase (GPO) 
 
b- Principle 
Determination of triglyceride after enzymatic splitting with lipoprotein lipase. 
Indicator is quninemine which is generated from 4-aminoantipyrine and 4-
chlorophenol by hydrogen peroxide under the catalytic action of peroxidase. 
 
c- Specimen 
Serum, heparin plasma or EDTA plasma 
Stability 2 days at 20-25 °C or 7 days at 4-8 °C or at least one year at -20 °C. 
 
d-  Sample procedures  
Add 10 µL of serum to 1000 µL from reagents mix; incubate for 20 minutes at 37 °C. 
Read absorbance within 60 minutes against blank.  
 
e- Calculations: 
The analyzer will divide absorbance of sample and absorbance of standard and 
multiply with the concentration of the standard to get the concentration of the 
cholesterol in the sample. 
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f- Normal range:  
Desirable                            < 200 mg/dl 
Borderline high risk          200 – 400 mg/dl 
High risk:                            > 400 mg/ dl (DiaSys, 2009) 
3.8.1.1.3 HDL precipitant 
a- Principle 
Chilomicrons, VLDL, LDL are precipitated by adding phosphotungestic acid and 
magnesium ions to the sample. Centrifugation leaves only HDL in the supernatant, the 
concentration of which is determined enzymatically by using Diasys cholesterol FS. 
b- Specimen 
Serum, heparin plasma or EDTA plasma 
Stability 2 days at 20-25 °C or 7 days at 4-8 °C or at least one year at -20 °C. 
c- Sample procedures  
Add 200 µL of serum to 500 µL from reagents mix; and stand for 15 minutes at room 
temperature, then centrifuge for 20 min at 2500 g. within 2 hours after centrifugation 
transfer 0.1 ml of the supernatant to the reaction solution for the determination of 
cholesterol.  
After centrifugation, the supernatant should be clear. Serum or plasma with 
triglyceride contents > 1000 mg /dl tends to produce turbid supernatant or flouting 
precipitates. In this case dilute the sample 1 + 1 with NaCl solution (9 g/L) and then 
perform the precipitation. Multiply the result by 2.  
d- Calculations: 
The analyzer will divide absorbance of sample and absorbance of standard and 
multiply with the concentration of the standard to get the concentration of the 
cholesterol in the sample.  
e- Normal range:  
HDL- Cholesterol     ≥ 35 mg/L (DiaSys, 2014b) 
3.8.1.1.4 LDL 
Low density lipoprotein was measured after measuring Cholesterol, Triglyceride, and HDL 
levels in the serum of participants by calculation: 
LDL = Cholesterol – HDL- (triglyceride/ 5) 
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3.8.2 Questionnaire  
The questionnaire consisted of closed end type question; all cases were interviewed to 
explain the questionnaire, which included many variables like: 
1. Socio demographic factors such as age, governorate, marital status, years of education, 
family income, and family members. 
2. Morbidity and family history were assessed also in this tool 
Donors were questioned if they suffer from any disease like diabetes, heart disease, liver, 
kidney, thyroid disordered, cerebrovascular, stomach, GIT, cancer, and depression. 
The participants were asked about their family history, this part was included questions if 
their parents or siblings suffered from obesity, diabetes, hypertension, and heart disease.  
3. Life style, this mean questions about smoking, physical activity, and nutrition. 
 
a- Smoking part 
The researcher used CDC questions that adopted to identify the state of smoking (see 
annexes), then the questions can categories the subjects into one of four categories: (1) 
smoker, (2) past smoker, (3) passive smoker, and (4) nonsmoker (Ellulu et al., 2014).  
 
 
b- Physical activity 
The researcher used Global Physical Activity questionnaire, which developed and 
approved by WHO (2002) as the tool for physical activity surveillance. GPAQ collect data 
in three main domains activity at work, travel to and from places, and recreational activity. 
Four-analysis purpose these domains have broken into five different sub-domais. These 
sub domains are: Work vigorous (codes P1-P3), Work moderate (codes P4-P6), Travel 
(codes P7-P9), Recreational vigorous (codes P10-P12), and Recreational moderate (codes 
P13-P15). So the questionnaire divided into 3 parts and 15 questions (see annexes). Finally 
the GPAQ can categorized the population into three groups high, moderate, and low 
activity (Ellulo et al., 2014).   
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3.9 Reliability and Validity 
3.9.1 Reliability 
Reliability means repeatability, and this means how far the researcher will repeat the same 
measurement if the investigations are conducted more than one time. It was defined as "the 
degree of stability exhibited when a measurement is repeated under identical conditions 
(Last, 1983).  
3.9.2 Validity 
Validity in general means the degree to which an instrument measures what is supposed to 
measure (Polit & Beck, 2004). As a process, validation involves collecting and analyzing 
data to assess the accuracy of an instrument. There are numerous statistical tests and 
measures to assess the validity of quantitative instruments, which generally involves pilot 
testing. 
3.9.2.1 Face validity 
The instrument should be clear well organized free from gaps that lead to mistakes in 
measuring the study variable. The Questions were organized with enough spaces to 
answer. Sequence of question was logic and we had to avoid leading questions. 
3.9.2.2 Content validity 
Content validity is concerned with sample adequacy of the content area being measured 
(Polit, 2004). Also content validity is defined as the extent to which a test reflects the 
variables it seeks to measure (Holm & Llewellyn, 1986). This necessitates review of the 
variable measures; international recognized criteria for measurements are preferable. 
Adaptations of instrument for the local use are commonly used by local experts and 
necessitate improvement of the validity by other experts. Holm, (1986) considered that 
content validity requires judgment matter that the items reflect the defined variable. 
Practically it is advised that the investigator be given enough chance to construct his 
instrument. 
The questionnaire of this study was sent to ten experts related to the research process and 
experts of statistical analysis to correct and judge it. 
 After one to two weeks, we returned the questionnaire and making revising besides 
correcting. 
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We selected 20 participants in the study, filed the questionnaires with them, enter their data 
on the SPSS file, and examine the variables and frequencies.      
 
3.9.2.2.1 Standardization of measuring techniques 
Anthropometry 
The weight and height of each donor under investigation were taken according to the 
following criteria: 
Weight was measured using electronic digital scale (Kg), Height (to the nearest 0.1 cm) 
was measured using a wall fixed stadiometer. Body mass index (BMI) was computed by 
dividing weight on square of height in meter (Kg/m
2
) and BMI of 25 was considered as the 
cut-off level for assessing the prevalence of overweight or obesity. BMI of the participants 
was categorized into four groups underweight (< 18.5), normal weight (18.5 – 24.9), over 
weight (25 – 29.9), and obese (≥ 30), (Brown et al., 2000). 
Waist circumferences was measured at minimal inspiration to the nearest 0.1 cm, midway 
between the last rib and the iliac crest (Janssen et al., 2000). It indicated the abdominal 
obesity. The WC was categorized into two groups: normal < 94 cm, and abnormal group ≥ 
94 cm.  
Blood pressure was measured for the participants by using Mercurial Sphygmomanometer, 
Systolic blood pressure was considered normal if <140 mm mercury, and abnormal if it 
was ≥ 140 mm mercury. Diastolic blood pressure was normal if it was < 90 mm mercury 
and abnormal if it was ≥ 90 mm mercury  
 
Laboratory methods  
Blood samples were taken in the morning after a fasting period of 10–14 hours. Fasting 
serum total cholesterol and triglyceride were tested enzymatically. Total cholesterol, total 
triglyceride, high-density lipoprotein concentrations were determined in the Biochemistry 
Laboratory of European Gaza Hospital, KhanYunis, Gaza. Total cholesterol, triglyceride, 
and high density lipoprotein were done by using (Mendry 380- Chemical Auto Analyzer), 
low density lipoprotein and very low density lipoprotein levels were calculated from 
specialized formula. 
 
  
47 
 
3.10 Pilot study 
A piloting process was done before starting the data collection. This process aimed to help 
in identifying problems in the research design, validity, reliability, sensitivity and 
objectively of the data collection tools. Pilot process was done on 20 blood donors who 
were involved in the beginning of data collection. 
3.11 Data collection 
Accurate and precise data was collected by using well-prepared questionnaire with close-
ended questions, which was collected by researcher; the researcher explained the questions 
to the participants in his study and asked them. The researcher filled the questionnaire by 
himself in a detailed explanation. The questionnaire included clear and short questions, and 
it included most the variables that considered determinants of hyperlipidemia. 
The participants were asked about socio demographic variables as age, marital status, 
residency, years of education, total income, and family members. The next questions were 
about the medical history of the participants, and if they have any morbidity condition that 
are present. 
 Another part was about family history of the participants, they were asked if their parents 
and siblings have high levels of cholesterol, triglyceride or not. In addition, if the parents 
and the siblings suffer from obesity, diabetes, hypertension, death due cardiac disease 
before the age 60. 
The next part was to collect data about the life style of the participants; first, the researcher 
asked them about physical activity at work, travelling to/from the work, and recreational 
activities. Second, the participants were questioned about smoking, and then the researcher 
obtained nutritional information by using food frequency questionnaire and questions 
about their dietary habits. 
The researcher measured the blood pressure, weight, height and waist circumferences of 
the participants, every variable was taken as the mean of the tow readings then we recorded 
them carefully.   
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The researcher wanted to run lipid profile tests like cholesterol, triglyceride, high-density 
lipoprotein, and low-density lipoprotein, so he asked them for fasting 12 – 16 hours. 
Blood samples were drawn and sent to the laboratory where they were analyzed by the 
biochemical-automated analyzer. The results were obtained for cholesterol, triglyceride, 
and high-density lipoprotein, and then low-density lipoprotein level was calculated.    
3.12 Data management 
Data management is the process by which we will make our research data is more 
intensive, more use in the future, and reach more benefits. It includes data entry and data 
analysis. 
3.12.1 Data entry 
Fist we checked up of all the filled questionnaires. Reviewed questionnaires were entered 
into the computer using SPSS (Statistical Package for Social Science) software version 20 
in ordered to analyze the data. Data was entered correctly and accurately then the data 
cleaning process was performed, by selecting then checking random numbers of filled 
questionnaires, and making frequencies and descriptive statistics for all variables.  
3.12.2 Statistical analysis 
Data was analyzed by using SPSS (Statistical Package for Social Science) version 20. 
Descriptive analysis was done for individual characters and descriptive results were 
expressed with mean ± SD (standard deviation). Prevalence of hypercholesterolemia, and 
triglyceridemia, among healthy population in Gaza governorates were obtained from the 
distribution of lipid profile among blood donors, who reflect healthy population group. 
Participants were classified into Hyperlipidemic or not according to their cholesterol and 
triglyceride laboratory results. This depended if total cholesterol was ≥ 200 mg/dl, or 
triglyceride reached the level ≥ 150 mg/dl, so we used Chi-square test between categorical 
variables like socio demographics, which were age, place of residency, marital status, years 
of education, family income and family members and lipids profile categorical variables. 
Chi square tests also were done between BMI, WC, and physical activity as independent 
variables and lipid profile groups as dependent variables. We used t- test also between lipid 
profile as a continuous variables and categorical variables like family history, and 
smoking. Correlation test was done between continuous variables like lipid profile and 
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blood pressure. P-value was considered statistically significant when it is lower than 0.05 
with confidence interval 95%. Interpretation of data was based on the conceptual 
framework and the objectives of the study. 
3.13 Limitation of the study 
 Participants in this study were blood donors, they had to attend fasting at least 12 
hours to the hospitals of the Ministry of Health, I took their mobile numbers from 
the records in blood banks and phoned them, explain my research purpose and what 
was required from them. Many of them were not pleased with my phone, another 
group refused to share in research, some were not have money to come, and others 
were in their work. Others cannot fast 12 -16 hours but we told them that we 
prepared juice and chocolate for them, also we paid for cars brought some of them 
and we told them that we will give them all the results about their serum lipid 
profile.  
 It is difficult to infer causality because the nature of cross sectional study by the 
fact that it is carried out at one time point and gives no indication of the sequence 
of events whether exposure occurred before, after or during the onset of the disease 
outcome.  
 Lack of resources including budget and facilities. 
 Time limitation because of the nature of researcher work and life condition. 
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4 Chapter 4:  
Results and Discussion 
This chapter clarifies the main results of the study variables that achieve the study 
objectives in away using statistical testing as chi square, and independent sample t- testing 
as statistical tools of measurement and p-value as a measure for statistical significant level. 
This prevalence and determinants provided an opportunity to establish baseline 
information by exploring the most common hyperlipidemia determinants and risk factors 
among healthy population in Palestinian community. These factors include demographic 
factors, socioeconomic, family history, medical history, obesity, and life style pattern 
which include smoking, dietary intake, and physical activity. A cross sectional study was 
carried out at the Ministry of Health hospitals in the five governorates in the Gaza strip. 
Our analysis is based on a sample of 379 males of blood donors who are used to visit blood 
banks for blood donation as a healthy group. The findings based on (379) interview 
questionnaires with response rate of 97.5% and results of serum lipid profile blood tests for 
the participants, and anthropometric measures.  
In this chapter, the researcher highlights the findings of this study compared with other 
global and regional studies and attempt to interpret the results of the study and its 
implication. The result could help in development of preventive health education and 
health promotion programs. 
4.1 Demographic and socioeconomic characteristics of the study population 
The sample distribution by age, place of residency, years of education, marital status, 
family members, and total income are presented in table (4.1). 
4.1.1 Ages groups 
Total population was 379 participants from blood bank donors in all governorates of Gaza 
Strip. The age of the study population was 20 – 50 years old with mean of 31.8 ± 9.1. Half 
of the participants who are blood donors were 20 - 30 years and the other half was with the 
age 30 - 50 years. These ages are the acceptable ages for donation in blood banks. 
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Table (‎4.1): Summary of socio-demographic characteristics of the study population 
  
 
Variable   NO. %  
Age    
20 - 30 years  193 50.9 
30 and above 186 49.1 
Total  379 100% 
Place of residency   
North 75 19.8 
Gaza 130 34.3 
Mid –Zone 57 15 
 
 
 
Khan –younis 72 19 
Rafah  45 11.9 
Total  379 100% 
Years of education   
Less than 12 years  153 40.4 
12 and above  226 59.6 
Total  379 100% 
Marital status    
Not Married   126 33.2 
Married  253 66.8 
Total  22 100% 
Family members 
 
 
 
 
 
  
Less than 6 196 51.7 
6 and above 183 48.3 
Total  379 100% 
Income    
Less than 1000 NIS 121 31.9 
1000 – 2000 NIS 162 42.7 
2000 and above NIS 96 25.4 
Total  379   100% 
 
A study was conducted to determine the prevalence of dyslipidemia in Kuwait republic 
among university students (AlMajed, et al., 2011), the population was healthy from the 
universities nearly 484 students aged 17-24 years (mean = 18.4±1.4). 35.7% of subjects 
were males, 64.3% females. Population was from students so all of the participants were in 
this level of age, but the participants in our study were males because they are main public 
group of blood donation in hospitals and blood banks. Another cross sectional study was 
conducted in Jeddah among preparatory and secondary school teachers aged up to 60 years 
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to determine prevalence and determinants of pre hypertension and hypertension. Teachers 
age <30 was 37.9%, (30 - <40) was 36.7%, and (40 - <60) was 21.9 (Ibrahim et al., 2008). 
Here the researcher conducted his study on this group in order to cover all ages of the 
teachers in these schools but we conduct our study on the excellent and suitable age for 
blood donation.  
4.1.2 Place of residency 
In this study the researcher, select the population proportional to the last census of 
population of Gaza Strip and distribution of males with age 20 – 50 years among the five 
governorates in the Gaza Strip, which is explained in the table (4.1). Taheri et al. (2015), 
tried to know lipid profile and prevalence of hyperlipidemia. He selected the participants of 
the study from middle and high school students of Birjand city, with considering the 
distribution of schools in different districts of the city, but Togha, (2011) selected the 
population from the consecutive patients with acute stroke admitted to the neurology 
department of Sina hospital, and affiliated to Tehran University of Medical Science. This 
action was to compare the difference of lipid profile among the three groups which were 
hemorrhagic stroke (group 1), ischemic stroke (group 2), and control (group 3). Control 
group was chosen from the healthy individuals who were living in the same community 
and matched for age and sex. Toga et al, (2011) differ from our study in his target 
population because he wanted to determine lipid profile as a risk factor of stroke so the 
population was selected from hospital population not from healthy community in the 
different governorates.  
4.1.3 Years of education 
In our study the education years were divided into 2 groups <12 years which was 40.4% 
and 12 years and more (59.6%). A according to Shahnam, et al., (2012) study, she 
categorized her study population into three groups depending on the years of education <5 
years 6 - 12, and >12 to explore the correlation between lipid profile and stress level 
among these groups. Lazzeri (2013) study was carried out in order to examine the 
relationship between the education level of the parents and obesity of children in the age of 
8/9 years. Lazzeri, et al., (2013) categorized the parents into 3 groups according to their 
educational level high level, medium, and low and compared the effect of educational 
levels on the obesity of children, because the children obesity is connected with the 
behavior and attitude of the child which are accepted from his parents. 
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4.1.4 Marital status 
In our study, marital status was categorized into two groups: married and not married. 
Married group was 66.8%, while not married was 33.2%. Hosseinpour-Niazi et al., (2013) 
study aimed to examine the potential effects of marital status and marital transition on 
metabolic syndrome during a 9.6-year follow-up in Tehran Lipid and Glucose Study. The 
sample was selected from males and females aged 15 – 90 years, marital status was 
categorized as consistent marital status and marital transition, the percentages of married, 
and not married of men were 74.9%, 25.1% respectively. There was a difference; married 
group in our study was less than the same group in the other study, because of the target 
population in both studies. Hosseinpour-Niazi et al, (2013) population include layer of age 
between 50 - 90 years which may was from married men category. 
 Zawawi, (2014) conducted his study by selecting 177 individual from three women fitness 
centers in Al Zarga governorate which located in Jordan, married and not married women 
percentages were 51.4%, and 48.6 with minimum age 20 years. There was a difference in 
the percentages of marital status, married group was higher than not married group, may be 
due to the reason that marriage is too costly and the men are get married in older ages. 
Another study was conducted among Taif university students in Sudia Arabi, (Issa, 2014), 
all the participants were male according to Saudian community roles in their universities, 
the age of them was 19 – 25 years, the participants were categorized into single and 
married with percentages of 91.8%, 8.2% respectively. Issa, (2014) in his categories 
differed from ours; because he selected his participants from students of the university, 
making the most of population not married. 
4.1.5 Family members 
Our population was categorized according to family members into < 6 members (51.7%), 
and ≥ 6 members (48.3%). Also in his study, Issa, (2014) categorized the population into 
two groups < 5 was (10.3%), and ≥ 5 was (89.7%). In our study, the two categories in our 
study are near together but not in (Issa, 2014) study. This may had come from early 
marriage in Saudian community and multi numbers of wives there. 
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4.1.6 Total income 
In our study the participants were divided into three groups according to the monthly 
income of the family, < 1000 NIS (31.9%), 1000 – 2000 NIS (42.7%), and ≥ 2000 NIS 
(25.4%), Issa (2014) also divided his participants into three groups low, middle, and high 
which were 19.6%, 34.4%, and 46% respectively. There was a difference between the 
categories in the two studies and this belongs to the difference of economic level between 
the two countries. 
4.2 Medical history of the population 
Table (‎4.2): Summary of medical history of the population 
Disease NO. % 
Hypertension 19 5 
Heart disease 4 1.1 
Diabetes 5 1.3 
GIT problems 9 2.4 
Psychiatric disease 2 0.5 
Vision 1 0.3 
Headache 1 0.3 
DVT 1 0.3 
 
 
 
 
 
In this study, 5% of the participants were hypertensive, 1.1% were heart disease, 1.3% 
were diabetes, 2.4% were GIT problems, 0.5% were psychiatric. There were low levels of 
diseases among the participants because of the study participants were from blood donors 
who are considered the healthiest group in our community. A study was carried out at 
Recep Tayyip Erdog University in Turkey (Uydu, et al., 2014), about 165 participants; 86 
men and 79 women, were included in the study. They were from cardiology department of 
the medical school at the university. The study aim was to explain the tendency of 
hyperlipidemic individuals, develop atherogenic dyslipidemia by analyzing plasma lipids 
and lipoproteins sub fractions. Medical history of the participants was recorded in this 
study, we can notice that from non hyperlipidemic individuals the percentage of 
hypertension was 42% and 43% from hyperlipidemic participants, another one was the 
percentages of diabetes among non hyperlipidemic and hyperlipidemic were 16%, and 
11% respectively. These percentages of hypertension and diabetes were higher than in our 
study because the participants were patients from cardiology department.  
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4.3 Family history 
The table (4.3) explains numbers and percentages of variables and diseases among 
participant's parents and siblings. Most of diseases in the family history of our study were 
obesity (41.7%), diabetes (43%), and hypertension (51.2%). Obesity was 41.7% among 
parents of blood donors, where in (Issa, 2014) study was 40.9% among students in Taif 
University because both population were healthy. In (Jin & Teng, 2014) study the family 
history of diabetes was 180 participants who were 3.3% from the whole population in that 
study. 
Table (‎4.3): Summary of family history of the population 
Disease Parents Siblings 
 No. % No. % 
High Cholesterol   55 14.5 15 4 
High Triglyceride  51 13.5 14 3.7 
Obesity  158 41.7 86 22.7 
Diabetes  163 43 36 9.5 
Hypertension  194 51.2 39 10.3 
Death from HD before 60  24 6.3 7 1.8 
 
Also, hypertension among family history was 51.2% while according to (Abed & Abu-
Haddaf, 2013) family history of the participants of their study about risk factors of 
hypertension was 85.8% and this percentage was higher than the percentage in our study  
because cases were hypertensive and not healthy population as in our study. 
4.4 Life style 
Participants in our study were questioned about their life style, so questionnaire included 
nutrition, smoking, and physical activity questions. Nutrition part includes two sections: 
one for dietary intake, and the other was about dietary habits.  
4.4.1 Nutrition  
4.4.1.1 Dietary Intake  
The table (4.4) shows dietary intake score among participants of the study population, the 
highest scoring belongs to bread (98.2%) and coffee-tea intake (90.2%). Moderate scoring 
was noticed among olives oil, vegetables, fruits, and sweet intake, which were 66.6%, 
61.0%, and 60.4% respectively. 
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Table (‎4.4): Summary of dietary intake of the population 
RII* Mean Never Seldom 2-3/week Once/day > 
once/day 
Food 
43.2 % 2.2 88 
23.2 
189 
49.7 
58 
15.3 
42 
11.1 
2 
0.5 
No. 
% 
Milk 
60 % 3.0 7 
1.8 
90 
23.7 
178 
46.8 
101 
26.6 
3 
0.8 
No. 
% 
Cheese, yogurt 
41.2 % 2.1 25 
6.6 
312 
82.1 
33 
8.7 
9 
2.4 
0 
0 
No. 
% 
Ice cream 
59.6 % 2.9 1 
0.3 
39 
10.3 
303 
79.9 
35 
9.2 
1 
0.3 
No. 
% 
Meat, Fish,  
Poultry 
59.4 % 2.9 9 
2.4 
91 
24 
148 
48.5 
91 
24 
4 
1.1 
No. 
% 
Eggs 
51.8 % 2.6 8 
2.1 
189 
49.9 
137 
36.1 
41 
10.8 
4 
1.1 
No. 
% 
Peanut butter, 
nuts 
50.2 % 2.5 14 
3.7 
175 
46.2 
172 
45.4 
16 
4.2 
2 
.5 
No. 
% 
Dry beans, peas, 
soy 
57.6 % 2.9 6 
1.6 
124 
32.7 
163 
43 
84 
22.2 
2 
0.5 
No. 
% 
Citrus fruits, juice 
66.2 % 3.3 2 
0.6 
53 
14 
152 
40.1 
171 
45.1 
1 
0.3 
No. 
% 
Vegetables 
61.0 % 3.0 2 
0.5 
85 
22.4 
193 
50.9 
87 
23 
12 
3.2 
No. 
% 
Fruits 
98.2 % 4.9 0 
0 
2 
0.5 
1 
0.3 
26 
6.9 
350 
92.3 
No. 
% 
Bread, cereals, 
rice,  
60.4 % 3.0 4 
1.1 
128 
33.8 
120 
31.7 
110 
29 
17 
4.5 
No. 
% 
Sweets 
46.2 % 2.3 37 
9.8 
235 
62 
65 
17.2 
35 
9.2 
7 
1.8 
No. 
% 
Salty snacks 
54.8 % 2.7 34 
9 
152 
40.1 
89 
23.5 
86 
22.7 
18 
4.7 
No. 
% 
Soda pop, Kool-
Aid 
66.6 % 2.3 10 
2.6 
57 
15 
122 
32.2 
175 
46.2 
15 
4 
No. 
% 
Olives oil 
90.2 % 4.5 350 
92.3 
5 
1.3 
4 
1.1 
16 
4.2 
4 
1.1 
No. 
% 
Coffee 
43.0 % 2.2 41 
10.8 
261 
68.9 
56 
14.8 
19 
5 
2 
0.5 
No. 
% 
Fast food 
56.2 % 2.8 5 
1.3 
144 
38 
158 
41.7 
64 
16.9 
8 
2.1 
No. 
% 
Fried food 
 
*RII: Relative Importance Index= mean * 20%  
 
Participants were found to take meat, eggs, juice, fried food, and soda as 59.6%, 59.4%, 
57.6%, 56.2% and 54.8% respectively, lower percentages of dietary intake were found in 
nuts, beans, milk, salty snacks, and fast food.  
4.4.1.2 Dietary Habits 
Results in table (4.5) explain that 13.2% from the study population follow diet regimen, 
86.8% were not, the percentage of the participants taking three regular meals was 30.3%, 
when comparing with the percentage of those who do not take three regular meals 69.7%. 
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About daily breakfast 60.4% of the participants take always the meal, 28.8% answered 
sometimes, and 10.8% were never taking breakfast. About 53.3% of the population was 
sometimes taking meals outside home vs. 43.3% who never eat outside home. 
Júnior, et al., (2012) in his study, found that prevalence of eating breakfast daily was low 
in boys (47.5%), and girls (44.7%) among the obese population, and the results showed 
that there was a negative correlation between taking breakfast and levels of triglyceride, 
and low density lipoprotein.  
Table (‎4.5): Summary of dietary habits of the population. 
Dietary habits    Yes 
                          
 
No  
No.  % No.  % 
Diet regimen 50 13.2 329 86.8 
3 regular meals 115 30.3 264 69.7 
 
Dietary habits    Always  Sometimes  Never  
No  % No  % No  % 
Daily breakfast 229 60.4 109 28.8 41 10.8 
Meals outside home 13 3.4 202 53.3 164 
 
 
43.3 
 Eating during watch TV 33 8.7 137 36.1 209 55.1 
Eating during internet 15 4 72 19 292 77 
4.4.2 Smoking 
Table (‎4.6): Distribution of smoking types among the population 
Smoking types 
 
 
Yes 
                          
 
No.  % 
Smoking cigarette 92 24.3 
Smoking argella   58 15.3 
Smoking cig + argella 104 27.4 
Past smoking 
 
108 28.5 
Smoking Exposed  
 
341 90 
 
Findings explained that percentage of smoking cigarette was 24.3% in this study, Issa, 
(2014) found that smokers percentage was 29.1%, it was higher than the percentage of 
smokers among our participants because his study population were from young age 
between 19 – 25 years. Also Tayem et al., (2012) conducted a study in the West Bank, 
which aimed to determine the prevalence and correlates of obesity and hypertension among 
students at a central university there. Tayem et al., (2012) found that the percentage of 
smoker was 29.1%, it was higher than 24.3% because the population in his study was from 
the students of university 17 - 26 years and it was include the female smokers. Abed & 
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Abu-Haddaf, (2013) in their case control study among hypertensive patients in UNRWA 
primary health care clinics, found that (8.3%) were smokers, and (93.3%) were exposed to 
smoking. There is clear difference in the percentage of current smokers, because of the 
increase in awareness of hypertensive patients about the danger of smoking on their health. 
This explained why in Abed & Abu-Haddaf, findings showed that the former smoker was 
15.5% among cases, and 1% among controls, diseased people tend to stop smoking. Our 
study found that past smokers were 28.5%. May this increase is due to the population in 
our study was larger or to increase of cigarette price at the present time. 
4.4.3 Physical activity 
Results in table (4.7) show that 28.8% of the study population was classified as low 
physical activity, 61.4% were moderate physical activity, and 9.8% of them were high 
physical activity.  
Table (‎4.7): Distribution of physical activity among study population 
PA categories   No. % Cumulative Percent 
 
Low 109 28.8 28.8 
Moderate 233 61.4 90.2 
High 37 9.8 100.0 
Total 379 100.0  
4.5 Biochemical tests 
Results in table (4.8), show that the means of total cholesterol, triglyceride, high-density 
lipoprotein, low-density lipoprotein, and very low-density lipoprotein were (175.95 ± 
39.25), (160.2 ± 112.5), (44.96 ± 4.26), (99.34 ± 36.1), and (32.04 ± 22.5), respectively. 
According to Khader, et al. (2010), North Jordanians' means of lipid profile were 197.8 ± 
39.25), (185.7 ± 116.1), (38.2 ± 8.1), (122.4 ± 34.7), respectively. The means in Khader, 
(2010) study,  were higher because of the increasing age among the participants. 
 
Table (‎4.8): Population means, (SD) and percentage of high biochemical tests 
Biochemical tests    Mean (mg/dl)   (SD)  High % 
Cholesterol   175.95 39.25 22.7 
Triglyceride  160.2 112.5 41.2 
HDL  44.96 4.26 11.9 
LDL  99.34 36.10 17 
  
59 
 
The mean of cholesterol (175.95) mg/dl was in the range of the acceptable normal value 
for cholesterol level which is up to 200 mg/dl, where the mean of triglyceride (160.2) 
mg/dl was higher than the normal range which is up to 150 mg/dl. High-density lipoprotein 
mean was 44.95 mg/dl in the normal range for HDL which is ≥40.0 mg/dl where the mean 
of low-density lipoprotein was 99.34 mg/dl and it is in the normal range for LDL which is 
<130 mg/dl.   
 
According to the table (4.9)  hypercholesterolemia among blood donors was 22.7%,  
Hypertriglyceridemia was 41.2%, low level of HDL was 11.9%, and high level of LDL 
was 17%. 
Table (‎4.9): Prevelance of  lipid profile among the study population 
In Abed & Abu-Haddaf, (2013) study the percentages of hypercholesrolemia, 
triglycerdemia, low HDL, and high LDL were 29.2%, 35.3%, 38.3%, and 24.3% 
respectively, the percentages in the last study were highest because of the second study 
participants were hypertensive. Khader, et al., (2000) found that 48.8% had high TC level, 
40.7% had high LDL, 40.1% had low HDL, 43.6% had high triglyceride levels, this 
difference in prevalence with our study because the participants were of age from 25 to 85 
years and this increase the risk to have hyperlipidemia. 
4.6 Anthropometric parameters 
Table (‎4.10): Means and (SD) of anthropometric parameters among the population 
Anthropometric 
parameters 
Mean  Standard deviation (SD)  
Weight (kg)  83.37 16.85 
Height (m) 174.80 6.56 
Waist circumferences (cm) 96.08 13.73 
Body Mass Index kg/ m
2
 
 
 
 
 
 
27.89 14.63 
 
Tests Groups No % 
Cholesterol < 200 
≥ 200 
293 
86 
77.3 
22.7 
Triglyceride < 150 
≥ 150 
223 
156 
58.5 
41.2 
HDL < 40 
≥ 40 
45 
334 
11.9 
88.1 
LDL < 130 
≥ 130 
313 
64 
83 
17 
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The population here was examined to determine the weight, height, waist circumferences 
(WC), and body mass index (BMI). The means of these parameters were (83.37), (174.8), 
(96.08), and (27.89) respectively. A cross sectional study was conducted among 839 
patients of metabolic syndrome (Gierach et al., 2014), men in Gierach, (2014) study were 
41.1% of total participants, with age (63.0±13.8) years and the study aimed to demonstrate 
a correlation between waist circumference (WC) and body mass index (BMI) in patients 
with metabolic syndrome in relation to hypertension, lipid disorders. The means of height, 
weight, BMI, and WC were 173, 92.5, 30.8, and 110.8 respectively. The BMI and WC in 
our study are lower than in Gierach, (2014), this difference is due to the type of population, 
which was taken in the two studies.  
Table (‎4.11): BMI categories among population 
BMI Cat. Frequency No Percent % 
Normal weight + Underweight* 138 36.4 
Overweight 134 35.4 
Obese 107 28.2 
Total 379 100.0 
 
*Normal weight cases were 137 and only one case was underweight. 
 
Body mass index categories in the study shows that 36.1% of population was normal 
weight, 35.4% overweight, and 28.2% were obese. Taheri et al., (2015), found that normal 
body mass index percentage was 84.4%, overweight was 7.5% and obese was 8.1%, this 
was different from this study findings because Taheri et al., (2015) studied lipid profile and 
prevalence among adolescent with low age 11-18 years. According to Abdeen et al., (2012) 
cross sectional study, the data was used from the First National Health and Nutrition 
Survey (1999-2000) in order to provide a baseline data on the prevalence and distribution 
of overweight and obesity and their associations among adults in Palestine. For all the 
population (n = 3378): 1.5% were underweight, 36.1% were in the normal range, 38.0% 
were overweight, and 24.4% were obese. There was slightly difference in the percentages 
of BMI categories, due to large number of participants in (Abdeen et al., 2012) study. 
Another study was conducted in the West Bank (Tayem, et al., 2012) showed that the 
percentages of the four BMI categories among male students of university were 2.1%, 
57.1%, 31.1%, and 9.4%. Normal BMI in Tayem, (2012) was higher because the 
population here was younger than our study what is making the normal percentage higher. 
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 Blood Pressure (BP)  
Population was classified according to the systolic blood pressure into two groups, normal 
or high systolic blood pressure. Normal took the value < 140, and high was  ≥ 140. 
Diastolic blood pressure also, classified into two groups, < 90, and ≥ 90. The mean of 
systolic blood pressure here was 115.9 with SD (11.9), and The mean (SD) of diastolic 
were 74.53 (10.27). Hypertensive participants were 2.1% among diastolic and 4.0% among 
systolic. 
Table (‎4.12): Systolic blood pressure (SBP) categories among population 
SBP No. % Cumulative % 
<140 371 97.9 97.9 
≥140 8 2.1 100.0 
Total 379 100.0  
 
 Table (‎4.13): Diastolic blood pressure (DBP) categories among population 
DBP No. % Cumulative % 
<90 364 96.0 96.0 
≥90 15 4.0 100.0 
Total 379 100.0  
 
 
Cross sectional study was conducted among 234 participants including 159 hypertensive 
patients and 75 normal hypertensive controls in the National Centre for Control of 
Rheumatic Fever and Heart Disease in Dhaka, Bangladesh (Wahiduzzaman, 2014). The 
study aimed to determine the association between serum lipid profiles in hypertensive 
patients with normotensive control group of participants. Wahiduzzaman, (2014) found 
that means (SD) of systolic and diastolic were 137.49 (9.58), and 94.42 (8.81), in 
respectively. The means in Wahiduzzaman, (2014) study were too higher because here the 
participants were from hypertensive patients and not from healthy population as in our 
study. 
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4.7 Lipid profile and socio demographic variables  
4.7.1 Cholesterol and socio demographic variables 
4.7.1.1  Cholesterol and Age 
Results in table (4.14) show the relation between Cholesterol groups and age groups. 
Cholesterol was classified into two categories normal cholesterol level (< 200 mg/dl), and 
high cholesterol level (≥ 200 mg/dl). Findings revealed that among population with age 
group (20 - 30) years, 89.1% were normal, 10.9 % were hypercholesterolemia, while 
normal, and high levels among age group ≥ 30 years were 65.1%, and 34.9% respectively. 
There was an association between age groups and cholesterol groups, 
Hypercholesterolemia was significantly higher in age group ( ≥ 30 years) than other group 
with (P = 0.00). Wahed, et al., (2016) study was conducted to determine the prevalence of 
dyslipidemia among healthy group in El - Fayoum governorates in Egypt. Population were 
from university students, with age (17 - 24) years, high total Cholesterol among ages < 20, 
and ≥ 20 was 38.7%, and 38.9% respectively. 
 
Table (‎4.14): Relation between Cholesterol level and Socio demographic Variables 
 Normal  Cholesterol  
< 200 mg/dl 
High Cholesterol 
 ≥ 200 mg/dl 
χ2 P value 
Age groups No % No % 
31.2 < 0.01 20 – 30 years 172 89.1 21 10.9 
≥ 30 years 121 65.1 65 34.9 
Place of residency     
3.93 0.91 
North 60 80 15 20 
Gaza 97 74.6 33 25.4 
Mid – Zone 42 73.7 15 26.3 
Khan – younis 61 84.7 11 15.3 
Rafah 33 73.3 12 26.7 
Years of education     
0.90 0.48 < 12 years 119 77.8 34 22.2 
≥ 12 years 174 77.0 52 23 
Marital status     
34.6 <0.01 Not Married   120 95.2 6 4.8 
Married 173 68.4 80 31.6 
Family members     
0.39 0.23 < 6 148 75.5 48 24.5 
≥ 6 145 79.2 38 20.8 
Total income     
4.82 0.09 
< 1000 NIS 99 81.8 22 18.2 
1000 – 2000 NIS 127 78.4 35 21.6 
≥ 2000 NIS 66 69.5 29 30.5 
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There was slightly difference in the two means but it does not reach statistically significant 
(P = 0.98), because the population were healthy and there was not a big difference between 
the means of ages between both groups. A study was conducted in Jordan by Hammoudeh 
et al., (2008) on lipid profile among individuals ≥ 18 years of age, who were presented for 
routine check-up, or for management of coronary disease-related admission. Findings 
revealed that in the six age groups, for both sexes, median levels of TC, TG, and LDL 
increased with age and peaked around 50 years of age in men and around 60 years in 
women. At a younger age (< 45 years), men had higher levels of TC, TG, and LDL than 
women did. Another study was conducted in China (Sun, et al., 2014) to estimate the 
prevalence of dyslipidemia, found that prevalence of high TC increases significantly with 
advancing of age. 
4.7.1.2 Cholesterol and place of residency 
Normal and high levels of Cholesterol were distributed among the population of the five 
governorates in the Gaza strip. High cholesterol levels among five governorates of the 
Gaza Strip: North, Gaza, Mid - Zone, Khan Younis, and Rafah, were 20%, 25.4%, 26.3%, 
15.3%, and 26.7% respectively. There was an association between total Cholesterol and 
place of residency but it did not reach statistically significant, because of Gaza strip is 
small area and there is no difference in the living circumstances among the population. 
4.7.1.3 Cholesterol and years of education 
In our study, population was classified according to the years of education into two groups, 
the first was < 12 years of education, and the second was ≥ 12 years. High Cholesterol 
level was found in 22.2% of the first group, and 23% in the second group. There was an 
association but it did not reach statistically significant difference in cholesterol levels 
between the two groups (P = 0.48). This may due to the lack of nutritional programs in 
curriculum, poor educational plan of the country, and wrong habits in our diets. Agreement 
with Schneider, et al. (2006) Among the low educated women 39% had normal total blood 
cholesterol levels and 61% presented either borderline high or high levels. Among the high 
educated women (more than 7 years); 50% had normal blood cholesterol levels, There 
were no statistically significant differences between these groups (p= 0.46). According to 
Sun, et al., (2014) study, high total cholesterol was inversely related with years of 
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education, high levels were among illiterate population (24.9%) and the lowest among 
primary and middle school educated individuals (18.4%), and (12.8%) respectively and 
returned to increase among high school educated or above (14.8%).  
4.7.1.4 Cholesterol and marital status 
Results in the table (4.14) show that normal Cholesterol among not married population was 
95.2%, while high cholesterol was 4.8%. On the other side, normal cholesterol levels were 
found among 68.4% of married population, while high levels were 31.6%. There was an 
association between cholesterol levels and marital status, high cholesterol level was higher 
in the married group than in not married; oppositely, the normal levels in married group 
were less than not married group. This difference between cholesterol and married status 
reached highly statistically significant level (P≤0.01). This difference because of married 
participants was older than not married and this makes the risk for having high cholesterol 
is more. Disagreement with Sun, et al. (2014) study, the results found that there was a 
significant association between the prevalence of high total cholesterol and marital status, 
comparing with married or widowed participants, unmarried persons had greater odds of 
having high cholesterol (P=0.02). 
4.7.1.5 Cholesterol and family members 
Family members were classified into two groups < 6, and ≥ 6 members. Normal 
cholesterol levels formed 75.5%, and 79.2% among both groups' respectively, but high 
levels of cholesterol formed 24.5%, and 20.8% among them. There was an association 
between cholesterol levels and family members groups in this study but this relation does 
not reach statistically significant (P = 0.23). 
4.7.1.6 Cholesterol and total income 
Total income in our study was classified into three groups: < 1000 NIS, 1000 - 2000 NIS, 
and ≥ 2000 NIS. Normal Cholesterol was 81.8 %, 78.4%, and 69.5% among the groups 
respectively. High Cholesterol was distributed as 18.2%, 21.6%, and 30.5% among groups 
respectively. There was significant association between the cholesterol level and total 
income. High level of cholesterol was the highest among the third group ≥ 2000 NIS, but 
this association does not reach statistical significant level (P = 0.09). According to Al-
Daghri et al., (2014) there was positive association between high income and prevalence of 
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metabolic syndrome disease among males in the study, and this belong to sedentary life. 
Furthermore, males in the lower income class seem to be involved with more physically 
demanding occupations and hence present a lower prevalence of metabolic syndrome. Sun 
et al, (2014) in his study found that family income was associated with increased odds of 
having high total cholesterol. 
4.7.2 Triglyceride and Socio demographic Variables 
Table (‎4.15): Relation between Triglyceride level and Sociodemographic Variables 
 Low 
 < 150 mg/dl 
High 
 ≥ 150 mg/dl 
χ2 P value 
Age groups No % No %  
 
30.5 
 
 
<0.01 
20 – 30 years 140 72.5 53 27.5 
≥ 30 years 83 44.6 103 55.4 
Place of residency      
 
 
 
 
13.2 
 
 
 
 
 
0.01 
North 34 45.3 41 54.7 
Gaza 88 67.7 42 32.3 
Mid – Zone 38 66.7 19 33.3 
Khan – younis 41 56.9 31 43.1 
Rafah 22 48.9 23 51.1 
Years of education      
 
0.73 
 
 
0.23 
< 12 years 86 56.2 67 43.8 
≥ 12 years 137 60.6 89 39.4 
Marital status      
 
38.1 
 
 
<0.01 
Not Married   102 81 24 19 
Married 121 47.8 132 52.2 
Family members      
 
 
3.0 
 
 
 
0.051 
< 6 107 54.6 89 45.4 
≥ 6 116 63.4 67 36.6 
Total income      
 
 
11.6 
 
 
 
0.01 
< 1000 NIS 80 66.1 41 33.9 
1000 – 2000 NIS 79 48.8 83 51.2 
≥ 2000 NIS 63 66.3 32 33.7 
 
4.7.2.1 Triglyceride and Age 
The participants in the study were tested to determine the level of triglyceride in their 
blood, and they were classified according to their results into two groups, normal which is 
< 150 mg/dl, and high triglyceride ≥ 150 mg/dl. Normal triglyceride was distributed among 
both categories of participants' ages as 72.5% among 20-30 years group, and 44.5% among 
≥ 30 years group. Also, high triglyceride was distributed among both categories of 
participants' ages as 27.5% among 20-30 years group, and 55.4% among ≥ 30 years group. 
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There was a relationship between triglyceride and age in our study, and there was 
difference of triglyceride among age categories. High levels of TG were found among ≥ 30 
years group more than the younger group. The association here was significant with 
(P=0.00), this significant difference belongs to the nature of food, level of physical activity 
or sports which is higher in young age. We agree with Marcovecchio et al., (2009) who 
found in his study that there were overall increase in lipid parameters with age was found 
and this was particularly evident in male participants and he concluded that Lipid levels 
were significantly influenced by age. 
4.7.2.2 Triglyceride and place of residency 
Findings in our study explained the distribution of normal and high triglycerides among the 
five governorates in the Gaza strip. The percentages of normal triglyceride among North, 
Gaza, Mid Zone, Khan Younis, and Rafah were 45.3%, 67.7%, 66.7%, 56.9%, and 48.9% 
respectively while percentages of high levels of triglyceride were 54.7%, 32.3%, 33.3%, 
43.1%, and 51.1% respectively. There was an association between TG and place of 
residency. High levels of triglyceride were in North (54.7%) and Rafah (51.1%), and Gaza 
was lower in high level of TG (32.3%). The difference between governorates reach 
statistically significant level (P=0.01). This difference may due to the age group difference 
among the participants in the study; the participants of young age in Gaza governorates 
were more than the old age. Mean age of North, Gaza, Mid Zone, Khan yunis, and Rafah 
were (37.04 ± 8.1), (29.7 ± 9.4), (29.9 ± 8.5), (30.9 ± 8.2), (32.9 ± 8.1) respectively. 
Moreover, may the difference due to distribution of sports and stadiums in Gaza more than 
other governorates. Wahed, et al., (2016) tried in his study to determine the prevalence of 
dyslipidemia in Al Fayoum governorates in Egypt, and classified the population according 
to place of residency into rural and urban, and results showed that high levels of TG found 
in rural than urban (P=0.007). 
4.7.2.3 Triglyceride and years of education 
Triglyceride levels were distributed among the two classes of education as it is shown in 
table (4.15). There was a relationship between triglyceride levels and years of education. 
Normal levels of triglyceride were 56.2%, and 60.6% among < 12 years, and ≥ 12 years 
groups respectively, and high levels were 43.8%, and 39.4% respectively among both 
groups. This difference does not reach statistically significant level (P=0.23). This may due 
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to the lack of nutritional programs in curriculum, poor educational plan of the country, and 
wrong habits in our diets. Agreement with Schneider et al., (2006) Among the low 
educated women 80% had normal total blood TG levels, and among the high educated 
women (more than 7 years); 70% had normal blood TG levels, There were no statistically 
significant differences between these groups (p= 0.15).  
4.7.2.4 Triglyceride and marital status 
Results in our study revealed that normal levels of TG were 81% among not married blood 
donors, and 47.8% among the married blood donors. High levels of TG were 19% among 
not married, and 52.2% among married participants. There was an association between 
triglyceride levels and married status in our study, hypertriglyceridemia was higher in 
married group than not married. This difference between the two groups reached a 
statistically significant level (P= 0.00).  
4.7.2.5 Triglyceride and family members 
Results in the table (4.15) explain the percentages of normal and high levels of triglyceride 
among two groups of population according to the number of family members. Normal TG 
was 54.6%, and 63.4% among < 6 and ≥ 6 groups respectively. High levels of TG were 
45.4% and 36.6% among both groups also. There was an association between TG levels 
and family members, and there was difference between the two classes < 6 and ≥ 6 but it 
did not reach statistically significant difference (P=0.051). 
4.7.2.6 Triglyceride and total income 
Table (4.15) also shows the distribution of normal and high levels of triglyceride among 
three population categories, which were classified according to total family income. 
Normal TG levels were found as 66.1%, 48.8%, and 66.3% among < 1000, 1000 - 2000, 
and ≥ 2000 groups respectively. There was a relationship between triglycerides levels and 
income. Population with income (1000 - 2000 NIS) has the highest percentege of high TG. 
This difference exists because this group was the largest group (42.5%) of population and 
half of population with age ≥ 30 years. The difference was statistically significant 
(P=0.003). 
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4.7.3 HDL and Socio demographic Variables 
4.7.3.1 HDL and Age 
Findings in our study show that there was an association between level of HDL and age in 
our study. Low levels of High Density Lipoprotein were 4.7% and 19.4% among age 
groups (20 - 30) years, and (≥ 30) years, respectively. High levels of HDL were 95.3%, 
and 80.6% among the two groups of age respectively. Age group ((≥ 30) years had larger 
percent of low HDL levels, but the younger group had large percent of high HDL. The 
difference between groups was significant (P=<0.001). This significant difference belongs 
to the nature of food, level of physical activity or sports which is higher in young age. 
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Table (‎4.16): Relation between HDL level and Sociodemographic Variables 
 Low 
 < 40 mg/dl 
High 
 ≥ 40 mg/dl 
χ2 P value 
Age groups No % No %  
 
19.5 
 
 
<0.01 
20 – 30 years 9 4.7 184 95.3 
≥ 30 years 36 19.4 150 80.6 
Place of residency      
 
 
 
 
4.7 
 
 
 
 
 
0.32 
North 11 14.7 64 85.3 
Gaza 13 10 117 90 
Mid – Zone 6 10.5 51 89.5 
Khan – younis 6 8.3 66 91.7 
Rafah 9 20 36 80 
Years of education      
 
0.35 
 
 
0.33 
< 12 years 20 13.1 133 86.9 
≥ 12 years 25 11.9 201 88.9 
Marital status      
 
19 
 
 
<0.01 
Not Married   2 1.6 124 98.4 
Married 43 17 210 83 
Family members      
 
.75 
 
 
0.24 
< 6 26 13.3 170 86.7 
≥ 6 19 10.4 164 89.6 
Total income      
 
 
3.4 
 
 
 
0.18 
< 1000 NIS 9 7.4 112 92.6 
1000 – 2000 NIS 23 14.2 139 85.8 
≥ 2000 NIS 13 13.7 82 86.3 
4.7.3.2 HDL and place of residency 
HDL levels were distributed among Gaza strip governorates from low levels of HDL (<40 
mg/dl) and high levels (≥ 40 mg/dl). North, Gaza, Mid Zone, Khan Younis, and Rafah had 
low levels of HDL as 14.7%, 10%, 10.5%, 8.3%, and 20% respectively. While high levels 
of HDL were 85.3%, 90%, 89.5%, 91.7%, and 80% among the five governorates 
respectively. An association was found between HDL levels and place of residency, but the 
relationship between HDL levels and governorates didn't reach statistically significant 
(P=0.32). 
4.7.3.3 HDL and years of education 
Table (4.16) illustrates that there was a statistical relationship between HDL level and 
years of education, levels of low and high HDL were 13.1%, and 86.9% among < 12 years 
group while levels of low and high HDL were 11.9%, and 88.9% among ≥ 12 years group. 
However, this relationship was not statistically significant (P=0.33). 
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4.7.3.4 HDL and marital status 
From the results, in table (4.16) we can conclude that there was a statistical relationship 
between the level of HDL and marital status, low and high levels of HDL were 1.6%, and 
98.4% among not married group, were the percentages of low and high levels were 17%, 
and 83% among married group. Low levels of HDL were higher in the married group 
while high levels were noticed to be higher in not married group. This difference reached 
statistically significant level (P=<0.001). This difference exists because of the difference in 
ages between two groups, and their physical activity. Atiku & Yusuf, (2011) found that 
high levels of HDL was vary with marital status, but oppositely married men had higher 
mean of HDL than not married.  
4.7.3.5 HDL and family members 
According to family members which was grouped into < 6 and ≥ 6 members low and high 
levels of HDL were 13.3%, and 86.7% among (< 6) members and 10.4%, 89.6% among (≥ 
6) members. There was an association between both categories and the levels of HDL, but 
no statistically significant relationship was found between family members and HDL 
percentages' (P=0.24).  
4.7.3.6 HDL and total income 
HDL was distributed among population with their classes according to the total family 
income. There was a significant relationship between High-density lipoprotein and family 
income. While low levels of HDL were 7.4%, 14.2%, and 13.7% among (< 1000 NIS), 
(1000 – 2000 NIS), and (≥ 2000 NIS) groups, high levels were distributed as 92.6%, 
85.8%, and 86.3%, among them respectively. This difference does not reach statistically 
significant level (P=0.18). According to Sun, et al. (2014), family income was associated 
with increased odds of having high total cholesterol and low high-density lipoprotein 
(P<0.05). 
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4.7.4 LDL and Socio demographic Variables 
4.7.4.1 LDL and Age 
Results in our study show that there was a relationship between levels of Low-density 
lipoprotein and age groups. Low levels of Low-density lipoprotein were 89.6% and 76.1% 
among age groups (20 – 30) years, and (≥ 30) years, respectively. High levels of LDL were 
10.4%, and 23.9% among groups of age respectively. Age group (20 – 30) years had larger 
percent of low LDL levels, but the (≥ 30) group had large percent of high LDL. The 
difference between groups reaches statistically significant level (P<0.001). This significant 
difference belongs to the nature of food, level of physical activity or sports, which is higher   
Table (‎4.17): Relation between LDL level and Socio demographic Variables 
 Low  
< 130 mg/dl 
High  
≥ 130 mg/dl 
χ2 P value 
Age groups No % No %  
 
12.2 
 
 
<0.01 
20 – 30 years 173 89.6 20 10.4 
≥ 30 years 140 76.1 44 23.9 
Place of residency      
 
 
 
 
1.6 
 
 
 
 
 
0.81 
North 64 85.3 11 14.7 
Gaza 104 80 26 20 
Mid – Zone 47 82.5 10 17.5 
Khan – younis 62 86.1 10 13.9 
Rafah 36 83.7 7 16.3 
Years of education      
 
0.21 
 
 
0.38 
< 12 years 127 84.1 24 15.9 
≥ 12 years 186 82.3 40 17.7 
Marital status      
 
17.5 
 
 
<0.01 
Not Married   119 94.4 7 5.6 
Married 194 77.3 57 22.7 
Family members      
 
0.09 
 
 
0.43 
< 6 163 83.6 32 16.4 
≥ 6 150 82.4 32 17.6 
Total income      
 
 
3.7 
 
 
 
0.15 
< 1000 NIS 104 86.7 16 13.3 
1000 – 2000 NIS 135 83.9 26 16.1 
≥ 2000 NIS 73 76.8 22 23.2 
 
 
In young age. According to Deng, et al. (2012) study which was conducted in China to 
determine the prevalence and determinants of hyperlipidemia, findings explained that 
prevalence of LDL increase by increasing of age.  
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4.7.4.2 LDL and place of residency 
LDL levels were distributed among Gaza strip governorates from low levels of LDL (<130 
mg/dl) and high levels (≥ 130 mg/dl). There was statistically difference between LDL 
levels and place of residency. North, Gaza, Mid Zone, Khan Younis, and Rafah had low 
levels of LDL as 85.3%, 80%, 82.5%, 86.1%, and 83.7% respectively. While high levels of 
LDL were 14.7%, 20%, 17.5%, 13.9%, and 16.3% among the five governorates 
respectively. The relationship between levels of low and high LDL levels among 
governorates was not statistically significant (P=0.81). 
4.7.4.3 LDL and years of education 
Table (4.17) explains the levels of low and high LDL among population classes according 
to the years of education. There was a significant relationship between LDL levels and 
years of education. Levels of low and high LDL were 84.1%, and 15.9% among < 12 years 
group while levels of low and high LDL were 82.3%, and 17.7% among ≥ 12 years group. 
This relation was not statistical significant (P=0.38). 
4.7.4.4 LDL and marital status 
Results, in table (4.17) indicate that there was a statistically relationship between Low-
density lipoprotein and marital status. We noticed that low and high levels of LDL were 
94.4%, and 5.6% among not married group, were the percentages of low and high levels 
were 77.3%, and 22.7% among married group. Low levels of LDL were higher in the not 
married group while high levels were higher in married group. The difference between 
groups was statistically significant (P<0.001), because of the difference in ages between 
two groups, and their physical activity. 
4.7.4.5 LDL and family members 
Family members were grouped into < 6 and ≥ 6 members. There was statistically 
relationship between LDL levels and family members in this study. Low and high levels of 
LDL were 83.6%, and 16.4% among (< 6) members and 82.4%, 17.6% among (≥ 6) 
members. However this difference in LDL levels between groups does not reach 
statistically significant level (P=0.43).  
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4.7.4.6 LDL and total income 
LDL was distributed among population with their classes according to the total family 
income; there was a statistically relationship between LDL and family income. While low 
levels were 86.7%, 83.9%, and 76.8% among (< 1000 NIS), (1000 – 2000 NIS), and (≥ 
2000 NIS) groups, high levels were distributed as 13.3%, 16.1%, and 23.2%, among them 
respectively, however, this difference doesn‘t reach statistically significant level (P=0.15).  
4.8 Lipid profile and family history 
Participants in our study were questioned about family history; the most problems were 
diabetes, obesity, and hypertension. They were categorized into two groups: yes, if they 
have family history of disease, and no, for free family history of this disease, chi square 
was done to examine the relation between lipid profile and family history. 
4.8.1 Cholesterol and family history 
Table (‎4.18): Relation between Cholesterol level and Family history 
Family history variables Cholesterol  
 No. Mean SD t  P value 
Diabetes      
 
2.65 
 
 
0.01 
Yes  163 181 40 
No  216 170 38 
Obesity      
 
3.9 
 
 
<0.01 
Yes  158 184.6 40.4 
No  221 169.1 37.1 
Hypertension      
 
0.71 
 
 
0.48 
Yes  194 176.9 33.9 
No  185 174.1 44.1 
 
Table (4.18) explains that there was a statistically relationship between family history of 
diabetes and cholesterol level, the mean of cholesterol among participants with positive 
family history of diabetes was (181 ± 40) and it was more than the mean of cholesterol 
among the negative group for family history of diabetes, which was (170 ± 38), this 
difference in means was statistically significant (P=0.01). Berentzen et al., (2016) in his 
study, found that there is independently association between children with strong family 
history of diabetes and higher levels of cholesterol. We agree with Van der Sande et al., 
(2001), in his study about if, family history has significant risk factor for non-
  
74 
 
communicable disease, that individuals with family history of diabetes had higher levels of 
cholesterol and there were highly statistically significant (P=<0.01). 
 In addition, mean of cholesterol among participants of family history of obesity was 
(184.6 ± 40.4), and it is more than the mean of cholesterol among the participants of no 
family history of obesity (169 ± 37.1). The difference in means here was highly 
statistically significant (P=<0.01), but it did not reach statistically significant level in (Van 
der Sande, 2001) study. 
There was a statistically relationship between cholesterol levels and the participants with 
positive family history of hypertension, compared with those without family history of 
hypertension, but it doesn‘t reach statistically significant level (P=0.48), here we disagree 
with (Van der Sande, 2001), who found highly statistically significant relationship between 
cholesterol level and the family history of hypertension (P=<0.01). 
4.8.2 Triglyceride and family history 
Table (‎4.19): Relation between Triglyceride level and Family history 
Family history variables Triglyceride  
 No. Mean SD t P value 
Diabetes      
 
2.83 
 
 
0.01 
Yes  163 178.9 128.2 
No  216 146.1 96.9 
Obesity      
 
2.48 
 
 
0.01 
Yes  158 177.1 129.5 
No  221 148.2 97.1 
Hypertension      
 
0.817 
 
 
0.41 
Yes  194 164.8 114.7 
No  185 155.4 110.3 
Results in table (4.19) show that there was a statistically relationship between triglyceride 
level and family history of diabetes. Mean of triglyceride among participants of positive 
family history of diabetes was (178.9 ± 128.2), and it was more than the mean among 
participants of no family history of diabetes which was (146.1± 96.9). This difference 
between means was statistically significant (P=0.01).  
The table also explains that there was a statistically relationship between triglyceride level 
and family history of obesity. Mean of triglyceride among participants of positive family 
history of obesity was (177.1 ± 148.2), and it was more than the mean among participants 
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of no family history of obesity which was (129.5 ± 97.1). This difference between means 
was statistically significant (P=0.01).  
Findings also explain that there was statistical relationship between the family history of 
hypertension and triglyceride levels. However, the relationship does not reach statistically 
significant level. Comparing our results to Van der Sande et al., (2001) study, we agree 
with him in statistically significant relationship between family history of diabetes and 
triglyceride levels (P <0.01), and disagree with him in the results about family history of 
obesity and triglyceride levels which was not statistically significant. Finally, we agree 
with him with his results about the relation of family history of hypertension and 
triglyceride levels, which was not statistically significant. 
4.8.3 High Density Lipoprotein and Family history 
Table (‎4.20): Relation between HDL level and Family history 
Family history variables High Density Lipoprotein 
 No. Mean SD t P value 
Diabetes      
 
-2.7 
 
 
0.01 
Yes  163 44.3 4.4 
No  216 45.5 4.1 
Obesity      
 
-2.68 
 
 
0.01 
Yes  158 44.3 4.2 
No  221 45.5 4.3 
Hypertension      
 
-.56 
 
 
0.58 
Yes  194 44.9 4.1 
No  185 45.1 4.5 
The results in table (4.20) show that there was a statistically relationship between HDL 
level and family history of diabetes. The mean of High Density Lipoprotein among the 
individuals who have positive family history of diabetes was (44.3 ± 4.4) lower than the 
mean of HDL levels among the individuals of no family history of diabetes (45.5 ± 4.1). 
This association was statistically significant (P=0.01). 
 Results also show that the mean of High Density Lipoprotein among the individuals who 
have positive family history of obesity was (44.3 ± 4.2) and it was lower than the mean of 
HDL levels among the individuals of no family history of obesity (45.5 ± 4.3). And this 
relation reach statistically significant level (P=0.01). 
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There was a statistically relationship between HDL level and family history of 
hypertension. The mean of High-density lipoprotein among the participants of positive 
history of hypertension is different from the mean in the other group but this difference 
does not reach statistically significant level (P=0.58).   
4.8.4 LDL and Family history 
The results in table (4.21) explain that there was a statistically relationship between low-
density lipoprotein level and family history of diabetes. Mean of low-density lipoprotein 
among the individuals who have positive family history of diabetes was (103.5 ± 37.8) 
higher than the mean of LDL levels among the individuals of no family history of diabetes 
(96.3 ± 34.5). This association was not statistically significant (P=.056). 
Results also show that the mean of low-density lipoprotein among the individuals who 
have positive family history of obesity was (106.9 ± 38.8) and it was higher than the mean 
of LDL levels among the individuals of no family history of obesity (94.03 ± 33.1). This 
relation reaches statistically significant level (P=0.01). The mean of Low-density 
lipoprotein among the participants of positive history of hypertension is different from the 
mean in the other group but this difference does not reach statistically significant level 
(P=0.47). 
Table (‎4.21): Relation between LDL level and Family history 
Family history variables Low density lipoprotein 
 No. Mean SD t P value 
Diabetes      
 
1.92 
 
 
0.055 
Yes  161 103.5 37.8 
No  116 96.3 34.5 
Obesity      
 
3.45 
 
 
0.01 
Yes  156 106.9 38.8 
No  221 94.03 33.1 
Hypertension      
 
0.732 
 
 
0.465 
Yes  192 100.7 33.2 
No  185 97.9    38.9 
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4.9 Lipid profile and obesity 
4.9.1 Cholesterol and obesity 
Table (‎4.22): Relation between Cholesterol level and Obesity: BMI, WC 
 Normal Cholesterol  
< 200 mg/dl 
High Cholesterol 
 ≥ 200 mg/dl 
χ2 P 
value 
BMI  No % No %  
 
 
42 
 
 
 
<0.01 
Normal+Underweight 130 94.2 8 5.8 
Overweight  99 73.9 35 26.1 
Obese  64 59.8 43 40.2 
WC       
 
39.7 
 
 
<0.01 
< 94 cm 157 92.4 13 7.6 
≥ 94 cm 136 65.1 73 34.9 
 
According to Body Mass Index, population was classified into four groups, under weight, 
normal weight, overweight and obese. Also the population was classified according to 
waist circumferences measure into normal and abnormal. Results in table (4.22) indicate 
that there was a statistically relationship between cholesterol levels and body mass index, 
normal and high levels of cholesterol were 94.2%, 5.8% among participants of normal 
weight+underweight, 73.9%, 26.1% among the participants of overweight and 59.8%, 
40.2% among the obese, respectively. The association was highly statistically significant 
(P<0.01). The difference between categories may return to the difference in diet habits, diet 
intake, and physical activity among the participants.  
Results also show that there was a statistically relationship between cholesterol levels and 
waist circumferences, normal and high cholesterol levels were distributed as 92.4%, 7.6% 
among normal group of waist circumferences (< 94 cm) and 65.1%, 34.9% among the 
abnormal group of waist circumferences (≥ 94 cm). The difference between categories 
reaches highly statistically significant level (P<0.01).  
4.9.2 Triglyceride and obesity 
Results in table (4.23) show that there was a statistically association between triglyceride 
levels and body mass index, normal and high levels of triglyceride were 81%, 19% among 
participants of normal weight+underweight, 53.7%, 46.3% among the participants of 
overweight and 36.4%, 63.6% among the obese, respectively. The association was highly 
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statistically significant (P<0.001). The difference between categories may return to the 
difference in diet habits, diet intake, and physical activity among the participants.  
Results also explain that there was a statistically relationship between triglyceride levels 
and waist circumferences, normal and high triglyceride levels were distributed as 77.1%, 
22.9% among normal group of waist circumferences (< 94 cm) and 44%, 56% among the 
abnormal group of waist circumferences (≥ 94 cm). 
Table (‎4.23): Relation between Triglyceride level and Obesity: BMI, WC 
 LowTriglyceride 
 < 150 mg/dl 
High Triglyceride 
 ≥ 150 mg/dl 
χ2 
P 
value 
BMI No % No %  
 
 
52.1 
 
 
 
<0.01 
Normal+Underweight 112 81 26 19 
Overweight 72 53.7 62 46.3 
Obese 39 36.4 68 63.6 
WC      
 
42.2 
 
 
<0.01 
< 94 cm 131 77.1 39 22.9 
≥ 94 cm 92 44 117 56 
 
The difference between categories reaches highly statistically significant level (P<0.001). 
Deng, et al. (2012), found that hypertriglyceridemia increased with the increase of Body 
Mass Index. Also in Khader et al., (2010), revealed that there was significant difference in 
means of triglyceride among body mass index categories, means of TG were increase from 
(34 ± 7) among normal weight group to (154 ± 31.7) among overweight group and (298 ± 
61.3) among obese group. Khader, et al. (2010), found also that there was a significance 
difference in the means of triglyceride among the waist circumferences of participants. The 
mean of TG among the group of high abdominal obesity was (283 ± 57.9) and it was 
higher than the mean of TG among the group of low abdominal obesity.  
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4.9.3 HDL and Obesity 
Table (‎4.24): Relation between HDL level and Obesity: BMI, WC 
 Low HDL 
 < 40 mg/dl 
High HDL 
 ≥ 40 mg/dl 
χ2 
P 
value 
BMI No % No %  
 
 
22.6 
 
 
 
<0.01 
Normal+ Underweight 3 2.2 135 97.8 
Overweight 19 14.2 115 85.8 
Obese 23 21.5 84 78.5 
WC      
 
20.5 
 
 
<0.01 
< 94 cm 6 3.5 164 96.5 
≥ 94 cm 39 18.7 170 81.3 
 
Results in table (4.24) show that there was a statistically relationship between high-density 
lipoprotein levels and body mass index, low and high levels of HDL were 2.2%, 97.8% 
among participants of normal weight, 14.2%, 85.8% among the participants of overweight 
and 21.5%, 78.5% among the obese, respectively. The association was highly statistically 
significant (P<0.001). The difference between categories may return to the difference 
levels of physical activity among the participants. 
Results also explain that there was significant relation between HDL levels and waist 
circumferences, low and high HDL levels were distributed as 3.5%, 96.5% among normal 
group of waist circumferences (< 94 cm) and 18.7%, 81.3% among the abnormal group of 
waist circumferences (≥ 94 cm). The difference between categories reaches highly 
statistically significant level (P<0.01). In Graversen, et al., (2014) study he found inverse 
relation between HDL and BMI. 
4.9.4 LDL and Obesity 
Results in table (4.25) show that there was a statistically relationship between low density 
lipoprotein levels and body mass index, low and high levels of LDL were 94.2%, 5.8% 
among participants of normal weight, 80.5%, 19.5% among the participants of overweight 
and 71.7%, 28.3% among the obese, respectively. 
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Table (‎4.25): Relation between LDL level and Obesity: BMI, WC 
 Low < 130 mg/dl High ≥ 130 mg/dl χ2 P value 
BMI No % No %  
 
 
22.5 
 
 
 
<0.01 
Normal +Underweight 130 94.2 8 5.8 
Overweight 107 80.5 26 19.5 
Obese 76 71.7 30 28.3 
WC      
 
24.3 
 
 
<0.01 
< 94 cm 159 93.5 11 6.5 
≥ 94 cm 154 74.4 53 25.6 
 
The association was highly statistically significant (P<0.01). The difference between 
categories may return to the difference levels of physical activity among the participants. 
Results also explain that there was a statistically relationship between waist circumferences 
and LDL levels, low and high LDL levels were distributed as 93.5%, 6.5% among normal 
group of waist circumferences (< 94cm) and 74.4%, 25.6% among the abnormal group of 
waist circumferences (≥94cm). The difference between categories reaches highly 
statistically significant level (P<0.01). 
From the results in our study we can see that body mass index and waist circumferences 
are closed related to the hyperlipidemia, the relationship was highly statistically significant 
(P=<0.01). We agree with Rao et al., (2014) in his findings that there were statistical 
significant relationships between BMI and WC with individuals with hyperlipidemia and 
this was higher than those without hyperlipidemia (P=<0.01). Another study was 
conducted by Bruggisser, et al., (2014) revealed that the mean of total cholesterol increased 
by increasing of the body mass index among study participants.  Whereas mean total 
cholesterol level was lower than 4.0 mmol/l among underweight young men (3.919 
mmol/l, 95 % CI 3.902–3.936), mean total cholesterol was ≥ 4.6 mmol/l in all WHO 
subcategories of obesity. Our results agreed with Wahed, et al., (2016) who found that 
there was highly statistically association between waist circumferences and high 
cholesterol (P<0.01), statistically significant relationship between WC and high 
triglyceride (P=0.01), statistically significant relationship between WC and high LDL 
(P=0.002), and statistically significant relationship between WC and low HDL (P=0.01). 
Body mass index was statistically significant related with lipid profile except low HDL 
(P=0.67). We agree with a study that was conducted in China, (Deng, et al., 2012) in the 
presence of highly statistically significant relationship between increasing BMI and 
hypercholesterolemia (p<0.001).  
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4.10 Lipid profile and life style 
4.10.1 Lipid profile and nutrition 
4.10.1.1 Cholesterol and Nutrition 
Results explain the relation between cholesterol levels and diet intake see Annex (9). Mean 
of taking milk among the participants of normal cholesterol was 2.17, and the mean of 
taking milk among high cholesterol level participants was 2.1, there was a statistically 
difference but it did not reach statistical significant level (P=0.46). There was a statistically 
association between the mean of taking cheese among the participants of normal 
cholesterol (2.98), and the mean of taking cheese among high cholesterol level participants 
(3.1), it does not reach statistical significant level (P=0.37). 
The mean of taking ice cream among the participants of normal cholesterol was (2.1), and 
the mean of taking ice cream among high cholesterol level participants was (1.97), this 
difference doesn‘t reach statistical significant level (P=0.06). Mean of taking meat, poultry, 
and fish  among the participants of normal cholesterol was (2.98), and the mean of taking 
meat, poultry, and fish among high cholesterol level participants was (3.0), this 
relationship was statistical, but it did not reach statistical significant level (P=0.06).  
Mean of taking eggs among the participants of normal cholesterol was (2.98), and the 
mean of taking eggs among high cholesterol level participants was (2.92), this difference 
was statistical but it did not reach statistical significant level (P=0.81). Mean of taking nuts 
among the participants of normal cholesterol was (2.6), and the mean of taking nuts among 
high cholesterol level participants was (2.5), this difference was statistical but it did not 
reach statistical significant level (P=0.26).  
Mean of taking beans among the participants of normal cholesterol was (2.6), and The 
mean of taking beans among high cholesterol level participants was (2.4), this difference 
did not reach statistical significant level (P=0.21). Mean of drinking juice among low level 
cholesterol participants was lower than the mean among high level cholesterol participants, 
this difference wasn‘t statistically significant (P=0.12). 
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 There were slightly significant difference in means of taking vegetables, fruits, and bread 
among participants with normal and high cholesterol levels but these differences in means 
did not reach statistically significance level (P=0.29, 0.43, 0.13) respectively. 
There was a statistically relationship between taking sweets, salty snacks and levels of 
cholesterol, the mean difference reaches statistical significant level (P=0.01), and (P=0.02). 
There were slightly statistically differences in means of taking soda, olives oil, coffee, tea, 
herbs, and fast food among the participants of different levels of  cholesterol but these 
differences weren‘t statistically significant (P>0.05). A statistically relationship was found 
between the means of taking fried food and levels of cholesterol among the participants, 
the difference in means reaches statistically significant level (P=0.02). 
4.10.1.2 Triglyceride and Nutrition 
There was a statistically relationship between the Mean of taking milk among the 
participants of normal triglyceride (2.18), and the mean of taking milk among high TG 
level participants (2.1), however, this difference did not reach statistical significant level 
(P=0.52) see Annex (10).  
Also a statistically relationship was found between the mean of taking cheese among the 
participants of normal TG (2.99), and the mean of taking cheese among high TG level 
participants (3.0), this difference did not reach statistical significant level (P=0.73). The 
mean of taking ice cream among the participants of normal TG was (2.07), and the mean of 
taking ice cream among high TG level participants was (2.0), this difference wasn‘t  
significant (P=0.6).  
A statistical relationship was found between the mean of taking meat, poultry, and fish  
among the participants of normal TG (2.95), and the mean of taking meat, poultry, and fish 
among high TG level participants (3.0), this difference reached statistical significant level 
(P=0.05). Mean of taking eggs among the participants of normal TG was (2.97), and the 
mean of taking eggs among high TG level participants was (2.96), however this difference 
did not reach statistical significant level (P=0.91). 
A statistical relationship was obtained between the mean of taking nuts among the 
participants of normal TG was (2.61), and it is higher than the mean of taking nuts among 
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high TG level participants (2.55), but this relationship  doesn‘t reach statistical significant 
level (P=0.46). The mean of taking beans among the participants of normal TG was (2.5), 
and the mean of taking beans among high TG level participants was (2.47), however there 
was a statistical relationship it did not reach statistical significant level (P=0.29). 
Mean of drinking juice among low-level TG participants was lower than the mean among 
high-level TG participants, this difference wasn‘t statistical significant (P=0.41). There 
was slightly statistically difference in means of taking, fruits, vegetables, bread, and sweets 
among participants with normal and high TG levels but these differences in means did not 
reach statistically significance level (P>0.05). There was a statistically relationship 
between taking salty snacks and levels of cholesterol, the relationship was statistically 
significant (P=0.02).  
There were slightly differences in means of taking soda, olives oil, coffee, tea, herbs, and 
fast food, fried food among participants with normal and high levels of TG but these 
differences weren‘t statistically significant (P>0.05).  
4.10.1.3 HDL and Nutrition 
Findings show that there were relationship between High-density lipoprotein levels and 
diet intake. Mean of taking milk among the participants of low HDL was (1.98), and the 
mean of taking milk among high HDL level participants was (2.2), the relationship 
between the two means was statistical but it did not reach statistical significant level 
(P=0.16) see Annex (11). 
There was a statistical relationship between taking cheese and HDL levels. Mean of taking 
cheese among the participants of low HDL was (2.98), and it was lower than the mean of 
taking cheese among high HDL level participants (3.0), this relationship did not reach 
statistical significant level (P=0.82). Another statistically relationship was found between 
taking ice cream and HDL levels,  the mean of taking ice cream among the participants of 
low HDL was (1.93), and the mean of taking ice cream among high HDL level participants 
was (2.1), this difference was statistically significant (P=0.04).  
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A statistically relationship was noticed between taking meat, poultry, and fish vs. HDL 
levels. The mean among the participants with low HDL levels was (2.98), it was lower 
than the mean of taking meat, poultry, and fish among high HDL level participants which 
was (2.99). The relation did not reach statistical significant level (P=0.86). 
There was a statistical relationship between taking eggs and HDL levels. Mean of taking 
eggs among the participants of low HDL was (2.7), and the mean of taking eggs among 
high HDL level participants was (3.0), this difference reached a statistically significant 
level (P=0.03). Mean of taking nuts among the participants of low HDL was (2.4), and the 
mean of taking nuts among high HDL level participants was (2.6), this relationship was 
statistical but it did not reach statistical significant level (P=0.07).  
There was a statistically relationship between consumption of beans and high-density 
lipoproteins levels. The mean of taking beans among the participants of low HDL was 
(2.4), and the mean of taking beans among high HDL level participants was (2.5), this 
relationship did not reach a statistically significant level (P=0.31). 
Mean of drinking juice among low level HDL participants was lower than the mean among 
high level HDL participants, this significant difference wasn‘t statistical significant 
(P=0.17). There were statistically relationships between  the consumption of  vegetables, 
fruits and bread among participants with low and high HDL levels  but these differences in 
means did not reach statistically significance level (P>0.05). There was a statistically 
significant relationship between taking sweets, salty snacks and levels of HDL, the mean 
difference reached statistically significant level (P=0.01), and (P<0.01) respectively.  
There were slightly statistically differences in means of taking soda, olives oil, coffee, tea, 
herbs, and fast food, vs. levels of low and high HDL but these relationships weren‘t 
statistically significant (P>0.05). A statistically relationship was found between taking 
fried food and levels of HDL among the participants, the difference in means reaches 
statistically significant level (P=0.04). 
 
4.10.1.4 LDL and Nutrition 
Means of taking milk, cheese, ice cream, meat, eggs,  and nuts among the participants of 
low LDL were (2.17), (2.99), (2.1), (3.0), (2.99), and (2.59) respectively and the means of 
taking these kinds of food among high LDL level participants were (2.1), (3.1), (2.0), (2.9), 
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(2.9), and (2.6). These differences were not statistically significant (P>0.05). There was a 
statistically relationship between taking beans and LDL levels. Mean of taking beans 
among the participants of low LDL was (2.5), and it was higher than the mean of taking 
beans among high LDL level participants which was (2.4), this difference did not reach 
statistical significant level (P=0.09). Oldewage-Theron, et al., (2007) found that the daily 
consumption of 40 g of whole soybean, had no significant positive effect on TC, but had a 
beneficial effect on LDL. 
Results show that mean of drinking juice among low level LDL participants was higher 
than the mean among high level LDL participants, this difference in means reached 
statistical significant (P=0.03). There were a statistically relationships between  the means 
of taking vegetables, fruits and bread among participants with low and high LDL levels  
but these relationships did not reach statistically significance levels (P>0.05). 
There was a statistically relationship between taking sweets, and levels of LDL, the mean 
of taking sweets among the participants of low LDL was higher than the mean among the 
participants of high LDL level. The relationship reached statistically significant level 
(P=0.03). There were slightly differences in means of taking salty snacks, soda, olives oil, 
coffee, tea, herbs, and fast food, fried food among the participants of low and high LDL 
levels, however these differences weren‘t statistically significant (P>0.05).  
According to Deng, et al. (2012) there was significant difference in percentage of taking 
fried food among hyperlipidemic men comparing with the percentage of 
nonhyperlipidemic participants, and there was significant difference between the two 
groups in taking vegetables. Deng also found the hyperlipidemic group was higher in 
percentage to have salty foods, late night snacks comparing with non-hyperlipidemic 
group. According to Afshan, et al.(2011) there was significant increase in TC, TG, LDL, 
and VLDL levels among the study group which used fast food and low level of HDL 
among the same group when compared with lipid profile among control group which was 
vegetarians group. 
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4.10.2 Lipid profile and Smoking 
Table (‎4.26): Lipid profile and Current cigarette smoking 
 Smoker N Mean Std. Deviation P value 
TC 
Yes 92 172.1 45.1  
0.37 No 287 176.7 37.2 
TG 
Yes 92 171.2 135.9  
0.28 No 287 156.7 103.9 
HDL 
Yes 92 45.1 4.5  
0.80 No 287 44.9 4.2 
LDL 
Yes 90 95.9 38.9  
0.29 No 287 100.4 35.2 
 
Results in the table (4.26) illustrated that there were statistically relationships between the 
means of lipid profile and current smoking groups. The relationships were not statistically 
significant. Our results were not in linear with (Rashan, et al., 2016)  because, he found 
that there were statistically significant relationships between LDL, TC, TG, and HDL 
among smokers and non smokers. The means of all lipid profiles among smokers were 
higher than the means in non-smokers but there was decrease in HDL mean among 
smokers than non-smokers (P=<0.001). We agree with (Barba, et al., 2004) in his study 
about influence of smoking on lipid profile, in the part of not statistical significant 
relationship between total cholesterol and smoking but we differ with him in his results 
which were belonged to statistical significant association between TG, HDL, and LDL and 
smoking. Similar to Al-Ajlan, (2013) study, in his results, there were differences in means 
of total cholesterol, high density lipoprotein, and low density lipoprotein among smokers 
and non smokers and theses relationships didn‘t reach statistically significant level.  
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Table (‎4.27): Lipid profile and Past cigarette smoking 
 Past Smoker No. Mean Std. Deviation P value 
TCL 
Yes 108 184.9 42.8  
<0.01 No 271 171.9 37.2 
TG 
Yes 108 187.9 116.3  
<0.01 No 271 149.2 109.2 
HDL 
Yes 108 44.2 4.7  
0.02 No 271 45.3 4.1 
LDL 
Yes 108 103.1 36.1  
0.20 No 269 97.8 36.1 
 
In the table (4.27) results reflect that there were statistically relationships between lipid 
profile and past smoking, the means of TC, TG, and LDL among past smokers were higher 
than among non past smokers. The mean of HDL among past smokers was lower than 
among non-smokers. These relationships were highly statistically significant between TC, 
and TG, vs. the past smoking (P=<0.001). Also, statistically significant association was 
obtained between HDL, and past smoking (P=0.02), but the difference of means of LDL 
doesn‘t reach statistically significant level (P=0.2). These statistical significant may be due 
to that past smokers had smoked high numbers of cigarettes and for long period and they 
quitted smoking because they afraid that they were at high risk.  
Results in table (4.28) show that there were statistically relationships between lipid profiles 
and exposure to smoke.  
Table (‎4.28): Lipid profile and exposed to smoking. 
 Exposed to Smoke No. Mean Std. Deviation P value 
TC 
Yes 341 176.5 39.3  
0.19 No 38 167.6 38.3 
TG 
Yes 341 162.2 108.8  
0.31 No 38 142.7 141.9 
HDL 
Yes 341 44.9 4.2  
0.59 No 38 45.3 4.7 
LDL 
Yes 339 99.9 36.1  
0.31 No 38 93.7 36.5 
 
Mean of cholesterol, among the participants who exposed to smoking was (176 ± 39.3) and 
it is higher than the mean of cholesterol among non-exposed participants (167 ± 38.3). 
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However, this difference in means did not reach statistically significant level (P=0.19). In 
addition, the mean of High-density lipoprotein, among those exposed to smoking was (44.9 
± 4.2) and it is lower than the mean of HDL among not exposed participants (45.3 ± 4.7). 
However, this difference in means was not statistically significant (P=0.59). Comparable to 
non-exposed participants the mean of Low-density lipoprotein among the participants who 
exposed to smoking was (99.9 ± 36) and it is higher than the mean of LDL among non-
exposed (93.7 ± 36.4). Nevertheless, this difference in means did not reach statistically 
significant level (P=0.31). Zakhar, (2016) found that there were difference in Triglyceride 
and Low density lipoprotein levels between smoking exposed group and unexposed but 
this difference didn‘t reach levels of confirmatory statistical significance. Holay, et al., 
(2004) in his study, found that total cholesterol, and LDL, in passive and active smokers 
were significantly more than in nonsmokers while total triglyceride and HDL cholesterol 
levels did not show statistically significant difference in all the three groups. 
4.10.3 Lipid profile and physical activity 
Table (‎4.29): Lipid profile and physical activity 
Lipid profile Physical activity categories  
χ2 P value 
Low Moderate High 
 No.  % No.  % No.  %   
Cholesterol          
 
<0.01 
< 200 74 67.9 186 79.8 33 89.2  
≥ 200 35 32.1 47 20.2 4 10.8 9.3 
Triglyceride          
 
0.22 
< 150 59 54.1 138 59.2 26 70.3  
≥ 150 50 45.9 95 40.8 11 29.7 3.0 
HDL         
 
0.19 
< 40 18 16.5 24 10.3 3 8.1  
≥ 40 91 83.5 209 89.7 34 91.9 3.3 
LDL         
 
0.02 
< 130 82 75.2 197 85.3 34 91.9  
≥ 130 27 24.8 34 14.7 3 8.1 7.6 
 
Results in the table (4.29) show that there was a statistical relationship between cholesterol 
levels and physical activity levels. Among the participants with low physical activity 
67.9% found to be, normal cholesterol level, and 32.1% was high cholesterol. Normal and 
high Cholesterol levels were 79.8%, 20.2% among the group of moderate physical activity 
and 89.2%, 10.8 among the high physical activity group respectively. This difference 
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reached statistically significant level (P<0.01), this due to the positive effect of physical 
activity on cholesterol level. A statistically relationship between triglyceride levels and 
degree of physical activity was found in our study, normal TG levels increase from 54.1% 
among low physical activity group to 59.2% among moderate physical activity and reach 
70.3% among high physical activity group where high levels of Triglyceride were: 45.9%, 
40.8%, and 29.7% among low, moderate and high physical activity respectively. This 
relationship was not statistical significant (P= 0.22), because of the extent of other factors 
like the nature of diet intake and diet habits among the participants.  
Low and high levels of high-density lipoproteins were distributed as 16.5%, 83.5% among 
low level of physical activity, 10.3%, 89.7% among moderate level of physical activity and 
8.1%, 91.9% among high physical activity group. The difference in HDL levels between 
PA groups did not reach statistically significant level (P=0.19), maybe this due to lack of 
continuous physical activity. 
Normal percentages of Low-density lipoproteins increased by the increasing of physical 
activity level: 75.2%, 85.3%, and 91.9% among low, moderate and high PA. High levels of 
LDL decreased as 24.8%, 14.7%, and 8.1% among low, moderate, and high levels 
respectively. This relationship between LDL levels and PA was statistically significant 
(P=0.02), and this happened because of LDL levels depend on practicing of walking and 
running sports.  
Abhayaratna & Flores (2011) found that sufficient PA levels were predictive of lower 
levels of TG (p=0.028) and HDL-C (p=0.003). also, Kannan et al (2010) studied the effect 
of exercise intensity on lipid profile in sedentary obese adults and found that there were 
significant changes in all lipid profile parameters and moderate and intensity physical 
activities. Deng, (2012) also in his study found that percentage of PA among 
hyperlipidemic participants was 59.8%, and it was lower than the percentage of PA among 
nonhyperlipidemic group. 
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4.11 Lipid profile and blood pressure 
Table (‎4.30): Correlation between Lipid profile and Systolic blood pressure 
Lipid profile  Mean SD r P value 
 Cholesterol  175.6 39.3 0.094 0.07 
Triglyceride  160.2 112.5 0.11 0.03 
HDL 44.9 4.3 -0.12 0.02 
LDL 39.3 36.1 0.05 0.32 
The table (4.30) explains that there was a correlation between lipid profile and systolic 
blood pressure. The relationships were statistical significant with triglyceride, and high-
density lipoprotein. The relationship did not reach statistical significant with cholesterol 
and low-density lipoprotein.  
Table (‎4.31): Correlation between Lipid profile and Diastolic blood pressure 
Lipid profile  Mean SD r P value 
 Cholesterol  175.6 39.3 0.22 0.00 
Triglyceride  160.2 112.5 0.22 0.00 
HDL 44.9 4.3 -0.27 0.00 
LDL 99.3 36.1 0.14 0.005 
The table (4.31) explains that there was a correlation between lipid profile and diastolic 
blood pressure. The relationships between diastolic blood pressure and lipoprotein levels 
reached statistical significant level. Wahiduzzaman (2014) in his study found that TC, TG , 
and LDL means were higher in hypertensive participants when comparing with 
normotensive, and the mean of HDL was lower in hypertensive than normotensive 
participants. The relation between systolic, diastolic pressure and lipid profile was 
statistically significant (P<0.001). Sarwar et al., (2014) also explore that serum total 
cholesterol (TC), triglyceride, LDL, VLDL, were significantly higher (p<0.05) whereas the 
level of HDL cholesterol was significantly lower in hypertensive patients as compared to 
control subjects (p<0.05). Pearson's correlation analysis reveals that HDL cholesterol was 
inversely correlated with systolic and diastolic blood pressure in both patient and control 
groups. However, serum TC, TG, LDL and HDL cholesterol were directly correlated with 
systolic and diastolic blood pressure in both groups. Another study revealed that diastolic 
blood pressure values correlated with all the components of lipid profile (P<0.001) (Varbo, 
et al., 2013). 
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Table (‎4.32): Summary of statistically significant variables with lipid profile 
Significant Study 
variables 
Lipid profile 
TC TG HDL LDL 
Age   P <0.001 P <0.001 P <0.001 P <0.001 
Marital status P <0.001 P <0.001 P <0.001 P <0.001 
Place of residency  P = 0.01   
Total income  P = 0.01   
Family history     
Diabetes P = 0.01 P = 0.01 P = 0.01  
Obesity  P < 0.001 P = 0.01 P = 0.01 P= 0.001 
Obesity      
BMI P < 0.001 P < 0.001 P < 0.001 P < 0.001 
WC P < 0.001 P < 0.001 P < 0.001 P < 0.001 
Life style     
Dietary intake     
Sweets  P = 0.01  P = 0.01 P = 0.03 
Salty snacks P = 0.02 P = 0.02 P <0.01  
Fried food P = 0.02  P = 0.04  
Meat   P = 0.05   
Ice cream   P = 0.04  
Eggs    P = 0.03  
Juice    P = 0.03 
Smoking     
Past smoking P <0.01 P <0.01 P = 0.02  
Physical activity P <0.01   P = 0.02 
Hypertension     
Diastolic BP P = 0.00 P = 0.00 P = 0.00 P = 0.005  
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5 Chapter 5:  
Conclusion and Recommendation 
5.1 Conclusion 
The aim of this study is to identify the prevalence and the most determinants of 
hyperlipidemia among blood donors in Gaza Governorates; the study was conducted to 
address this information gap. The researcher extracted data of these determinants from 
healthy group male adults and highlighted the problem as a public in nature and it needs to 
put community based interventions programs supported with educational programs. The 
study might encourage future national efforts to educate the public about the health 
determinants and it may enhance the generation of future hypotheses. It might increase the 
awareness of the associated determinants of the elevated cholesterol, triglyceride, low-
density lipoprotein, and low levels of high-density lipoprotein before starting any public 
intervention that is targeted to reduce the high prevalence, motivating the efforts to provide 
services related to health promotion, risk detection, and risk reduction. It might support the 
determination of the causes and mechanisms of hyperlipidemia determinants including 
biologic, social, and epidemiologic and influence effective interventions.   
Total of (379) adults were included in the current study, data collected by using an 
interviewed questionnaire, which included demographic, socioeconomic, medical history, 
family history, and life style which includes smoking questions, physical activity 
questions, dietary habits questions, and dietary investigation through food frequency 
questionnaire. Anthropometric measurements, physical examination (BP), and blood 
samples were drawn from the participants to measure total cholesterol, triglyceride, high-
density lipoprotein, and low-density lipoprotein.  
 
From the study findings it appears that, a number of modifiable factors are responsible for 
the elevated of hyperlipidemia among the healthy population in the Gaza Governorates. 
For example obesity and overweight increased the levels of TC, TG, LDL, and decrease 
the levels of HDL. Also to be past smoker you have risk to have abnormal lipid profile 
except LDL. Another modifiable factor is physical inactivity; it was related to high levels 
of cholesterol and low-density lipoprotein. Hyperlipidemia was associated with another 
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modifiable determinant which is dietary intake like taking sweets, salty snakes, fried food, 
meat, ice cream, eggs, and juice.  
The non-modifiable factors were the age, marital status, family history of obesity, and 
diabetes.  
In order to better, characterize Palestinian population it should be possible to reduce the 
prevalence of non-communicable disease, which are responsible for major morbidity and 
mortality, changing modifiable determinants through introducing public health policies, 
programs, and regulations that reduce exposure to such these determinants. It's important 
to apply a research study on the population in the Gaza Strip to know exactly the major 
modifiable determinants of hyperlipidemia among all age groups like children, old age, and 
pregnant women both adult sexes in order to determine the trends of smoking, lifestyle, 
obesity, and lipid profile tests.  
 Findings in the study explained that the means of total cholesterol, triglyceride, 
high density lipoprotein, and low density lipoprotein were 175.9, 160.2, 44.9, and 
99.34 mg/dl respectively. 
 The prevalence of lipid profile was 22.7% for TC, 41.2% for TG, 11.9% for HDL, 
and 17% for LDL. 
 The means ± standard deviations (SD) of the anthropometric parameters among the 
population of the study were (83.3±16.8), (174.8±6.6), (96.1±13.7), and 
(27.8±14.6) for weight, height, WC, and BMI respectively. 
 Body mass index of the population of the study was classified as 
normalweight+underweight (36.4%), overweight (35.4%), and obese (28.2%).  
 There was statistically significant relationship between total cholesterol levels and 
age groups, the high total cholesterol percentage was increasing among ≥ 30 years 
group than the younger group. 
 Another association was noticed between total cholesterol level and marital status, 
it was statistically significant, and high TC percentage was higher among the 
married group. 
 There was a statistically significant relationship between triglyceride levels and age 
group, the percentage of high triglyceride was higher among the older group. 
 Triglyceride levels were related to the Gaza Governorates, and the findings of the 
study showed that there was a statistically significant relationship with place of 
residency, the percentage of high TG level was higher in the north governorates. 
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 A statistically and significant relationship was obtained between TG levels and 
total income of the participants families, the high percentage of TG was obtained 
with the 1000-2000 NIS group. 
 There was a statistically significant relationship between high-density lipoprotein 
level vs. age group, and marital status. High levels of HDL were noticed among the 
younger group, and the not married group. 
 There was a statistically significant relationship between low-density lipoprotein 
level vs. age group, and marital status. High levels of LDL were noticed among the 
older group, and the married group. 
 A positive family history of diabetes and obesity was in relation with lipid profile 
levels, the relationships were statistically significant with all lipid profile except 
between diabetes and LDL levels. 
 Highly statistically and significant relationships were noticed between total 
cholesterol levels triglyceride levels, high-density lipoprotein levels, low-density 
lipoprotein levels as dependent variables, vs. body mass index, and waist 
circumferences categories as independent variables. 
 The participants were asked about dietary intake, by using food frequency 
questionnaire, the highest scoring belongs to bread (98.2%) and coffee-tea intake 
(90.2%). Moderate scoring was noticed among olives oil, vegetables, fruits, and 
sweet intake, which were 66.6%, 61.0%, and 60.4% respectively. Participants were 
found to take meat, eggs, juice, fried food, and soda as 59.6%, 59.4%, 57.6%, 
56.2% and 54.8% respectively, lower percentages of dietary intake were found in 
nuts, beans, milk, salty snacks, and fast food.  
 Findings explained that percentage of smoking cigarette was 24.3% in this study, 
exposed to smoking percentage was 90%, past smoking percentage was 28.5%. 
 Finding in the study showed that there was a statistically significant relationship 
between total cholesterol, triglyceride, high-density lipoprotein, and past smoking, 
but it wasn‘t significant with current smoking and exposed. 
 The population was distributed according to physical activity into low PA (28.8%), 
moderate PA (61.4%), and high PA (9.8%).  
 Cholesterol levels were low among the participants with high physical activity 
(89.2%), and the low-density lipoprotein levels were lower among the participants 
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with higher physical activity (91.9%). There were statistically significant 
relationships between TC and LDL vs. physical activity.  
 There were statistically relationship between triglyceride levels and high-density 
lipoprotein with physical activity. TG levels were lower among the participants 
with high physical activity (70.3%), and HDL levels were higher among them 
(91.9%), but the relationships did not reach the significant level.  
 This study reveals that high prevalence of hyperlipidemia, hypertriglyceridemia, 
and hypercholesterolemia were found. Hyperlipidemia is associated with non 
modifiable risk factors as age marital status, and family history of diabetes, obesity, 
and group of modifiable variables as obesity, lack of physical activity, smoking. 
Interventions to control modifiable risk factors can reduce risk for hyperlipidemia 
and subsequently minimize associated morbidity and mortality.  
5.2 Recommendations 
The finding of this study give the researcher chance to highlight the problem as a public in 
nature and help her to provide number of recommendations and suggestions to be as  a 
cornerstone in the prevention and control of hyperlipidemia. 
5.2.1 Study recommendations 
1- Increase the awareness about the importance of NCDs in Gaza strip and how to 
manage risk factors associated with NCDs 
2- Apply regular programs with experts to give advices about how to decrease of 
weight, BMI, and WC and to encourage sports and physical activity to all ages 
3- Encouragement of Healthy Diet programs in the Palestinian communities.  
4- Anti-smoking campaigns and support companies that give advices about the 
danger of smoking 
5- Encourage further research about Risk factors for NCDs in Gaza and support the 
research in all aspects 
6- Apply and support more advanced tests for detecting of hyperlipidemia like 
genetic tests 
7- Family history and lipid profile screening programs should be implemented in 
schools, universities, and at work places to determine high-risk group. 
8- Treatment of potential abnormalities of lipid and lipoprotein supported by 
community-wide lipid profile awareness and education campaign 
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5.2.2 Future research recommendations 
 Large better-funded research should be carried out to verify the finding of this 
study should consider the inclusion of weekend sampling. 
 Further research should be conducted as community-based study with larger sample 
to estimate the prevalence of hyperlipidemia and dyslipidemia in the Palestinian 
society.  
 More studies must be conducted to assess the tobacco control and the relation 
between smoking and the non-communicable diseases in Palestine  
 Further studies must be conducted to estimate the familial hyperlipidemia among 
the Palestinian community. 
 Large study must be conducted in the future to assess the effect of stress, on lipid 
profile. 
 More interventional studies must be conducted to reduce the prevalence of 
hyperlipidemia. 
 Large research must be carried out among large sample to assess the awareness of 
the risk factors of non-communicable disease.  
 More research is needed to study the relationship between the consumptions of 
calorically sweetened beverages and weight gain. 
 More research is needed to study the effect of olives oil consumptions on the lipid 
profile among Palestinian population. 
 Further research to estimate the prevalence of hypothyroidism among 
hyperlipidemic  patients.  
 Large study must be done to estimate hyperlipidemia among children in the 
Palestinian schools.  
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7 Annexes 
Annex (1): Palestine map 
 
http://www.tahrirnews.com/posts/446833/12/11/2016 
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Annex (2): Gaza Strip map 
 
http://www.wafainfo.ps/picts/GazaStrip 
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Annex (3): Sample size calculation 
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Annex (4): Questionnaire 
 
Interview Questionnaire 
(English version) 
 
 
 
Prevalence and Determinants of Hyperlipidemia Among 
Blood Donors Gaza Governorates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hospital Name: …………………………………...……………………………. 
Date of Interview: ……………………………………...………………………. 
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Reference No. 
               
Section 1: Socio demographic characteristics  
1- Tel. / Mobile No: …………………..(Optional) 
2- Place of residence:  □ North □ Gaza  □ Mid Zone  □ Khan Younis  □ Rafah 
3- Gender:                  □ Male                        □ Female 
4- Age: ……………………………... 
5- Type of citizenship: □ Refugee           □ Non Refugee 
6- Marital status: □ Single □ Married □ Divorced □ Widowed □ Separated 
7- Years of Educational ……………….(Years) 
8- Occupation: …………… 
9- Family members: ……... 
10- Income: ……………….. 
11- How many persons depend on this income?........................ 
 
Section 2: Medical history: 
A- Participants medical history 
1- Has your doctor ever told you that you had any of the following diseases? 
 Hypertension      □ Yes        □  No 
If yes, please describe the treatment………….. Since how many years……………... 
Heart disease   □ Yes          □  No  
If yes, please describe the treatment………….. Since how many years…………….. 
brain stroke     □ Yes        □ No 
If yes, please describe the treatment………….. Since how many years…………….. 
Diabetes Mellitus    □ Yes       □ No  
If yes, please describe the treatment……………. Since how many years…………….. 
Cancer    □ Yes          □ No  
If yes, please describe the treatment……………Since how many years…………….. 
 
GIT problems(gastritis, IBS, Stomach ulcers, food allergies or intolerance, colitis, crohns 
disease,…etc) 
    □ Yes        □ No  
If yes, specify……………describe the treatment………………… Since how many 
years…………… 
Liver disease        □ Yes            □ No  
If yes, please describe the treatment………………………….........Since how many 
years…………….. 
Renal disease       □ Yes            □ No  
If yes, please describe the treatment……………………………… Since how many 
years…………….. 
Hypothyroidism         □ Yes       □ No  
If yes, please describe the treatment……………………………… Since how many 
years…………….. 
Psychiatric diseases      □ Yes          □ No  
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If yes, please describe the treatment……………………………… Since how many 
years…………….. 
High Triglyceride        □ Yes            □ No  
If yes, please describe the treatment……………………………… Since how many 
years…………….. 
High Cholesterol           □ Yes            □ No  
If yes, please describe the treatment……………………………… Since how many 
years…………….. 
Cerebrovascular disease       □ Yes        □ No  
If yes, please describe the treatment……………………………….Since how many 
years…………….. 
Others diseases mention ………….. 
 Treatment…………… 
B- Family medical history: 
1- Did your parents have high cholesterol?                        □ Yes         □ No      □ Don‘know 
2- Did any of your siblings have high cholesterol?         □ Yes          □ No      □ Don‘know 
3- Did your parents have high triglyceride?                       □ Yes          □ No     □ Don‘tknow 
4- Did any of your siblings have high triglyceride?          □ Yes           □ No     □ Don‘tknow 
5- Did your parents have over weight or obesity?             □ Yes            □ No    □ Don‘t know 
6- Did any of your siblings have over weight or obesity? □Yes            □ No      □ Don‘t know 
7- Did your parents diagnosed for diabetes?                      □ Yes           □ No      □ Don‘t know 
8- Did any of your siblings diagnosed for diabetes?          □ Yes           □ No      □ Don‘t know 
9- Did your parents diagnosed for hypertension?               □ Yes           □ No      □ Don‘t know 
10- Did any of your siblings diagnosed for hypertension? □ Yes          □ No       □ Don‘t know 
11- Did your parents died from heart disease, heart attack, or stroke before age 60? 
    □ Yes     □ No       □ Don‘t know (DK) 
6- Did any of your siblings died from heart disease, heart attack, or stroke before age 60? 
    □ Yes      □ No      □ Dk 
7- Is there any other significant disease not mentioned? ………………… 
Section 3: Life style Information:  
A- Physical activity: 
Code Response (Part I) Activity at work 
P1 Yes 
No(If No 
skip to P4) 
1- Does your work involve 
vigorous-intensity activity thatcauses large increases in 
breathing orheart rate like for at least 10 minutes 
continuously? Ex:[carrying heavyloads, digging or construction 
work] 
P2 
 
No. of 
days:.......... 
2- In a typical week, on how many 
days do you do vigorous intensity 
activities as part of your work? 
P3 Hrs : Min 
........:......... 
3- How much time do you spend 
doing vigorous-intensity activities at 
work on a typical day? 
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P4 Yes 
No     (If No 
skip to P7) 
4- Does your work involve 
moderate-intensity activity that 
causes small increases in breathing or heart rate such as brisk 
walking [or carrying light loads] for at least 10 minutes 
continuously? 
P5 No. of 
days:.......... 
5- In a typical week, on how many 
days do you do moderate intensity 
activities as part of your work? 
P6 Hrs : Min 
........:......... 
6- How much time do you spend 
doing moderate-intensity activities at 
work on a typical day? 
Code Response (Part II) Travel to and from places 
P7 YesNo(If No 
skip to P10) 
1- Do you walk or use a bicycle for at least 10 minutes 
continuously to get to and from places? 
P8 No. of days:.......... 2- In a typical week, on how many days do you walk or bicycle 
for at least 10 minutes continuously to get to and from places? 
P9 Hrs : Min........:......... 3- How much time do you spend walking or bicycling for 
travel on atypical day? 
Code Response (Part III) Recreational activities 
P10 Yes 
No(If No 
skip to P13) 
1- Do you do any vigorous intensity sports, fitness, or 
recreational (leisure) activities that cause large increases in 
breathing or heart rate like [running or football,] for at least 10 
minutes continuously? 
P11 No. of days: ........ 2- In a typical week, on how many days do you do vigorous 
intensity sports, fitness or recreational (leisure) activities? 
P12 Hrs : Min ........:......... 3- How much time do you spend 
doing vigorous-intensity sports fitness or recreational activities 
on a typical day? 
P13 Yes 
No 
(If No Stop 
questions) 
4- Do you do any moderate intensity sports, fitness or 
recreational (leisure) activities that cause a small increase in 
breathing or heart rate such as brisk walking, (cycling, 
swimming, and volleyball) for at least 10 minutes 
continuously? 
P14 No. of days: .......... 5- In a typical week, on how many 
days do you do moderate-intensity 
sports, fitness or recreational (leisure) activities? 
B-  Smoking: 
1- At the present time, are you smoker?                    □Yes        □ No 
If yes how many cigarette?.................. 
2- Have you ever smoked?                                       □ Yes        □ No 
3 - How long have you been quit smoking?              (..................years) 
4- How much did you smoke before stop smoking? (.......... Cigarettes) 
5- Currently, are you exposed to smoke? (passive)   □ Yes        □ No 
6- Other types of smoking………………………. 
C-Nutritional information 
(Part I)Dietary Intake 
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Food Frequency Questionnaire for Adolescents 
How often do you eat the following foods? (Put an ―X‖ on the line.) 
   
Never 
 
Seldom 
2-3 
times/week 
 
 
Once/day 
More than 
once/day 
 
 
 
 
 
       Milk  Fruits 
       Cheese, yogurt  Vegetables/salad 
       Ice cream  Milk products 
       Meat, fish, poultry  Meat 
       Eggs  Fish 
       Peanut butter, nuts  Chicken 
       Dry beans, peas, tofu, soy  Lentil/beans 
       Citrus fruits, juice (i.e., orange, 
grapefruit, tomato) 
 Nuts 
       Dark green leafy or deep orange 
vegetables collards, broccoli, carrots, 
sweet potatoes 
 Canned fruit juice 
       Other fruits, vegetables, potatoes   
       Bread, cereals, rice, pasta   
       Sweets (cakes, donuts, pies, cookies, 
candy) 
  
       Salty snacks: potato chips, corn 
chips, tortilla chips, pretzels, etc. 
  
       Soda pop, Kool-Aid   
       Olives oil   
       Coffee, tea   
       Vitamins, herbs, other supplements   
       Fast food   
       Fried food   
 
(Part II)Dietary Habits 
1- Do you follow any special diet regimen? □ Yes □ No 
If the answer yes, specify.  □ Low fat      □ Low salt       □ Special diet for DM.     □ Special diet 
for weight loss      □others, specify 
…………………………………………………………………………….. 
2- Do you get breakfast daily?                              □ Always        □ Sometimes       □ Never 
3- Do you take three regular meals daily?            □ Yes               □ No 
4- I take my daily dietary meals outside home.    □ Always         □ Sometimes      □ Never 
5- Do you eat during watching TV?                     □ Always         □ Sometimes      □ Never 
6- Do you eat during using internet?                   □ Always           □ Sometimes     □ Never 
7- Do you consider your weight as?   □ Normal weight   □ Underweight   □ Overweight    □ Obese 
8- Did you take a multivitamin and/or mineral supplement?     □ Yes      □ No 
9- How many hours do you sleep 
daily…………………………………………………………………….. 
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Section 4: Biochemical tests 
 
Result 
 
Test 
 Total Cholesterol 
 Triglyceride 
 HDL 
 LDL 
 
Section 5: Anthropometric and physical measurements 
 
 
 
Mean Second measure 
First 
measure 
Parameter 
   Weight (kg) 
   Height (M) 
   Waist circumferences (cm) 
   Blood pressure  (mmHg) 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you 
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Annex (5): List of Experts 
 
No. Name Position 
1. Dr Bassam Abu Hamad Al - Quds University 
2. Dr Khitam Abu Hamad Al - Quds University 
3. Dr Mohammed Abu Hasheesh Al - Quds University 
4. Dr Ali Belbeesy MoH-European Gaza Hospital 
5. Dr Reema El Qishawi MoH-Al Rimal central lab. 
6. Dr Amaal Abu Jamea MoH-Al Shefa Hospital 
7. Dr Hatem Dabbakkeh Al - Quds University 
8. Dr Akram Abu Salah MoH 
9. MPH Yamin Geshta MoH 
10. Dr Salah El shami MoH-European Gaza Hospital 
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Annex (6): Hilsinki approval 
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Annex (7): Ministry of Health Approval  
 
 
Based on: Email between Human Resources Department and MoH Hospitals  
Date: 24/02/2016  
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 ومىرج مىافقت
 عزيزي المتبرع 
 .د٠ظ أثٛ -اٌمذط جبِؼخرخظض ػٍُ أٚثئخ ث -ثجشٔبِج اٌظحخ اٌؼبِخ خٍِزحماٌطبٌجخ /ػٛاؽف فب٠ض ػجذ اٌمبدس  أٔب
 
 ٌمذ رُ اخز١بسن ثشىً ػشٛائٟ ٌٍّشبسوخ فٟ ٘زٖ اٌذساعخ ٚاٌزٟ رٙذف إٌٝ ِؼشفخ ٔغجخ أزشبس ِٚحذداد اسرفبع اٌذْ٘ٛ 
عزغُٙ فٟ رحذ٠ذ أعجبة ِشىٍخ  ّزجشػ١ٓ ثٛحذاد اٌذَ فٟ ِغزشف١بد ِحبفظبد لطبع غضح ٚاٌزٟث١ٓ اٌ ٚاٌىٌٛغزشٚي
     .اسرفبع اٌذْ٘ٛ ٚرغبػذ فٟ ٚػغ اٌحٍٛي إٌّبعجخ ٌٙب
 ؽٛػٟ ٚ٠حك ٌه اٌمجٛي ٚاٌشفغ اٚ الأغحبة فٟ أٞ ٚلذ. شْ اشزشاوه فٟ ٘زا اٌجحاٌّزجشع: إ أخٟ 
اٌضلاص١خ ٚفحٛطبد  ٚ اٌذْ٘ٛ اٌىٌٛغزشٚياء فحٛطبد ِضً ِؼذي جشإعُ ٚعٛف ٠زُ  5ٕخ دَ حٛاٌٟ ػ١ ع١زُ 
عبػخ حزٝ  61 -21ج١ذ ٚ٠ٍضَ فٟ ٘زٖ اٌحبٌخ اٌظ١بَ ٌّذح اٌاٌج١ذ ٚغ١ش  اٌىٌٛغزشٚياٌزٟ رج١ٓ  LDL ,LDH
 .دل١مخج رىْٛ إٌزبئ
  .خز ل١بط اٌطٛي ٚاٌٛصْ ِٚح١ؾ اٌخظش ٚػغؾ اٌذَ١زُ أع 
رزؼٍك ثبٌج١بٔبد اٌشخظ١خ ٚٔظبَ عئٍخ أ ثٛاعطخ اٌجبحضخ رؼُ دل١مخ رمش٠جب 51ٌّذح  الاعزجبٔخ عٛف ٠زُ رؼجئخ 
 ... ٌٍّشبسو١ٓ فٟ اٌذساعخ.ٓوً ٚاٌش٠بػخ ٚاٌزذخ١الأ
  .ٔزبئج فحٛطبره فٟ أٞ ٚلذ رشبء اخز ره عزىْٛ عش٠خ ٚثئِىبٔهوً ث١بٔب 
 
 ٌزؼبٚٔىُ ٚشىشا  
 
 اٌجبحضخ/ ػٛاؽف ػجذ اٌمبدس
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Annex (9): Relation between Cholesterol groups and dietary intake 
 Cholesterol Groups N Mean SD P value 
Milk  
< 200 293 2.1775 .91556 
0.46 
≥ 200  86 2.0930 .95336 
Cheese, yogurt 
< 200 293 2.9829 .76506 
0.37 
≥ 200  
86 
 
3.0698 .83723 
Ice cream 
< 200 293 2.0887 .50237 
0.06 
≥ 200  86 1.9767 .48451 
Meat, fish, poultry 
< 200 293 2.9863 .43771 
0.81 
≥ 200  86 3.0000 .55307 
Eggs 
< 200 293 2.9898 .80871 
0.46 
≥ 200  86 2.9186 .70653 
Nuts 
< 200 293 2.6143 .76171 
0.26 
≥ 200  86 2.5116 .71528 
Beans 
< 200 293 2.5461 .67395 
0.12 
≥ 200  86 2.4186 .62243 
Juice 
< 200 293 2.9147 .81692 
0.12 
≥ 200  86 2.7791 .67565 
Vegetables 
< 200 293 3.2901 .73172 
0.29 
≥ 200  86 3.3837 .67158 
Fruits, vegetables 
< 200 293 3.0410 .78406 
0.43 
≥ 200  86 3.1163 .74231 
Bread 
< 200 293 4.9249 .31158 
0.13 
≥ 200  86 4.8605 .43825 
Sweets 
< 200 293 3.0853 .92319 
0.01 
≥ 200  86 2.8023 .89205 
Salty snacks 
< 200 293 2.3754 .85348 
0.02 
≥ 200  86 2.1279 .79404 
Soda pop, Kool-Aid 
< 200 293 2.7611 1.06191 
0.56 
≥ 200  86 2.6860 1.05453 
Olives oil 
< 200 293 3.3276 .88082 
0.68 
≥ 200  86 3.3721 .85470 
Coffee, tea 
< 200 293 4.5085 .88988 
0.65 
≥ 200  86 4.5581 .91529 
Vitamins, herbs 
< 200 293 1.1570 .65892 
0.53 
≥ 200  86 1.2093 .75329 
Fast food 
< 200 293 2.1672 .70421 
0.55 
≥ 200  86 2.1163 .65832 
Fried food 
< 200 293 2.8532 .78664 
0.02 
≥ 200  86 2.6279 .85470 
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Annex (10): Relation between Triglyceride groups and dietary intake 
 TG by groups N Mean Std. Deviation P value 
Milk  
< 150 223 2.1839 .89910 
0.52 
≥ 150  156 2.1218 .95946 
Cheese, yogurt 
< 150 223 2.9910 .77687 
0.73 
≥ 150  156 3.0192 .79084 
Ice cream 
< 150 223 2.0762 .50092 
0.55 
≥ 150  156 2.0449 .49959 
Meat, fish, poultry 
< 150 223 2.9507 .45746 
0.05 
 ≥ 150  156 3.0449 .47305 
Eggs 
< 150 223 2.9776 .81342 
0.91 
≥ 150  156 2.9679 .74850 
Nuts 
< 150 223 2.6143 .80212 
0.46 
≥ 150  156 2.5577 .67433 
Beans 
< 150 223 2.5471 .69508 
0.29 
≥ 150  156 2.4744 .61643 
Juice 
< 150 223 2.8565 .82584 
0.41 
≥ 150  156 2.9231 .73211 
Vegetables 
< 150 223 3.2780 .74363 
0.28 
≥ 150  156 3.3590 .68107 
Fruits, vegetables 
< 150 223 3.0135 .77390 
0.28 
≥ 150  156 3.1218 .77329 
Bread 
< 150 223 4.9148 .32453 
0.76 
≥ 150  156 4.9038 .37294 
Sweets 
< 150 223 2.9955 .90294 
0.52 
≥ 150  156 3.0577 .95201 
Salty snacks 
< 150 223 2.4036 .88449 
0.02 
≥ 150  156 2.1987 .77393 
Soda pop, Kool-Aid 
< 150 223 2.7040 1.05366 
0.38 
≥ 150  156 2.8013 1.06813 
Olives oil 
< 150 223 3.3139 .90052 
0.53 
≥ 150  156 3.3718 .83641 
Coffee, tea 
< 150 223 4.4753 .90945 
0.25 
≥ 150  156 4.5833 .87221 
Vitamins, herbs 
< 150 223 1.1435 .63462 
0.39 
≥ 150  156 1.2051 .74243 
Fast food 
< 150 223 2.1435 .62026 
0.69 
≥ 150  156 2.1731 .78833 
Fried food 
< 150 223 2.8386 .79466 
0.29 
≥ 150  156 2.7500 .82403 
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Annex (11): Relation between High-density lipoprotein groups and dietary intake 
 HDL by Groups N Mean Std. Deviation P value 
Milk  
< 40 45 1.9778 .96505 
0.16 
≥ 40 334 2.1826 .91674 
Cheese, yogurt 
< 40 45 2.9778 .83907 
0.82 
≥ 40  334 3.0060 .77496 
Ice cream 
< 40 45 1.9333 .44721 
0.04 
≥ 40  334 2.0808 .50468 
Meat, fish, poultry 
< 40 45 2.9778 .54309 
0.86 
≥ 40  334 2.9910 .45511 
Eggs 
< 40 45 2.7333 .65366 
0.03 
≥ 40  334 3.0060 .79787 
Nuts 
< 40 45 2.4000 .68755 
0.07 
≥ 40  334 2.6168 .75724 
Beans 
< 40 45 2.4222 .65674 
0.31 
≥ 40  334 2.5299 .66486 
Juice 
< 40 45 2.7333 .65366 
0.17 
≥ 40  334 2.9042 .80340 
Vegetables 
< 40 45 3.4667 .62523 
0.12 
≥ 40  334 3.2904 .72871 
Fruits, vegetables 
< 40 45 3.1111 .85870 
0.63 
≥ 40  334 3.0509 .76354 
Bread 
< 40 45 4.9111 .28780 
0.98 
≥ 40  334 4.9102 .35219 
Sweets 
< 40 45 2.6667 .92932 
0.01 
≥ 40  334 3.0689 .91273 
Salty snacks 
< 40 45 1.9333 .61791 
<0.01 
≥ 40  334 2.3713 .85944 
Soda pop, Kool-Aid 
< 40 45 2.7556 1.06931 
0.94 
≥ 40  334 2.7425 1.05957 
Olives oil 
< 40 45 3.3111 .99595 
0.85 
≥ 40  334 3.3413 .85791 
Coffee, tea 
< 40 45 4.4222 1.05505 
0.44 
≥ 40  334 4.5329 .87188 
Vitamins, herbs 
< 40 45 1.2444 .82999 
0.43 
≥ 40  334 1.1587 .65894 
Fast food 
< 40 45 2.0667 .65366 
0.36 
 ≥ 40  334 2.1677 .69880 
Fried food 
< 40 45 2.5778 .83907 
0.04 
≥ 40  334 2.8323 .79904 
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Annex (12): Relation between Low-density lipoprotein groups and dietary intake 
 LDL by Groups N Mean Std. Deviation P value 
Milk  
<130 313 2.1693 .92339 
0.64 
≥130 64 2.1094 .94478 
Cheese, yogurt 
<130 313 2.9872 .77614 
0.48 
≥130 64 3.0625 .81406 
Ice cream 
<130 313 2.0799 .50321 
0.17 
≥130 64 1.9844 .48770 
Meat, fish, poultry 
<130 313 3.0000 .44578 
0.40 
≥130 64 2.9375 .55990 
Eggs 
<130 313 2.9936 .79660 
0.34 
≥130 64 2.8906 .73716 
Nuts 
<130 313 2.5911 .75459 
0.98 
≥130 64 2.5938 .75000 
Beans 
<130 313 2.5431 .67384 
0.09 
≥130 64 2.3906 .60729 
Juice 
<130 313 2.9233 .80892 
0.03 
≥130 64 2.6875 .66368 
Vegetables 
<130 313 3.2971 .72361 
0.27 
≥130 64 3.4063 .68357 
Fruits, vegetables 
<130 313 3.0479 .77683 
0.57 
≥130 64 3.1094 .77903 
Bread 
<130 313 4.9201 .31523 
0.32 
≥130 64 4.8594 .46691 
Sweets 
<130 313 3.0639 .92460 
0.03 
≥130 64 2.7969 .89407 
Salty snacks 
<130 313 2.3227 .85186 
0.83 
≥130 64 2.2969 .82960 
Soda pop, Kool-Aid 
<130 313 2.7604 1.06070 
0.48 
≥130 64 2.6563 1.07229 
Olives oil 
<130 313 3.3355 .88030 
0.95 
≥130 64 3.3438 .85855 
Coffee, tea 
<130 313 4.5016 .90626 
0.45 
≥130 64 4.5938 .84925 
Vitamins, herbs 
<130 313 1.1789 .70252 
0.57 
≥130 64 1.1250 .57735 
Fast food 
<130 313 2.1534 .70402 
0.72 
≥130 64 2.1875 .63932 
Fried food 
<130 313 2.8339 .80734 
0.11 
≥130 64 2.6563 .80116 
 
  
 421
 
 وسبت ومحذداث ارتفاع الذهىن لذي المتبرعيه بالذم في محافظاث قطاع غزة
 
 
 ف فب٠ض ػجذ اٌمبدسػٛاؽ إعذاد:
 د. ٠ح١ٝ ػبثذ إشراف:
 ملخص:
 مقذمت:
ٚاٌذْ٘ٛ اٌضلاص١خ /أٚ اٚي ٌغزشاٌذٕ٘١بد ِضً اٌىٛ أٔٛاعأٚ جّ١غ  أحذاٌذْ٘ٛ حبٌخ ؽج١خ رزّ١ض ثبسرفبع اسرفبع  ٠ؼزجش
خطش الإطبثخ ٌ الإٔغبْ٠ؼشع طحخ  الأػّبسؼشع ٌٍذْ٘ٛ فٟ جّ١غ ، ٚاٌزLDHٚ  LDL اٌجشٚر١ٓ اٌذٕٟ٘ فٟ اٌذَ
رؼزجش ِٓ  ح١شأِشاع اٌمٍت ٚالأٚػ١خ اٌذِٛ٠خ ٚاٌغشؽبْ ٚاٌغىشٞ، ٚاسرفبع ػغؾ اٌذَ ٚالأِشاع الأخشٜ، ث
 الأعجبة اٌشئ١غ١خ ٌلإطبثخ ثبلأِشاع ٚاٌٛف١بد فٟ اٌؼبٌُ.
 
 الهذف مه الذراست:
 ث١ٓ اٌّزجشػ١ٓ ثبٌذَ فٟ ِحبفظبد لطبع غضح اسرفبع اٌذْ٘ٛ ِٚؼذي ٔغجخرحذ٠ذ  
 اسرفبع اٌذْ٘ٛ ٚ اٌؼٛاًِ الاجزّبػ١خ ٚاٌذ٠ّٛغشاف١خِؼشفخ اٌؼلالخ ث١ٓ  
 اٌغّٕخ ِؤششاد  دساعخ اٌؼلالخ ث١ٓ اسرفبع اٌذْ٘ٛ ٚ 
 ل١بط ػلالخ اسرفبع اٌذْ٘ٛ ِغ اٌزبس٠خ اٌطجٟ ٌٍؼبئٍخ 
 رحذ٠ذ ػلالخ اسرفبع اٌذْ٘ٛ ثبلأِشاع 
 ٌجذٟٔ، ٚ اٌزغز٠خدساعخ اٌؼلالخ ث١ٓ اسرفبع اٌذْ٘ٛ ّٚٔؾ اٌح١بح اٌزٞ ٠ؼُ اٌزذخ١ٓ ، إٌشبؽ ا 
 
 وىع الذراست: 
 .عٕخ 03 إٌٝ 02ِٓ ػّش  973 ٚوبْ ػذدُ٘ دساعخ ِمطؼ١خ أجش٠ذ ث١ٓ اٌّزجشػ١ٓ ثبٌذَ اٌزوٛس
  
 جّغ اٌج١بٔبد:
ثبٌّؼٍِٛبد الاعزجبٔخ رزؼٍك  ،ٌىً ِشبسن بثٕفغٙ اٌجبحضخ إػذادِٓ  اعزجبٔٗ رؼجئخ جّغ اٌج١بٔبد ِٓ خلايلبَ اٌجبحش ث
. ِضً اٌؼّش ِٚىبْ الإلبِخ ٚاٌحبٌخ الاجزّبػ١خ ِٚغزٜٛ اٌذخً ٚاٌزؼٍ١ُ ٚػذد أفشاد الأعشح خغشاف١ّٛالاجزّبػ١خ ٚاٌذ٠
ٌذٜ ا٢ثبء  أِشاعاٌظحٟ ِٓ ح١ش ٚجٛد  ربس٠خ الأعشح ٌٍّشزشن ٚ اٌزبس٠خ اٌطجٟٚرؼّٕذ الاعزجبٔخ أعئٍخ ػٓ 
 اٌّزٕبٚيإٌشبؽ اٌجذٟٔ، ٚاٌزذخ١ٓ ٍٚخ ػٓ ٚالإخٛح ٚ الأخٛاد.ٚلذ رُ عؤاي اٌّشزشن ػٓ ّٔؾ اٌح١بح ٚاٌزٞ ٠ؼُ أعئ
 اٌغزائٟ، ٚػبداد إٌظبَ اٌغزائٟ.
فٟ  شو١ٓزاٌخظش ٚػغؾ اٌذَ. ٚػلاٚح ػٍٝ رٌه رُ جّغ ػ١ٕبد دَ ِٓ اٌّشِح١ؾ  اٌٛصْ ٚاٌطٛي ٚ ل١بعبد رُ أخز 
 ٌج١ذ ٚغ١ش اٌج١ذ.ا اٌىٌٛغزشٚيٚاٌذْ٘ٛ اٌضلاص١خ ٚ  اٌىٌٛغزشٚيفحٛطبد  ٌم١بطعبػخ  61 – 21ثؼذ ط١بَ  اٌذساعخ
ػٍٝ ػ١ٕخ اعزطلاػ١خ لجً اٌجذء  الاعزجبٔخرطج١ك  إٌٟ ثبلإػبفخِٓ لجً ِحىّ١ٓ  الأداحٚلذ رُ فحض طذق ٚصجبد 
 اٌجحض١خ وبٌحظٛي ػٍٝ ِٛافمخ ٌجٕخ ٍ٘غٕىٟ ٚاٌّشبسوخ اٌطٛػ١خ. الأخلال١خثبٌّؼب٠١ش  اٌجبحضخثبٌجحش. وّب اٌزضِذ 
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 تحليل البياواث:
 لاخزجبس اٌؼلالخ ث١ٓ اٌّزغ١شاد فحٛطبدٌّؼبٌجخ اٌج١بٔبد إحظبئ١ب ٚرُ اعزخذاَ  SSPSِج الإحظبئٟ رُ اعزخذاَ اٌجشٔب
 :ٟٚ٘
 "noitalerroc dna tset-t tnednepedni ,erauqs-ihC,eulav-P"
 
 الىتائج:
ٌه وز %)، ٚ7.22(فٟ اٌذَ ث١ٓ اٌّشزشو١ٓ فٟ اٌذساعخ وبٔذ    اٌىٌٛغزشٚي ٔغجخ اسرفبعأظٙشد إٌزبئج أْ  
%) 9.11ٚأظٙشد إٌزبئج أْ ٔغجخ أخفبع اٌىٌٛغزشٚي اٌج١ذ ( %).2.14اٌذْ٘ٛ اٌضلاص١خ (ٔغجخ اسرفبع 
 %).71(  LDL ث١ّٕب وبٔذ ٔغجخ اٌىٌٛغزشٚي اٌغ١ش ج١ذ
 
ٚاٌحبٌخ  اٌؼّشص٠بدح  ِغ ِزٕبعجب LDHٚأخفبع  LDLٚاٌذْ٘ٛ اٌضلاص١خ ٚ  اسرفبع اٌىٌٛغزشٚيوبْ  
اصداد ػٕذ وجبس اٌغٓ ٚاٌّزضٚج١ٓ ِمبسٔخ ثّؼذلاد LDL dna ,GT ,CT ي الاجزّبػ١خ ، ح١ش اْ ِؼذ
 .اٌزٟ أخفؼذ ٌذٜ اٌفئخ اٌؼّش٠خ الأوجش ٚ ٌذٜ اٌّزضٚج١ٓ  LDH
 
ٚاٌزبس٠خ اٌّشػٟ ٌؼبئلاد  aimedipilrepyHأظٙشد ٔزبئج اٌذساعخ أْ ٕ٘بن ػلالخ لٛ٠خ جذا ث١ٓ  
ْٛ وبٔذ ِشرجطخ ثبٌغّٕخ ِٚشع اسرفبع اٌغىش ٚػغؾ اٌّشزشو١ٓ فٟ اٌذساعخ ح١ش أْ ِؼذلاد اسرفبع اٌذ٘
 اٌذَ ٌذٜ ػبئلاد اٌّشزشو١ٓ. 
 
% 4.53% ، 4.63ل١بط اٌغّٕخ ث١ٓ اٌّشزشو١ٓ فٟ اٌذساعخ وبٔذ  ِغزٜٛ أْ ِؼذلادٔزبئج اٌذساعخ  أظٙشد 
ٛ٠خ جذا ػٍٝ اٌزٛاٌٟ ، وّب أٗ رج١ٓ ٚجٛد ػلالخ ل % ٌذٜ اٌٛصْ اٌطج١ؼٟ ، اٌٛصْ اٌضائذ ٚ اٌغّٕخ2.82ٚ 
 IMB.ٚ ِؼذي ل١بط اٌغّٕخ  LDL ,LDH ,GT ,CTفحٛطبد ث١ٓ ِغزٛ٠بد 
 
ح١ش  CWٚ ِغزٜٛ ِح١ؾ اٌخظش  aimedipilrepyHا٠ؼب وبْ ٕ٘بن اسرجبؽب لٛ٠ب ث١ٓ اسرفبع اٌذْ٘ٛ  
 ).)mc49 ≥اٌّشرفغ  CWاصدادد ٔغجخ اٌذْ٘ٛ ٌذٞ اٌّشزشو١ٓ اٌز٠ٓ ٠زجؼْٛ ِغزٜٛ 
 
% ث١ّٕب وبٔذ ٔغجخ اٌز٠ٓ ٠زؼشػْٛ 3.42اٌّذخٕ١ٓ ث١ٓ اٌّشزشو١ٓ وبٔذ  اظٙشد ٔزبئج اٌذساعخ اْ ٔغجخ 
ث١ٓ ِؼذلاد  إحظبئ١خوبْ ٕ٘بن ػلالخ رٚ دلاٌخ  %.5.82% ٚرج١ٓ اْ ٔغجخ اٌّمٍؼ١ٓ ػٓ اٌزذخ١ٓ 09ٌٍزذخ١ٓ 
 مب ٌٚىٕٙب ٌُ رىٓ وزٌه ِغ اٌّذخٕ١ٓ اٌحبٌ١١ٓ.ٚ ث١ٓ اٌّشزشو١ٓ اٌّذخٕ١ٓ عبث LDH ,GT ,CT
 
% ِٚزٛعؾ ثٕغجخ 8.82رظٕ١ف اٌّشزشو١ٓ فٟ اٌذساعخ حغت إٌشبؽ اٌجذٟٔ ِٕخفغ ثٕغجخ  وبٔذ ٔزبئج 
وبٔذ ِٕخفؼخ LDL ٚاٌىٌٛغزشٚي  اسرفبع ٔغجخ أْاٌذساعخ  أظٙشد%.ٌٚمذ 8.9% ِٚشرفغ ثٕغجخ 4.16
 ٌذٜ اٌّشزشو١ٓ رٚ إٌشبؽ اٌجذٟٔ اٌّشرفغ.
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اٌحٍٜٛ ٚاٌٛججبد اٌخف١فخ  ْٛ٠غزٍٙى ٓشو١ٓ اٌز٠زأخفبع اٌىٌٛغزشٚي اٌج١ذ ػٕذ اٌّشاظٙشد ٔزبئج اٌذساعخ  
زٕبٌٚٛا اٌٛججبد ٠اٌّبٌحخ، ٚاٌطؼبَ اٌّمٍٟ ، فٟ ح١ٓ أْ ِغزٜٛ اٌذْ٘ٛ اٌضلاص١خ اسرفغ ث١ٓ الأشخبص اٌز٠ٓ 
 .اٌؼظ١ش ٌذٜ اٌّششو١ٓ اٌز٠ٓ رٕبٌٚٛاِغزٜٛ اٌىٌٛغزشٚي أخفغ ٚ .اٌخف١فخ اٌّبٌحخ ٚاٌٍحَٛ
 
غ١ش لبثٍخ اٌثؼٛاًِ اٌخطش  بِشرجط وبْشٚي.ٌغزالأزشبس اٌّشرفغ ٌٍذْ٘ٛ ٚ اٌىٛ أْ ٘زٖ اٌذساعخ وشفذالاستىتاج: 
ِٓ اٌّزغ١شاد اٌمبثٍخ ٌٍزؼذ٠ً وبٌغّٕخ ٚلٍخ  أخشٜ ، ٚربس٠خ الأعشح ِٚجّٛػخاٌضٚج١خاٌؼّش ٚاٌحبٌخ  ٟٚ٘ ٌٍزؼذ٠ً
 اٌزٟ رمًٍ ِٓٚ اٌمبثٍخ ٌٍزؼذ٠ً  خً ٌٍغ١طشح ػٍٝ ػٛاًِ اٌخطشاٌزذشجغ ػٍٝ ػشٚسح ٠ ِّب،  إٌشبؽ اٌجذٟٔ، ٚاٌزذخ١ٓ
 .اٌّشرجطخ ثٙب ٚالأِشاعاٌٛف١بد  ِؼذلاد رمٍ١ً ثبٌزبٌٌٟذْ٘ٛ اخطش 
 التىصياث:
 ص٠بدح اٌٛػٟ ثبلأِشاع اٌغ١ش ِؼذ٠خ ٚاٌؼٛاًِ اٌّشرجطخ ثٙب 
، لإػطبء إٌظبئح حٛي و١ف١خ إٔمبص اٌٛصْ، ِؤشش وزٍخ اٌجغُ ٚالاعزؼبٔخ ثبٌخجشاء إٌّزظّخرطج١ك اٌجشاِج  
 الأػّبسٚرشج١غ اٌش٠بػخ ٚإٌشبؽ اٌجذٟٔ ٌجّ١غ  ِح١ؾ اٌخظش
 فٟ اٌّجزّؼبد اٌفٍغط١ٕ١خ رٕظُ  ثشاِج ِٓ خلاي اٌزشج١غ ػٍٝ "ارجبع ٔظبَ غزائٟ طحٟ" 
 اٌزٟ رؼطٟ ٔظبئح حٛي خطش اٌزذخ١ٓ اٌّؤعغبدٚدػُ  اٌخبطخ اٌحّلاد ِٓ خلايِىبفحخ اٌزذخ١ٓ  
فٟ لطبع غضح، ٚدػُ  ٟ رزغجت فٟ حذٚس الأِشاع اٌغ١ش ِؼذ٠خاٌزشج١غ إجشاء اٌّض٠ذ ِٓ اٌجحٛس حٛي ر 
 اٌجحٛس فٟ جّ١غ جٛأت
 اٌج١ٕ١خ اٌفحٛطبداٌذْ٘ٛ ِضً ػٓ ىشف ٍأوضش رطٛسا ٌ فحٛطبد رٛف١ش ٚرطج١ك 
 
 
